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PREFACE 
 
This PhD thesis was focused on the production and characterization of 
encapsulation systems for cell therapy and tissue engineering applications. 
The structure of the work is organized in four main chapters: (i) the general 
characteristics of hydrogel based devices for cell encapsulation, (ii) the 
description of the experimental encapsulation procedures for microcapsular 
devices for the embedding of different cell types, (iii) the design of new 
strategies for engineered and or fibrous scaffolds and finally (iv) the main 
conclusion gathered by the entire experimental results of the research 
project.  
In detail, chapter 1 presents an overview of commonly applied biomaterials, 
as well as the characteristics of optimal encapsulation systems for in vivo 
application. In particular hydrogels performances are discussed analysing 
advantages and disadvantages for cell therapy applications. Chapter 2 and 3 
are devoted to the description of different fabrication techniques to process 
hydrogels containing different cell types into scaffolds.  
Each chapter refers to one or more journal articles dealing with the 
experiments performed to produce the encapsulation devices. Particularly, 
chapter 2 is related to papers on various procedures for microcapsule 
production, while chapter 3 is relative to contributions about new scaffolds in 
form of engineered microcapsules or multifunctional microfibres. 
 
The scientific work presented in the current PhD thesis program has 
beneficed of the skilled collaboration of researchers and scientific Institutions: 
 
1. Prof. S.F. Badylak, MacGowan Institue for Regenerative Medicine, 
University of Pittsburgh, Pittsburgh, PA, USA 
2. Prof. X. Zhang, Engineering and the Environment, University of 
Southampton, Southampton, UK 
3. Biomaterials Group, King‟s College, London, UK 
4. Prof. C. Nastruzzi, Dipartimento di Scienze farmaceutiche, Università degli 
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Studi di Ferrara, Ferrara, Italy 
5. Prof. R. Piva, Dipartimento di Biochimica e Biologia Molecolare, Università 
di Ferrara, Ferrara, Italy 
6. Prof. E. Becchetti, Dr. G. Luca, Dr. M. Calvitti, Dr. F. Mancuso, 
Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università 
degli Studi di Perugia, Perugia, Italy. 
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CHAPTER 1 
 
Bioencapsulation for cell therapy: 
general considerations 
 
1.1. Introduction 
 
Millions of surgical procedures are performed each year to replace or 
reconstruct damaged tissue resulting from chronic/degenerative diseases, 
injury, congenital malformations and cancer. Unfortunately, there is a wide 
gap between the demand for organs and replacement tissue and patients 
actually receiving transplants. The cellular therapy and tissue engineering 
based protocols offer a potential solution to the shortage of organ donors and 
the problems relating with the repair of damaged tissues (i.e. risk of graft 
failure) [1]. Cellular therapy is indeed a novel technology based on the use of 
cells to treat a wide range of human diseases by replacing damaged cells or 
tissues. 
These approaches are based on the administration/transplant of living cells 
to specific body sites, where cells can exert therapeutic effects through: (a) 
the repair/replacement of damaged tissue/organs or (b) the 
production/release of specific bioactive molecules (e.g. enzymes, growth 
factors and antibodies) [2].  
Recently, cells have been increasingly exploited as alternative controlled 
drug delivery vehicles. Cells can indeed act as drug depots enabling the 
delivery of “de novo” produced therapeutic products with site specificity over 
an extended time period, providing the possibility to treat various diseases 
that cannot be cured with currently available therapeutic protocols [3]. 
In this respect, different cell types (primary, stem and bioengineered cells) 
have been considered as potential therapeutic tools and tested in preclinical 
and clinical studies for the treatment of many pathologies, such as diabetes, 
anemia, hemophilia, bone defects and cancer [4-6].  
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For instance, biomolecules secreted by cells may be delivered continuously 
such as an angiogenesis inhibitor to a tumor [7], or in response to a 
physiologic signal, such as insulin to glucose for the treatment of diabetes 
[8]. Erythropoietin cell production in response to oxygen delivery can found 
application for the treatment of anemia [9]. A selected protein may also be 
expressed and produced by the cell implant after genetic modification, such 
as the coagulation factors VIII and IX for the treatment of hemophilia A and 
B. Moreover, stem cells can secrete a diverse array of growth factors, 
including vascular endothelial growth factor (VEGF) and nerve growth factor, 
which are used to treat ischemia and neuronal damage, respectively [10,11]. 
 
Over the years, two conceptually different strategies to deliver cells into 
diseased tissue have been developed: the first approach consists of the 
injection of free autologous, allogenic or xenogenic cells, the second one is 
based on cells seeded or embedded in scaffold; notably, the latter approach 
finds applications both in vitro (basic and applied research) and in vivo 
(reconstructive medicine) [12]. 
Unfortunately, the use of free cells, in spite of the superior handling, holds 
the major drawback to elicit the host immune rejection. Furthermore, 
transplanted cells not protected from external mechanical loadings or not 
surrounded by the proper microenvironment may rapidly lose their viability 
and functionality. Therefore, an increasing number of natural and synthetic 
structures have been developed as potential immunoisolating scaffold for cell 
embedding [13]. 
Cell immunoisolation into scaffolds represents the major advance in cell 
based therapy since it avoids constraints associated with cell sources, 
making allogenic and xenogenic cells a good alternative to the limited 
autologous donors. 
 
A cellular based therapy requires the combined use of suitable scaffolds and 
selected cell populations to create biocompatible devices that once 
transplanted, can immunoisolate the cells from the host's immune system, 
Stefania Mazzitelli Chapter 1 
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possibly eliminating or reducing the requirement for immunosuppressant 
systemic drug administration (Fig. 1). Non-specific suppression of the 
immune system may lead to a variety of unwanted complications in patients, 
including infections and failure of tumor surveillance [14]. 
A key role in preserving cell functions is played by the biomaterial used to 
produce the cellular scaffolds suitable for implanting cells into the host in 
order to regenerate a tissue or to obtain a long-term systemic delivery of 
biomolecules. 
 
Fig. 1. Schematic representation of a system for cell therapy protocols based on cells and 
biomaterials. 
 
Cells can be adequately combined with biomaterials following two main 
approaches. On the one hand, cells are isolated from the host‟s body by a 
microcapsular structure allowing exchange of nutrients; on the other one, 
cells can be seeded onto a preformed scaffold, that is generally implanted 
into the host after a given cultivation time.  
The concept of cell immunoisolation was initially described by Chang in 
1960s and since then, various biomaterials have been proposed to embed 
cells in immunoisolating microenvironments, manly in form of microcapsules, 
creating a semi-permeable membrane/barriers that control the outward and 
inward diffusion of gases (oxygen and carbon dioxide), metabolic and 
therapeutic molecules.  
Stefania Mazzitelli Chapter 1 
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Irrespectively of the strategy employed, the success of any bioencapsulation 
approach is mostly related to the properties of the biomaterial, that should be 
biocompatible, easy to sterilize and biodegradable over an appropriate length 
of time into products metabolized or excreted by the recipient without 
inducing adverse inflammatory responses.  
Ideally, the selected biomaterials should be reproducibly processed into a 
desired shape and structure (i.e. spherical or tubular configurations), 
maintained even after the in vivo implantation. 
Moreover, an immunoisolation biomaterial must provide a structured 
protective environment with tissue-specific mechanical properties and porous 
niche for cells capable of delivering potentially therapeutic factors. 
Finally, the biomaterial should offer an appropriate regulation of cell 
behaviour including adhesion, proliferation, migration and differentiation. 
When in vivo implanted, the biomaterials must provide temporary mechanical 
support sufficient to withstand forces exerted by the surrounding tissue.  
 
It is important to underline that the different, and in a certain sense opposite 
biomaterial characteristics, are provided by a very limited number of 
materials. In this respect, hydrogel forming biomaterials occupy a prominent 
position, thanks to their special physical properties and feasibility for cell 
encapsulation procedures. Hydrogels provide a highly controlled, synthetic 
3D environment that is structurally and biomechanically similar to native 
extracellular matrix (ECM) topology and provides a rich ligand landscape to 
influence cell behaviour [15]. 
 
1.2. Hydrogels 
 
Hydrogels represent an important class of biomaterials for biotechnology and 
biomedical applications, since they exhibit excellent biocompatibility with 
minimal inflammatory responses and tissue damage. By definition, the 
hydrogel structure is constituted of a polymeric network with three-
dimensional conﬁguration capable of imbibing high amounts of water or 
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biological ﬂuids. The high water afﬁnity is attributed to the presence of 
hydrophilic groups such as –OH, –CONH2– and –SO3H, in the polymers 
forming hydrogels, that create a hydrated network with different degrees 
(sometimes, more than 90% of water by weight), depending on the nature of 
the aqueous environment and the polymer chemical composition. The 
polymeric network is usually cross-linked by different modalities, including 
covalent bonds, hydrogen binding, van der Waals interactions, or physical 
entanglements. Hydrogels are extremely suitable for a variety of applications 
in the pharmaceutical and medical industry since they hold a number of 
appealing features [16]. Thanks to the presence of large amounts of water, 
hydrogels resemble certain native tissues; their framework presents a 
defined pore size allowing the diffusion of water/metabolites and exchange of 
nutrients/wastes, but strictly avoiding the overall migration or leakage of 
individual cells. Moreover, hydrogels can be easily fabricated into different 
shapes and sizes, from nano-scale particles to centimetre long sheets. In 
conclusion, the embedding of cells on hydrogels is very suitable for in situ 
cell delivery and cell therapy as demonstrated by numerous articles having 
as topic the regeneration of cartilage, cornea, nerve and liver [17]. 
Classification of hydrogels can be made according to various criteria 
including: the material used for their preparation, the preparation method, the 
overall charge and the mechanical characteristics.  
With respect to materials, hydrogels can be obtained by natural or synthetic 
polymers. To the first class belongs polysaccharides (e.g. agarose, alginate) 
and proteins (e.g. collagen and gelatin); to the other one poly(ethylene 
glycol) (PEG), poly(vinyl alcohol) (PVA), poly-lactic-co-glycolic acid (PLGA) 
and poly (hydroxylethyl methacrylate) (PHEMA) [18]. 
Concerns regarding synthetic polymers inducing non-physiologic cellular 
responses have caused a shift of interest to using more natural materials, 
such as stand-alone products, chemically derived, physically derived, or 
extracellular matrix-derived materials. 
The advantage of employing some natural biomaterials, such as collagen, 
fibrin, hyaluronan (HA), gelatin is their ability to mimic certain features of 
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native extracellular matrix (especially those of ECM origin), facilitating cell 
adherence, migration, differentiation. Cells indeed in the body are exposed to 
a complex milieu regulated by their interactions with other cells, the 
surrounding cell matrix and soluble factors. A key element of this 
microenvironment is the three dimensional (3D) architecture of the 
extracellular matrix. By removing the cells from this microenvironment many 
cell types quickly loose their function. Therefore, the ability to resemble the in 
vivo microenvironment of cells outside the body could be a potentially 
powerful tool. 
In table 1 and in the following sections are briefly described some example of 
natural polymer usually employed for the preparation of hydrogels that have 
found a large number of applications in cell based protocols. 
 
Table 1. Natural biomaterials used for cell based therapy and tissue engineering 
applications. 
Biomaterials Source 
Chemical 
composition 
Gelation 
method 
Mechanism of 
degradation 
Collagen animal/human protein neutralization Enzymatic 
Gelatin animal/human protein thermal Enzymatic 
Hyaluronan animal/human protein 
chemical 
crosslinking 
Enzymatic 
Agarose seaweed polysaccharide thermal Non-degradable 
Alginate seaweed polysaccharide 
inotropic cross-
linking 
Ion exchange 
 
1.2.1. Collagen 
Collagen is the major structural component of mammalian connective tissue 
and has been used in cell immobilization due to its biocompatibility, 
biodegradability, abundance in nature and the ability to bind cells. The main 
sources of collagen are generally represented by cartilage, tendon, skin, 
bone, cartilage and ligament, where it is present in high concentrations. 
Collagen can be readily processed into different shaped scaffold including 
porous sponges, fibres, films, membranes and injectable cell immobilization 
carriers, since the gelation process occurs without chemicals modifications 
[19]. However, to improve the mechanical properties of scaffolded gels 
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different methods have been proposed such as crosslinking by chemicals, 
UV, temperature or polymeric agents. Collagen plays an important in 
regulating essential cellular events, such as proliferation, migration and 
differentiation via cell–matrix interaction and via integrin binding. Its natural 
ability to bind cells makes it a promising material for controlling cellular 
distribution within immunoisolated systems and its enzymatic degradation 
can provide appropriate degradation kinetics for tissue regeneration in 
microporous scaffolds. Moreover, collagen contains cell-adhesion domain 
sequences (e.g. RGD) that exhibit specific cellular interactions that can help 
to retain the phenotype and activity of many types of cells, including 
fibroblasts and chondrocytes. 
Collagen has been extensively used to produce scaffold for many 
biomedical/regenerative applications, nevertheless it still has some 
constrains mainly related to the presence of antigenic components 
associated to the collagen molecules that can evoke host immunoreactions 
[20]. 
 
1.2.2. Gelatin 
Gelatin is a naturally derived protein from collagen via a partial hydrolysis of 
the native collagen. During the manufacturing of gelatin, raw animal material 
is treated with dilute acid or alkali, resulting in partial cleavage of the 
crosslinks. Moreover, gelatin is a product of the meat-processing industry 
and it is a readily and economically available material, which has been used 
for decades in the food and pharmaceutical industries [21]. At a temperature 
of about 40°C, gelatin aqueous solutions are in the sol state and form 
physical thermoreversible gels after cooling. During the gelation process, the 
chains undergo a conformational disorder-order transition and tend to 
recover the original collagen triple-helix structure. 
It is widely used for its non-toxicity, non-irritant and biodegradable properties 
and its mild gelling process that makes it is an attractive candidate as starting 
material for preparing hydrogels for drug delivery systems (i.e. hard and soft 
capsules, microspheres) and tissue engineering approaches (i.e. vascular 
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prostheses and wound dressing). As a biomaterial, gelatin displays several 
advantages: it is a natural polymer that has not shown antigenicity, it is 
completely resorbable in vivo and the presence of the large number of 
functional groups in the side chain offers the possibility to bind and release 
growth factors or incorporate proteins that can influence cell adhesion and 
growth in a controlled manner [22]. 
Compared to collagen, gelatin does not express antigenicity in physiological 
conditions, due to the denaturing process, and it is much cheaper and easier 
to obtain in concentrate solutions. Conversely, gelatin based hydrogels 
exhibits poor mechanical properties that can be overcame only via 
chemically cross-linking with various bifunctional agents, including 
glutaraldehyde or water-soluble carbodiimide that unfortunately reduce the 
initial high gelatin gel biocompatibility [23]. 
 
1.2.3. Hyaluronic acid 
Hyaluronic acid (HA) is a nonsulphated glycosaminoglycan, composed of 
alternating units of D-glucuronic acid and D-N-acetylglucosamine, linked 
together via alternating β-1,4 and β-1,3 glycosidic bonds. HA is one of the 
major components of the extracellular matrix of skin, cartilage and the 
vitreous humor. 
It plays a vital role in maintaining tissue integrity, as well as in facilitating 
adhesion and differentiation of cells during inﬂammation, wound repair, and 
embryonic development. Covalently cross-linked HA hydrogels can be 
formed by means of multiple chemical modifications. Hyaluronan is highly 
non- antigenic and non-immunogenic, owing to its high structural homology 
across species, and poor interaction with blood components [24]. 
A variety of commercially available preparations of HA derivatives and cross-
linked HA materials have been developed for the production of drug delivery 
systems (microspheres, liposomes, fibres) or hydrogel-based scaffolds. 
Application of HA as a cell delivery vehicle has been investigated for 
cartilage, bone and osteochondral regeneration. Although the main 
mechanism of HA is unknown, in vivo, in vitro and clinical studies have 
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demonstrated various physiological effects of exogenous including 
chondroprotective properties. 
Recently, HA has become recognized as an important building block for the 
creation of new biomaterials for use in cell therapy, three-dimensional (3-D) 
cell culture and tissue engineering applications. One of the key advantages 
of using HA gels for tissue engineering is that their degradation can be 
mediated by hyaluronidase, an enzyme secreted by a various cell types. On 
the other hand, the obtained HA based hydrogels are characterized by a 
weak mechanical strength resulting in scaffolds difficult to handle or to 
maintain the characteristics during the sterilization process. 
 
1.2.4. Agarose 
Agarose is a natural polysaccharide extracted from the cellular walls of 
agarophyte seaweed. Agarose gel is formed by cooling aqueous agarose 
solution, obtained by heating an aqueous suspension of agarose powder, 
until a clear solution forms. Since agarose gel networks are formed solely 
through hydrogen bonds without the use of chemicals, they are widely used 
in molecular biology and in immunoisolation protocols where it has been 
demonstrated they are well accepted following implantation [25]. The gelation 
mechanism is indeed governed completely by hydrogen bonding between 
agarose molecules and the resulting gel network is stabilized by structured 
water. In detail, agarose gels are formed when random coils, in a heated sol, 
become ordered as the sol cools. As cooling progresses, helices are formed 
which aggregate to form a gel network composed of thick bundles of agarose 
chains, large pores of water, exhibiting high turbidity and strong elasticity. 
Due to their soft tissue-like mechanical properties and biocompatibility, 
agarose gels have been investigated as potential scaffolds for neural [25] 
and cartilage tissue engineering [26]. The major drawbacks of agarose are 
the low cell adhesiveness and proliferation, since it does not contain any side 
groups to bind cell adhesive proteins. Moreover, due to the non-degradable 
nature of the gel, it has not been widely used in tissue engineering where 
usually scaffold materials should degrade over time in order to allow space 
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for accumulation of new tissue. With respect to application of agarose to cell 
capsulation procedures some important features should be considered. After 
melting, agarose can be easily transformed into a variety of controlled 
shapes, including microbeads, by simple and mild temperature reduction 
(usually below 30°C). In spite this advantageous characteristic, a possible 
drawback of agarose resides in the slow setting of gels, resulting in the 
possible cell protrusion from the capsular shell. 
 
1.2.5. Alginate 
Alginate is an example of a naturally derived polymer well suited for 
biomaterial scaffolds in cell-based therapy [27].  
Alginates are extracted from three species of brown Algae such as Laminaria 
hyperborean, Ascophyllum nodosum, Macrocystis pyrifera and generally sold 
as sodium salt. Alginate is a water-soluble linear polysaccharide and consists 
of a mixture of -D-mannuronic acid (M) and -L-guluronic acid (G) residues. 
The ratio of M to G blocks can vary significantly depending upon the source 
of the raw materials used in alginate manufacture. Due to the shape of the 
monomers and their various ways to link, the geometries of the G-block and 
M-block regions, are substantially different. In detail, G-blocks have a bucked 
shape while the M- block tends to be as an extended ribbon (see Fig. 2) 
 
Fig. 2. Chemical structure of alginate constituted of 2 guluronic acid (G) monomers and 2 
mannuronic acid (M) monomers, with (1–4) linkages. 
 
Two G-blocks aligned side by side, result in the formation of a hole with 
specific dimension able to bind selectively divalent ions in a cooperative 
fashion. On dissolution in an aqueous medium, alginate forms a hydrocolloid, 
which gels ionotropically following the addition of divalent cations, including 
Ca2+, Sr2+, or Ba2+ (Fig. 3). The most important property of alginate is 
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indeed this ability to form gels under extremely mild conditions without the 
use of chemicals or a particular pH. 
.  
Fig. 3. Mechanism of ionotropic gelation of alginate based polymer in the presence of 
divalent cations (M
2+
). 
 
The polymer cross-linking occurs following the exchange of sodium ions from 
the guluronic acids with the divalent cations resulting in a chain-chain 
association that constitutes the junction zones of the so-called “egg box 
model” (Fig.4). 
 
Fig. 4. The egg-box model after binding of divalent cations to homopolymeric G-blocks. 
 
The buckled chain of guluronic acid units is shown as a two-dimensional 
analogue of a corrugated egg-box with interstices in which the divalent ions 
may pack and be coordinated. Since hydrogel formation occurs following 
selectively linkage between the carboxylic moieties on the G blocks of 
alginate and cations, high ratio of G:M results in stiff gels. 
In general, as polysaccharide, alginates are characterized by a polydispersed 
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molecular weight and, for this reason, the molecular weight is not one unique 
value. 
Polymer molecular weight is important because it determines many physical 
properties. If molecular weight is too low, the mechanical properties will 
generally be too low for the polymer material to have any useful practical and 
commercial applications. 
If the Ni is the number and Wi is the weight of polymer molecules having a 
specific molecular weight Mi, the total number and weight of the polymer is 
 
 
The fraction is called the polydispersity index and it has been 
reported to be between 1.4 and 6.0 for alginates, relating to the various 
purification processes.  
The molecular weight distribution has a significant impact on some of the 
alginate gel properties including biocompatibility, stability, mechanical 
resistance, permeability, biodegradability and most important the gel 
formation [28]. 
Alginate is used extensively in food industry as a thickener, emulsifier and as 
a stabilizer. Furthermore, being an anionic polymer with carboxyl end groups, 
it has found application as pharmaceutical excipient to promote the 
mucoadhesive properties towards mucosal tissues. After the early study of 
Lim in 1980s, describing the use of alginate for cell microencapsulation, this 
polymer became the most widely used biomaterial for cell entrapment.  
Although the suitability of other natural and synthetic polymers is currently 
under investigation, none has reached the same level of performance as 
alginates. For their ability to form gels in very mild conditions, alginate cross-
linked with Ca2+ or Ba2+ ions has been used successfully to encapsulate cells 
maintaining a good viability and functions also during long-term culture [29]. 
Among biomaterials, alginate hydrogels are thought to be inert because they 
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lack native ligands that could allow interaction with mammalian cells, 
providing numerous advantages for tissue engineering including the 
possibility of minimally invasive injection of hydrogel/cell microcapsules. 
Alginate gels have a defined pore size and a narrow pore-size distribution; in 
addition, they are mechanical and chemical stabile and contain low amount 
of toxic, pyrogenic and immunogenic substances. 
Unfortunately, all the above features do not pertain at all the commercially 
available alginates; for biomedical procedures (i.e. cell encapsulation) only 
ultrapure alginates should be considered. 
Alginate has been extensively characterized in terms of purity, 
biocompatibility and in vivo performances. In fact, as a natural derived 
material, alginate may contain impurities such as are polyphenols, proteins 
and lipopolysaccharide (LPS) (endotoxin) that cause a reduction in its 
biocompatibility. Even commercially available ultrapure alginates have been 
found to contain residual contaminants that can limit their use for the 
production of microcapsule. Inflammatory responses due to impurities can 
influence the performance and function of the devices. For instance, NO, 
produced form macrophages stimulated by alginate contaminants, thanks to 
small molecular dimensions can diffuse rapidly through the gel matrix 
causing severe cytotoxic effects on the encapsulated cells. 
In this respect, an efficient purification process, designed to remove 
contaminants, including potentially immunogenic compounds, represents a 
mandatory step for tissue engineering application. Nevertheless, it is 
important that the purification process does not alter the polymer features 
(especially number and weight average molecular weights) that are critical 
for the gelation process and therefore the microcapsule formation. 
Alginate beads are generally prepared by dripping a sodium alginate solution 
containing the desired cells into a divalent crosslinking solution such as Ca2+, 
Sr2+, or Ba2+ (gelling bath). Ca2+ ions are preferred for gelation of alginate; 
especially, for the encapsulation procedures, because of the high 
biocompatibility. After preparation, calcium gelified beads are usually coated 
by a cationic polyelectrolyte. The coating is performed to slow down the 
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swelling and in vivo degradation of the microcapsules, however it may cause 
immunological reactions and fibrotic growth; this latter can subsequently 
decrease the therapeutic efficacy of the entrapped cells sharply reducing the 
diffusive properties of the alginate capsule [30]. 
In this respect, the use of the positively charged polyelectrolytes for the 
capsular coating (i.e. poly-L-lysine) can induce a more intense overgrowth 
compared to negative ones. This funding was attributed to activated 
macrophages that preferentially adhere to positive charged surfaces. 
Other cross-linking ions as an alternative for calcium have been used as well 
as Ba2+. It has been proved that Ba2+ ions provide stronger gels [30] allowing 
the transplantation of microcapsules without the need of coating procedure. 
As drawback, barium is known to be toxic and concerns have been raised 
about its use as crosslinking agent. Recent studies have shown that when 
using low concentrations of barium, short time of gelling incubation and 
intensive rinsing of the obtained barium beads, no barium leakage from the 
microcapsules was observed [31]. For this reason, the alginate gelation with 
barium is preferred since it forms stronger crosslinks with alginate, which 
results in stronger gels than with calcium. 
 
1.3. Scaffold design and their characteristics 
 
The essential function of a hydrogel based scaffold for cell therapy is to 
provide a temporary 3D structure for cells. The main criteria for scaffold 
design include controlled biodegradability, suitable mechanical strength and 
appropriate surface chemistry. Another important role of the scaffold is its 
porosity; this property greatly influences indeed the diffusion of nutrients, 
therapeutic proteins and catabolites.  
A large variety of immobilization devices of different geometries have been 
proposed for cell transplantation purposes and they are generally classified 
in macrodevices and microdevices (Fig 5) [32]. 
Macrodevices, usually characterized by dimensions comprised between 0.5-
1.5 mm in diameter and 1-10 mm in length are able to entrap thousands to 
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millions of cells within their wall. The most common geometric configurations 
for macrodevices are vascular chambers, hollow fibres and flat membranes 
(sheets). An example of the use of macrodevices for cell transplantation is 
represented by cells seeded in a special compartment chamber, directly 
anastomosed to blood vessels, usually as arterio-vein shunts. In this way, the 
cells are continuously perfused by blood ultrafiltrate, which seemingly 
facilitated biochemical exchange. The membrane, in contact with the blood 
stream, is associated with an appropriate molecular weight cut off (commonly 
below 100 kD) to avoid that immune cells or antibodies would cross the cell 
containing chamber. However, the requirement of a surgery for implantation 
and/or retrieval as well as the risk of blood clotting have resulted in the lack 
of interest for these devices over the last years. 
 
Fig. 5 General scheme of hydrogel based scaffolds suitable for in vivo cells transplantation 
protocols: vascular chamber, hollow fibre (cylinder) and microcapsule containing embedded 
cells. 
 
Moreover, the bigger the grafted encapsulated tissue volume, the more 
frequent is the incidence of adverse side effects in the recipients.  
Among microdevices, microcapsules represent the most widely studied 
immunoisolating systems [33]. In this respect, in the current PhD thesis, a 
number of new or revisited technologies for the production of 
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immunoisolating microdevices are investigated and optimized.  
The spherical shape of microcapsules is considered advantageous since 
provide an optimal surface-to-volume ratio for protein and nutrient diffusion, 
improving the cell viability and functions compared to other scaffold 
geometries. Furthermore the small microcapsule dimensions, usually with a 
diameter comprised between 250 to 750 μm, facilitate the implantation in 
different body sites through small diameter catheters without the need for 
invasive surgery. 
 
Fig.6. Schematic representation of a microcapsular device for cell encapsulation protocol. 
 
The cell encapsulation in immmunoisolatig microcapsule, schematized in Fig. 
6, can result in a number of potential advantages: (a) the physically isolation 
of cells from the external environment within a 3-D semipermeable 
membrane barrier, (b) the transplantation of cells without needing of the 
lifetime systemic administration of immunosuppressive drugs required to 
prevent the host rejection process, (c) the possibility to co-encapsulate 
(within the same device) cells from different sources and with distinct 
characteristics, including genetically engineered cells, (d) compared with 
encapsulation of proteins, cell immobilization allows a controlled release of 
produced therapeutic products giving rise to more physiological blood 
concentrations and (e) in case of mechanical failure of the encapsulation 
device, the possible toxic effects of a rapid and massive release of the 
therapeutic products, is avoided compared to macrodevices [34]. 
Microcapsule surrounding membranes are expected to permit the diffusion of 
nutrients and molecules such as oxygen and growth factors essential for 
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cellular metabolism, proliferation, differentiation and morphogenesis, while 
excluding the entry of all high molecular weight molecules such as 
immunoglobulins and immune system cells [33]. 
Microcapsules are generally constituted of hydrogels that offer highly 
hydrated microenvironment with a high degree of diffusion for low-molecular 
mass (Mr) biochemical and physical stimuli for cellular processes. 
Additionally, gels can be prepared by mild and rapid procedures, leading to a 
uniform distribution of cells into the gel matrix and high biocompatibility 
associate to minimal host-cell adhesion and protein adsorption phenomena. 
Nevertheless, the success of therapeutic approaches based on cell 
encapsulation require a detailed characterization of the biomaterials 
employed and of the cell–material and material-host tissue interactions, with 
special regard to the biocompatibility and immunogenicity of the cell-
microcapsule assembly. 
In conclusion, many requisites have to be considered for the clinical success 
of microcapsule, including dimensional, mechanical and biocompatibility 
properties; many of them are below discussed.  
 
1.3.1. Dimensional, permeability and morphological properties 
Dimension and morphology represent a critical characteristic that deeply 
influence many practical aspects related to the microcapsule use, including: 
cell loading capacity, diffusive properties (later discussed), method of 
implantation (gauge of the catheter) and finally biocompatibility. 
It has been demonstrated that the microcapsule diameter can affect the host 
immune response, revealing that small dimensions resulted in a cellular 
reaction. 
The success of cell-encapsulating microcapsules is also determined by their 
abilities to facilitate the transport of biological molecules into and from the 
encapsulated cells by the microcapsule pores. Extensive efforts are being 
made to control the pore size in order to prevent the entry of immunogenic 
molecules and cells. Specifically, the alginate microcapsules calcium cross-
linked alginate hydrogel have generally pores ranging from 5 to 20 nm, able 
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to prevent the diffusion of large molecules, but allowing the diffusion of small 
ones. As already discussed, the pore size is further controlled by the 
deposition of polyelectrolyte complex layers on the surface by the exposure 
of alginate hydrogels to polycations such as poly-L-lysine.  
Microcapsular shape also influences the in vivo performances, irregular 
geometries, such as the presence of fused or partially fused microparticles (a 
phenomenon usually named as “coalescence”) or tear shaped microparticles 
(phenomenon usually named as “tail”) result in the formation of capsular 
fibrotic overgrowth [35]. Moreover, microcapsular defects, in term of cracks 
or surface fissures, together with an irregular (rough or waved) surface, often 
cause a marked immunological in vivo response. Immediately following 
implantation, the surface of the material is coated with plasma proteins that 
further direct cellular adhesion and activation. The growth of host cells on the 
biomaterial device surface is considered to have negative effects because of 
reduced diffusion of oxygen and nutrients to the encapsulated graft resulting 
in necrosis of the enveloped cells. 
Noteworthy, the surface roughness of the device has recently been 
described to provoke a strong tissue response in rats when alginate 
microcapsules were implanted with a strong surface roughness as visualized 
by atomic force microscopy [30]. 
 
1.3.2. Mechanical properties 
The mechanical properties of cell-encapsulating microcapsules are highly 
important to ensure the therapeutic efficacy of transplanted cells. Some 
hydrogels do not provide an optimal mechanical stiffness (resistance to 
deformation) and toughness (resistance to fracture) able to structurally 
protect the embedded cells usually exposed to many different mechanical 
stresses during the processing, post processing and in vivo implantation 
procedures.  
Cell encapsulation devices may also lose their mechanical and structural 
integrity, sometimes due to the action of the host immune system. The 
structural failure is indeed critical when the scaffold is in vivo implanted, in 
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which high mechanical stress is exerted. In this respect, the mechanical 
properties are generally studied and determined by specific test such as 
compression analysis between two flat surfaces resulting in force–
displacement and force–time plots by which it is possible to obtain 
mechanical property parameters. The determination of the mechanical and 
elastic properties can be used to tune the microcapsule by adjusting the 
polymer source and concentration, processing methods, formulation and 
gelling conditions (i.e. the ionic strength of the gelation medium and the type 
of divalent cations). For example, increasing the polymer and the cross-
linking agent concentrations led to an increase of the mechanical stiffness 
and toughness [30]. 
 
1.3.3. Biocompatibility properties 
Biocompatibility of the microcapsules and the biomaterial constituents is the 
most critical issue for their end applications. Microcapsule biocompatibility is 
usually referred to different specific properties related to the host reaction to 
the encapsulation device; for instance the potentiality to, in vivo, elicits 
immune responses [36]. Following the implantation of the cell-encapsulating 
device, the host immune response is activated by the adsorption of proteins 
on the surface, which will stimulate the recruitment of immune cells. The 
immune cells directly destroy the transplanted cells or causes fibrotic 
overgrowth around the capsule limiting the efflux of nutrients or the bioactive 
molecules secreted by the entrapped cells. These cascade events are 
reduced by with the use of biocompatible materials, which present minimal 
amounts of toxins and prevent protein adsorption.  
Other critical issues related to microcapsule performances are the body site 
and the implantation methods used. Both factors can indeed affect the type 
and the intensity of host response towards the implanted microcapsules. 
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CHAPTER 2 
 
Bioencapsulation for cell therapy:  
experimental procedures for the production and 
characterization of microcapsules 
 
This chapter is extracted from the articles: 
2. “Induction by TNF-α of IL-6 and IL-8 in cystic fibrosis bronchial IB3-1 
epithelial cells encapsulated in alginate microbeads” 
M. Borgatti, S. Mazzitelli, G. Breveglieri, R. Gambari and C. Nastruzzi, 
Journal of Biomedicine and Biotechnology, 2010, Article ID 907964 (Borgatti 
and Mazzitelli equal contribution). 
 
2. “Encapsulation of mesenchymal stem cells from Wharton's jelly in alginate 
microbeads” 
L. Penolazzi, E. Tavanti, R. Vecchiatini, E. Lambertini, F. Vesce, R. Gambari, 
S. Mazzitelli, F. Mancuso, G. Luca, C. Nastruzzi, R. Piva, Tissue Eng Part C 
Methods, 2010, 16(1), 141-55. 
 
3. “Preparation and characterization of polysaccharidic microbeads by a 
microfluidic technique: application to the encapsulation of Sertoli cells” 
L. Capretto, S. Mazzitelli, G. Luca and C. Nastruzzi, Acta Biomaterialia, 
2010, 6(2), 429-35 (Capretto and Mazzitelli equal contribution).  
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2.1. Cell encapsulation in microparticles: methods of preparation 
 
Although the concept of cell therapy is very appealing, in practice a great 
deal of technology and know-how is needed for the production of long-term 
functional cell based devices. 
Many types of natural and synthetic polymers have been explored for 
microencapsulation protocols. As reported in Chapter 1, the capsular 
material must be biocompatible, mechanically stable and provide an 
environment assuring the cell survival and the secretion of therapeutic 
products [1]. 
As already discussed, alginate is the most used encapsulation polymer for 
the immunoisolation of allogeneic and xenogeneic cells. Alginate based 
microcapsules are usually produced by the extrusion of cell containing 
alginate droplet into a gelling bath, followed by a polycation coating, that 
assures the control of molecular weight cut-off of the microcapsular structure 
[2]. 
The production of alginate microcapsules can be performed by a few 
alternatives including coaxial bead generator, jetcutter and electrostatic 
droplet generation technologies (Fig. 1) [3]. 
 
Fig. 1. Microcapsule production by coaxial bead generator (left), electrostatic droplet 
generation (center) and jetcutter technologies (right). 
 
Irrespectively of the preparation strategy, the microcapsule formation 
consists of three main steps, as below described. 
1. The suspension of viable cells in the aqueous colloidal alginate dispersion 
(the polymer is usually employed at a concentration ranging from 1 to 3 %, 
w/v).  
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2. The generation of alginate droplets, representing the precursors of the 
microcapsules; this step is preferably achieved by a controlled size 
procedure. 
3. The consolidation of the droplets by a gelation process, resulting in the 
final formation of soft hydrogel based microparticles. 
Specifically, the formation of uniform alginate microdroplets (step 2) 
represents the most critical step of many preparation processes described in 
the literature. 
The underlying principle of the droplet generation is that a liquid, when forced 
through a nozzle, is extruded initially as individual droplets.  
However, with an increasing flow rate, the liquid forms a laminar jet that 
breaks into small droplets either naturally (by gravity) or with the aid of 
various means. Generally, the alginate droplet break-off, at the nozzle tip, is 
achieved by an air-jet directed to the forming droplet, electrostatic forces, a 
mechanical cutting of the alginate flow or the vibration of the micronozzle. 
Varying different experimental settings such as the nozzle diameter, the 
alginate pumping rate and the applied air-flow or electric field, the droplet 
diameter can be adjusted. 
In Fig. 2 are reported the general scheme of the currently employed 
procedures for the production of alginate microcapsules.  
One of the main aim of the PhD thesis was the development of new or more 
performing encapsulation procedures based on a variety of physical 
principles and instrumentations, including coaxial bead generator (Fig. 2 A), 
vibrating-nozzle procedure (Fig. 2 B) and microfluidics. (Fig. 2 C). The 
studied and well-validated encapsulation procedures were thereafter applied 
to the entrapment of different cell systems including bronchial epithelial cell 
line, mesenchymal stem cells and Sertoli cells. 
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Fig. 2. Schematic representations of different encapsulation protocols: coaxial bead 
generator (A), vibrating-nozzle procedure (B) and microfluidic based approach (C). 
 
3.2. Cell encapsulation by coaxial bead generator 
 
The encapsulation procedure based on the use of a coaxial bead generator 
(Fig. 2 A), represents one of the most used instrumentation for the production 
of polysaccharidic microcapsules, intended for cell encapsulation. Various 
encapsulation systems are commercially available for the production of 
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alginate microbeads in a controllable manner (i.e. Coaxial Airflow Induced 
Dripping VAR J1 from Nisco Engineering Inc, Switzerland, see Fig. 3).  
The general principle of the instruments is based on a coaxial air stream that 
blows polymer droplets from a needle tip into a gelling bath. 
 
Fig. 3. Pictures of the Coaxial Coaxial Airflow Induced Dripping VAR J1 from Nisco 
Engineering Inc. The instrument is connected with hoses providing alginate solution and air, 
respectively. 
 
In our laboratory, we have recently designed and produced a new model of 
coaxial bead generator, named “gas driven mono-jet device”. The entire 
project was developed with the aim to improve some instrumental 
characteristics and performances of coaxial bead generators on the market 
available including the connectivity (to alginate-cell suspension and gas/air 
generator) and the possibility to change the internal diameter of the nozzle, in 
order to obtain microcapsules with different diameters. 
 
Fig. 4. Schematic and 3-D representation of the gas driven mono-jet device showing the two 
lateral and top inlets for the alginate feeding (1) and the atomizing gas (2). 
 
In this respect, our device is equipped with two lateral and one top standard 
rapid connectors based on female luer lock (as air and alginate inlets) and an 
internal nozzle (commercially available blunt end needles) that is 
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easily interchangeable, depending on the dimensions of the final droplets 
required. The complete encapsulation system is composed of a gas driven 
mono-jet device connected to a precision peristaltic pump (for the alginate 
feeding) and to a gas flask (usually nitrogen) equipped with a flow meter 
(providing the gas for the atomization of the alginate). The generated 
microdroplets are then consolidated to give microparticles by a gelation 
procedure generally based on calcium or barium ion solutions. Typically, the 
cell suspension is continuously mixed by a magnetic stirrer to prevent cell 
clumping, which could lead to inhomogeneous cell distribution within the 
microparticles. 
 
2.2.1. Application of a coaxial bead generator to IB3-1 cells 
 
Cystic ﬁbrosis (CF) is an autosomal recessive disorder caused by mutations 
of the CF transmembrane conductance regulator (CFTR) gene, which 
encodes a transmembrane protein present on a variety of cell types and 
organelles [4]. The CF lung is characterized by chronic bacterial infection of 
the airways, thickened airway mucous, and bronchiectasis [5]. The excess of 
mucus is largely caused by the inﬂux of neutrophils, attracted to the site by 
the increased expression of chemokines such as interleukin-6 (IL-6) and 
interleukin-8 (IL-8), by bacterial products and inﬂammatory cytokines [6]. In 
particular, IL-8, that is potent chemokine, is induced transcriptionally by a 
wide variety of stimuli including tumor necrosis factor-alpha (TNF-a), 
hyperosmotic shock and bacterial [7]. In order to possibly study in detail the 
mechanism(s) of activation of IL-8 in CF, the IB3-1 cell system has been 
recently proposed [8]. IB3-1 is a bronchial epithelial cell line, derived from a 
CF patient with a CFTR genotype of F508del/W1282X, therefore carrying the 
associated cystic ﬁbrosis mutation. This cell line can be induced to high 
expression of proinﬂammatory proteins, following infection with 
Pseudomonas aeruginosa or by treatment with TNF-a, for at least 24 h. In 
order to develop a speciﬁc system to possibly study the mechanism of 
bacterial activation of IB3-1 cells as well as the eﬀect of the secreted 
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chemokines on target cell populations, in co-culture experiments (eg. 
Pseudomonas aeruginosa or polymorphonuclear cells) alginate 
microcapsules containing IB3-1 cells were produced. The co-culture 
experiments could be performed in the presence/absence of a 
semipermeable membrane embedding the IB3-1 cells, representing a 
physical barrier to cell/cell interactions but allowing the cross-talking among 
the diﬀerent cells mediated by soluble factors. 
 
2.2.1.1. Materials and methods 
 
Cell cultures 
IB3-1 cells were obtained from LGC Promochem (Teddington, Middlesex, 
UK) and were grown in LHC-8 basal medium (Biofluids, Rockville, MD, USA), 
supplemented with 5% FBS in the absence of gentamycin. All culture flasks 
and plates were coated with a solution containing 35 mg/mL bovine collagen 
(Becton-Dickinson Italia, Milan, Italy), 1 mg/mL bovine serum albumin 
(Sigma, St. Louis, MO, USA), and 1mg/mL human fibronectin (Becton-
Dickinson).  
Encapsulation of IB3-1 cells 
Before encapsulation, confluent monolayers of IB3-1 were scraped off by 
0.05% trypsin/EDTA (Gibco, Grandisland, NY, USA) (2min), washed with 
PBS, counted by hemocytometric analysis, and assayed for viability by 
double staining with propidium iodide (PI) and Calcein-AM (Sigma), following 
the manufacturer‟s indications. Briefly, IB3-1 cells were suspended in a 1.5% 
(w/v) aqueous solution of highly purified sodium alginate (Inotech, Dottikon, 
Switzerland), further purified by a multistep filtration process, at a 
concentration of 8–12 × 106 cells/ml. The resulting cell suspension was 
continuously aspirated by a syringe pump and extruded through the gas 
driven mono-jet, developed in our laboratory, under sterile conditions. The 
generated microdroplets were hardened by an ionotropic gelling process into 
a 1.2% (w/v) barium chloride solution that resulted in the production of 
barium alginate microbeads. After 3 min of incubation into the gelling bath, 
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the microbeads were washed twice with saline and placed in LHC-8 basal 
medium (Biofluids), supplemented with 5% FBS at 37◦C in an humidified 
atmosphere of 5% CO2.  
Dimensional and morphological characterization of alginate microbeads 
The morphology of barium alginate microbeads was evaluated by optical 
microscopy and stereomicroscopy (Nikon microscopes, Tokyo, Japan). 
Microbead size was determined by photomicrograph analyses (Eclipsenet 
version 1.16.5; Laboratory AU5c Imaging s.r.o. for Nikon B.V.). Samples of 
200–400 beads were considered.  
Viability determination of encapsulated IB3-1 cells 
After encapsulation and after different lengths of time, the viability of IB3-1 
cells was analysed by double staining with propidium iodide (PI) and Calcein-
AM, following manufacturer‟s instructions. For the propidium iodide (PI) and 
Calcein-AM analysis, cells were visualized under a fluorescence microscope 
(Nikon, Optiphot-2, Nikon Corporation, Japan). Viable cells were stained in 
green while the dead ones were stained in red. 
Experimental Design and Statistical Analysis 
To study the effect and the influence of different experimental parameters on 
the size and size distribution of alginate microbeads, a randomized central 
compositive face centered design (CCF) consisting of 17 runs was used. The 
experimental design and the evaluation of the experiments were performed 
by the PC software MODDE 8.0 (Umetrics AB, Sweden), followed by multiple 
linear regression (MLR) algorithms. The following experimental parameters 
(“factors”) were considered: the atomizing air flow (“air”), the alginate 
pumping rate (“pump”), and the distance between the nozzle of gas driven 
mono-jet device and the surface of the gelling bath (“height”). 
Treatment of monolayers 
IB3-1 cells were seeded at the initial concentration of 30,000 cells/cm2 and 
the cell number/ml determined after 3 days of culture. Cell number/ml was 
determined after trypsin treatment by using a model ZBI Coulter Counter 
(Coulter Electronics, Hialeah, FL, USA). Treatment of monolayers with 80 
ng/ml TNF-  (PeProTech EC, London, UK) was performed on 70% confluent 
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cells for 24 hours. Treatment of encapsulated cells: equal quantity (20x106 
cells) of free and encapsulated cells (derived from the same flask, previously 
cultured for 3 days and successively detached by trypsin) were treated with 
80 ng/ml TNF-  for 24 hours.  
Cytokine profiles 
Cytokines in tissue culture supernatants released from the cells under 
analysis, were measured by Bio-Plex cytokine assay (Bio-Rad Laboratories, 
Hercules, CA) [9] as described by the manufacturer. The Bio-Plex cytokine 
assay is designed for the multiplexed quantitative measurement of multiple 
cytokines in a single well using as little as 50 µl of sample. In our 
experiments, the premixed multiplex beads of the Bio-Plex human cytokine 
7-plex which included seven cytokines (IL-1r , IL-6, IL-8, G-CSF, MCP-1 
(MCAF), RANTES, VEGF) were used. 50 μl of cytokine standards or 
samples (supernatants recovered from treated cells) were incubated with 50 
μl of anti-cytokine conjugated beads in 96-well filter plates for 30 min at room 
temperature with shaking. Plates were then washed by vacuum filtration 
three times with 100 μl of Bio-Plex wash buffer, 25 μl of diluted detection 
antibody were added, and plates were incubated for 30 min at room 
temperature with shaking. After three filter washes, 50 μl of streptavidin-
phycoerythrin was added, and the plates were incubated for 10 min at room 
temperature with shaking. Finally, plates were washed by vacuum filtration 
three times, beads were suspended in Bio-Plex assay buffer, and samples 
were analysed on a Bio-Rad 96-well plate reader using the Bio-Plex 
Suspension Array System and Bio-Plex Manager software (Bio-Rad 
Laboratories, Hercules, CA).  
Quantification of IL-8 and IL-6 transcripts 
Total RNA was isolated (High Pure RNA isolation kit, Roche), retro 
transcribed (Promega Corporation, Madison, USA) and the resulting cDNA 
was quantified by relative quantitative real-time PCR. The sequences of the 
oligonucleotides used for amplification of IL-8 mRNA were: 5‟-GTG CAG TTT 
TGC CAA GGA GT-3‟ (forward) and 5‟-TTA TGA ATT CTC AGC CCT CTT 
CAA AAA CTT CTC-3‟ (reverse); for IL-6 mRNA: 5‟-AGG AGA CTT GCC 
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TGG TGA AA-3‟ (forward) and 5‟-CAG GGG TGG TTA TTG CAT CT-3‟ 
(reverse); for GAPDH mRNA: 5‟-AAG GTC GGA GTC AAC GGA TTT-3‟ 
(forward); 5‟-ACT GTG GTC ATG AGT CCT TCC A-3‟ (reverse). For PCR, 
0,5/20 μl aliquots of cDNA were used for each Sybr Green real-time PCR 
reaction to quantify the relative tissue expression of IL-8 and IL-6 transcripts. 
Each 25 μl of total reaction volume contained 0.5 μl of cDNA, 10 pmol of 
primers, 1 x iQ™ SYBR® Green Supermix (Bio-Rad Laboratories, Hercules, 
CA). Real-time PCR reactions were performed for a total of 40 cycles 
(denaturation, 95°C for 10 s; annealing, 68°C for 30 s for IL-8, 65°C for 30 s 
for IL-6; elongation, 72°C for 60 s) using an iCycler IQ® (Bio-Rad 
Laboratories, Hercules, CA). The relative proportions of each template 
amplified were determined based on the threshold cycle (Tc) value for each 
PCR reaction. The ΔΔCt method was used to compare gene expression 
data. Each sample was quantified in duplicate from at least two independent 
experiments. Mean ± S.D. values were determined for each fold difference. 
Amplification of human GAPDH cDNA served as internal standards 
(housekeeping gene). Duplicate negative controls (no template cDNA) were 
also run with every experimental plate to assess specificity and indicate 
potential contamination. 
Data Analysis and statistics 
Statistical analysis was performed by one-way analysis of variance followed 
by the Student‟s t test. A P value <0.05 was considered statistically 
significant. 
 
2.2.1.2. Results  
 
Release of pro-inflammatory proteins by IB3-1 cells exposed to TNF- : a Bio-
Plex analysis 
IB3-1 cystic fibrosis cell monolayers (see Figure 5 A-B) were treated, after 3 
days cell culture, for 24 hours in the presence of 80 ng/ml of TNF-
thereafter, the conditioned media, from treated and control cell 
populations, were analysed for presence of pro-inflammatory cytokines by 
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Bio-Plex mediated analysis.  
 
 
     C                        D 
         
Fig. 5. Morphology (panels A and B) and viability (insets) of IB3-1 cell monolayers, as 
determinated by bright field and fluorescence photomicrographs. Analysis of the release of 
pro-inflammatory cytokines by IB3-1 cells, as determinated by Bio-plex analysis (panels C 
and D). The indicated proteins were analyzed in the IB3-1 cell culture medium, namely: IL-
1r  (Interleukin-1 receptor alpha), G-CSF (Granulocyte-colony stimulating factor), MCP-1 
(Monocyte chemotactic protein-1), IL-6 (Interleukin 6), IL-8 (interleukin 8), RANTES 
(Regulated upon activation, normal T cell expressed and secreted), VEGF (Vascular 
endothelial growth factor). Data are referred to control untreated cells (open bars) and to 
cells treated for 24 hours with TNF- 80 ng/ml) (closed bars). Data represent the average of 
three independent experiments±SD. 
 
Before each induction experiments IB3-1 cell monolayers were assayed by 
“live/dead cells” test, and in all cases the determinated viability was  90%, 
as indicated by the fluorescence photomicrographs reported in the insets of 
Figure 5 A-B.  
The Bio–Plex 200 multiplex suspension array represents, in fact, an assay 
system, employing Luminex xMAP–technology, for the simultaneous 
detection and quantitation of multiple bioanalytes (proteins, peptides, DNA 
and RNA) in a single microplate, requiring only very small sample volumes. 
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A number of proteins were considered in the analysis of IB3-1 medium, 
namely: IL-1r , G-CSF, MCP-1, IL-6, IL-8, RANTES and VEGF. The 
obtained data, reported in Figure 5 (panels C and D), indicate that, apart from 
RANTES and VEGF (which values are not statistically different in control vs. 
treated cells), all other proteins are differentially expressed and released in 
untreated IB3-1 cells and after TNF-  treatment. In particular, IL-6 and IL-8 
were present at high concentrations, in the medium of TNF-  treated cells, 
reaching values of 5.71 and 5.84 ng/mL, respectively. 
 
Encapsulation of IB3-1 in alginate microbeads 
IB3-1 were embedded into alginate microbeads by the gas driven mono-jet 
device for cell encapsulation (see scheme in Figure 6). The encapsulation 
procedure was relatively simple and consisted of a limited number of steps. 
In order to achieve complete biocompatibility, essential for mammalian cells, 
the entire procedure was conducted at room temperature, under physiologic 
pH and tonicity using a pyrogen-free alginate, purified by a filtration 
procedure in order to remove possible contaminants. 
The hardening of the generated alginate microdroplets was accomplished by 
an ionic gelation procedure with barium chloride. The resulting barium 
alginate microbeads were elastic and transparent, thus facilitating the 
microscopic observation of cell morphology and viability, during the in vitro 
studies, as evident by the bright field and dark field stereophotomicrographs 
shown in Figure 7. 
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Fig. 6. General scheme of the encapsulation procedure for IB3-1 cells by the gas driven 
mono-jet device. The lower part of the figure summarizes the procedure for the in vitro 
experiments with free (right) and encapsulated IB3-1cells (left) treated with TNF-α. 
 
For the screening and optimisation of the experimental parameters, a “design 
of the experiments” (DoE), was performed, after design by MODDE software.  
DoE offers a rational approach for experiment-based research by reducing 
the number of experiments and providing more precise information about the 
effects of different variables and their possible interactions. The DoE process 
can help to improve the accuracy with which it is possible to predict operating 
characteristics of many industrial processes. 
A central composite design (one of the most used designs in 
pharmaceuticals and biological studies) was applied to the optimization of 
alginate microbeads. 
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Fig. 7. Bright field (A, B, C, D) and dark field (F) stereophotographs of empty (A,B) and IB3-1 
containing (C-F) alginate microbeads. Microbeads were produced by the gas driven mono-jet 
device. Alginate microbeads were prepared using the experimental parameters reported in 
Table 1 (batch #15a, b, c). Bar corresponds to 400 (A, B, E) and 250 m (B, D, F). 
 
This experimental design required 17 experiments (2 k + 2 k + 3, where k is 
the number of variables) including three center points in order to have an 
estimation of the experimental error. The high and low values of each 
variable were defined based on preliminary experiments. The 
factors/responses and the general results of DoE analysis are reported in 
Table 1 and Figures 8 and 9, respectively. In particular, in Figure 8 are 
shown the contour plots, while the response surface plots of the investigated 
factors are given in Figure 9; the influence of factors on “size” are in panels 
A-C and on “SD” in panels D-F.  
The main observation was that a change in “air” value from a low to a high 
level (12 to 20 bar) results in a sharp decrease of the microbead “size” while 
the “SD” response presents a biphasic trend showing a minimum at the 
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central value for both “air” and “pump”. The “height” and “pump” parameters 
exert an influence at high and low levels causing the increase of the both 
responses. 
 
Table 1. Experimental design matrix and results of the DoE (design of experiments) 
approach for alginate microbeads. 
Batch #  Factors  Responses 
 
Atomizing air 
(Bar) 
Nozzle to  
gelling bath 
(cm) 
Polymer 
pumping rate  
( m/mL) 
Mean diameter 
( m) 
Standard 
deviation 
(± m) 
 “air” “height” “pump” “size” “SD” 
#1 12.0 2.2 75.0 1350.5 63.2 
#2 20.0 2.2 75.0 983.1 68.4 
#3 12.0 3.0 75.0 1234.1 389.5 
#4 20.0 3.0 75.0 917.5 60.5 
#5 12.0 2.2 125.0 1177.5 296.5 
#6 20.0 2.2 125.0 716.7 99.2 
#7 12.0 3.0 125.0 1161.1 83.6 
#8 20.0 3.0 125.0 724.8 106.7 
#9 12.0 2.6 100.0 1293.6 47.6 
#10 20.0 2.6 100.0 835.4 322.3 
#11 16.0 2.2 100.0 970.5 54.8 
#12 16.0 3.0 100.0 851.6 36.3 
#13 16.0 2.6 75.0 920.6 47.2 
#14 16.0 2.6 125.0 974.9 58.1 
#15a 16.0 2.6 100.0 920.8 43.1 
#15b 16.0 2.6 100.0 920.8 43,1 
#15c 16.0 2.6 100.0 920.8 43.1 
 
After investigation of the factor influence, the validity and the significance of 
the model was estimated by analysis of variance (ANOVA). All the data 
obtained fit well the model determining a good reproducibility of the studied 
model. We get a large regression coefficient R2 that is a necessary condition 
for a validity model with a significant power of prediction of the model Q2 
(data not shown). 
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Fig. 8. DoE analysis for the production of alginate microbeads containing IB3-1 cells. 
Contour plots of the responses: “size” (A-C) and “SD” (D-F). The following interactions were 
reported: “height versus air” (A,D); “pump versus air” (B,E); and “pump versus height” (C,F).  
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Fig. 9. 
DoE analysis for the production of alginate microbeads containing IB3-1 cells. Response 
surface plots of the responses: “size” (A-C) and “SD” (D-F).  
 
Viability of Encapsulated IB3-1 Cells. 
A crucial issue that should be always investigated in the case of 
embedding/seeding protocols for cell scaffolding concerns the effect of the 
A B 
C D 
E F 
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encapsulation procedure on viability of cells. For this purpose, the viability of 
encapsulated cells in alginate beads was determined by the live/dead test. 
Beads were incubated with Calcein-AM (a marker of living cells; fluorescent 
signal was monitored using 485 nm excitation wavelength and 530 nm 
emission wavelength) and with PI (a marker of cell death; excitation, 535nm; 
emission, >610 nm). The observation of the fluorescent images recorded 
immediately after the encapsulation procedure at the typical excitation 
wavelengths (Figure 10) indicated that the cells were highly viable (>95%) 
after different lengths of culture time (up to 7 days). 
 
Fig. 10. Fluorescence photomicrographs of alginate microbeads containing IB3-1 cells after 
1 (A) and 7 days (C) of cell culture. Fluorescence photomicrographs were taken after double 
staining with Calcein-AM and propidium bromide. 
 
Increase of Accumulation of IL-8 and IL-6 mRNAs in Encapsulated IB3-1 
Cells Treated with TNF-α 
Free and encapsulated IB3-1 cystic fibrosis cells were treated for 24 hours in 
the presence of 80 ng/mL of TNF-α. After this treatment, microcapsules were 
separated from the culture medium, washed, fused and entrapped cells 
isolated, washed, and finally lysed for RNA isolation. RT-PCR was performed 
using primers amplifying IL-8, IL-6, and GAPDH RNA sequences. The results 
obtained are reported in Figure 11(A), which clearly indicates that 
encapsulation has only minor effects on IL-8 mRNA accumulation. 
Consistently, in TNF-α-treated cells (closed bars) the levels of IL-6 and IL- 8 
mRNA sequences are higher than those usually found in TNF-α untreated 
IB3-1 cells (open bars). Moreover, TNF-α induction of IL-6 (Figure 11 A, left 
side of the panel) and IL-8 (Figure 11 A, right side of the panel) gene 
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expression is clearly evident, both in free (-) and encapsulated (CAPS) IB3- 1 
cells, strongly indicating that (a) TNF-α transfer within the alginate 
microbeads takes place with high efficiency and (b) its expected effects on 
gene expression is detectable, mimicking the well-known effect of TNF-α on 
free IB3-1 cells. In order to determine whether the increases of IL-6 and IL-8 
mRNA direct synthesis of the respective proteins and their secretion outside 
the alginate microbeads, Bio-Plex analysis on the medium was performed. 
 
Increased Release of IL-6 and IL-8 outside the Microcapsules Entrapping 
IB3-1 Cells Treated with TNF-α 
Free and encapsulated IB3-1 cystic fibrosis cells were treated for 24 hours in 
the presence of 80 ng/mL of TNF-α. After this treatment, microcapsules were 
separated from the culture medium, which was analysed for content of IL-6 
and IL- 8. Figure 11 B shows that minor differences in the amounts of 
secreted IL-6 and IL-8 protein levels are present when mediums isolated 
from cultures of free (-) and encapsulated (CAPS) IB3-1 cells are compared. 
On the contrary, when release by TNF-α-treated cells is compared to that of 
control IB3-1 cells (compare black to white histograms of Figure 11 B), the 
levels of IL-6 and IL-8 increase significantly both in free (-) and in 
encapsulated (CAPS) IB3-1 cells. The TNF-α-mediated fold induction of IL-8 
release was found similar in free and encapsulated IB3-1 cells (Figure 11 B, 
right side of the panel), while in the case of IL-6, the fold increase was more 
evident in free IB3-1 cells (Figure 11 B, left side of the panel). This 
observation was reproducibly obtained in several experiments. 
 
2.2.1.3. Discussion 
 
The first aim of the current work was to verify if IB3- 1 cystic fibrosis cells 
could be encapsulated in alginate microbeads and to test if the immobilized 
cells could be induced to express proinflammatory genes, after treatment 
with TNF-α (see the scheme of the experiment shown in Figure 6). 
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A        B 
  
 
Fig. 11. Analysis of the mRNA levels (A) and release (B) of interleukins 6 and 8 (IL-6, IL-8) 
by IB3-1 cells. Data are referred to control free cells growing as monolayer (-) and cells 
encapsulated in alginate microbeads (CAPS). Both free and encapsulated cells were 
cultured for 24 hours, in the absence (open bars) or in the presence of TNF-α (80 ng/mL) 
(closed bars). Data represent the average ±SD (N = 3). 
 
In this respect, we demonstrated that IB3-1 cells can be efficiently 
encapsulated in microbeads that posses a number of specific requisites, 
such as spherical shape, very narrow size distribution, good mechanical 
stability, and biocompatibility, assuring cell viability and functions. 
Furthermore, by this technique, microparticles with different morphological 
characteristics can be prepared by changing the main experimental 
parameters, namely: nozzle-to-gelling bath distance, atomizing gas flow, 
alginate concentration and pumping rate. 
The second aim of our experimental strategy was to verify whether TNF-α 
efficiently induces gene expression alterations in the encapsulated IB3-1 
cells. The results obtained by RT-PCR analysis of RNA firmly demonstrate 
that (a) encapsulation induces only a limited increase of the basal IL-6 and 
IL-8 mRNA content, whereas (b) TNF- α stimulates a sharp increase of 
content of IL-6 and IL-8 mRNAs in both free and encapsulated IB3-1 cells. 
This latter result suggests that TNF-α efficiently diffuses through the alginate 
microbeads matrix. Therefore, alginate microbeads could be suitably 
employed in experiments, in which the target cells are grown in a 
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physically separated, immunoisolated environment, being accessible to 
externally added soluble proteins possibly causing alterations of gene 
expression. 
However, in order to propose the described system as an experimental 
model to study cystic fibrosis, further experiments are required to control 
several unmet issues, including the fact that the encapsulated cells are non 
adherent, are not polarized and are unable to bind to bacteria (such as 
Pseudomonas aeruginosa) and immune cells inducing responses very 
different from those of soluble mediators (i.e. TNF-α). These are several 
parameters playing important roles in modification of gene expression in 
cystic fibrosis cells [10-11]. In this respect, we like to underline that the 
alginate-based encapsulation strategy can be further improved. For instance, 
in our laboratories, experiments in progress are aimed to the production of 
composites multifunctional microbeads simultaneously containing (a) living 
cells and (b) an extracellular matrix component, namely, a particulate ECM, 
that is able to modulate cell adhesion, migration, and polarization. In addition, 
co-encapsulation of epithelial cells and effector cells is technically feasible 
and might be explored. 
Finally, the third aim of our experimental strategy was to verify whether TNF-
α treatment leads to increased production and release of IL-6 and IL-8, 
confirming the permeability of the alginate microbeads membrane to these 
proteins. The results obtained firmly demonstrate that IL-6 and IL-8 release 
outside the microbeads increases in IB3-1 encapsulated cell cultures strongly 
suggesting that the alginate microbeads membrane is permeable to these 
proteins. However, while the TNF-α-mediated fold induction of IL-8 release 
was found similar in free and encapsulated IB3-1 cells, we reproducibly 
noted that in the case of IL-6 the fold increase was more evident in free cells 
than that in encapsulated IB3-1 cells. This might be due to a differential 
intracellular synthesis of IL-6 and IL-8 mRNAs or to a differential permeability 
of the capsule membranes to IL-6 and IL-8, or both. While additional 
experiments are required to explain this phenomenon, the possibility that the 
chemical composition of the microcapsule influences drug release 
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characteristics has been recently proposed by Jaya et al. and might be used 
to develop microbeads allowing selective releases [12].  
In this respect, the use of cell-based drug delivery has been proposed as a 
very promising application of encapsulation of cells relevant for production of 
therapeutic proteins. For instance, erythropoietin-secreting cells immobilized 
in microcapsules have been described by Murua et al. [13]. The applications 
in biomedicine of this strategy are very high, in consideration of the 
importance of erythropoietin for several biological functions, and the 
pathological conditions due to its disregulation. Similarly, continuous 
production of IL-12 by microencapsulated engineered cells modified with 
murine interleukine-12 (mIL-12) gene has been reported by Zheng et al. [14]. 
The microencapsulated cells have a significant therapeutic effect on 
experimental colon tumors by activating antitumor immune responses in vivo. 
These and similar papers support the concept that microencapsulated and 
genetically engineered cells may be an extremely versatile tool for cellular 
therapy [15]. 
In our case, we demonstrate that microencapsulated cells can be induced to 
produce IL-8 in the presence of high levels of TNF-α. This result allows 
hypothesizing that the experimental strategy outlined permits the 
development of a “cell-based microparticle sensor” releasing specific proteins 
(selective release can be improved by changing the chemical composition of 
the microcapsules) upon stimulation. This might be of great interest in 
biomedicine. Bioencapsulation has been indeed shown to be efficacious in 
mimicking the cell‟s natural environment and thereby improves the efficiency 
of production of different metabolites and therapeutic agents, while protecting 
the cells from larger proteins (e.g., antibodies) and immune cells [15]. 
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2.3. Cell encapsulation by a vibrating-nozzle procedure 
 
In order to produce large amount of alginate based microparticles, the cell 
embedding was also performed by an alternative procedure, based on the 
optimization of a vibrating-nozzle encapsulator procedure (EncapBioSystems 
Inc.), the scheme of which is reported in Fig. 12 [16]. 
 
Fig. 12. Schematic representation (left) and photograph (right) of the encapsulation device 
based on a vibrating nozzle, commercialized by EncapBioSystems Inc. 
 
The Encapsulator from EncapBioSystems Inc. is a vibrating nozzle device 
capable of producing microcapsules under sterile working conditions. The 
bead formation is based on the fact that a laminar liquid flow is broken up 
into equal beads, if it is vibrated at an optimal frequency. 
This procedure is carried out by the following steps: 1. the cell to be 
encapsulated are mixed with the encapsulating polymer (alginate); 2. the 
alginate/cell suspension is forced into the pulsation chamber (usually by a 
syringe pump) and then passes through a precisely drilled nozzle (with an 
internal diameter usually ranging from of 200 to 600 mm); 3. the alginate/cell 
suspension separates into equal size droplets, that later pass through an 
electrical field between the nozzle and the electrode resulting in a surface 
charge. The result is that alginate drops in the liquid jet are highly negatively 
charged at their surface. As consequence, the charged droplets are deflected 
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from the vertical resulting in the drops impacting the surface of the gelation 
solution over a defined area. This device enables the formation of small 
diameter (<300 mm) beads since the linear velocity of the drops is such that, 
in the absence of the electrostatic device, the distance between drops is 
approximately one bead diameter. If all such beads fell vertically, they would 
impact the hardening solution at the same position and thus impact each 
other, creating no spherical, coalescent drops. Depending on several 
variables, 50–3000 beads are generated per second. 
 
2.3.1. Application of a vibrating-nozzle procedure to Mesenchymal stem cells 
 
Mesenchymal stem cells (MSCs), which have largely been investigated, are 
functionally defined as non-hematopoietic multipotential cells, able to self-
renew and to highly proliferate [17]. 
Many studies suggest that MSCs may differentiate toward cells of different 
lineages, including chondrocytes, adipocytes, osteocytes, miocytes, neurons, 
and tenocytes [18-24]. Because of their peculiar characteristics, MSCs are 
considered to be very important for several applications in the field of 
regenerative medicine, including the development of cell based therapies 
and tissue repair procedures [25]. 
Different adult human tissues have been considered as MSC sources, 
including bone marrow, trabecular bone, adipose tissue, peripheral blood, 
synovium, skeletal muscle, dental pulp, and periodontal ligament [26]. 
Although bone marrow still represents the main and most investigated source 
of adult MSCs, the isolation and use of these cells still present some 
drawbacks. For instance, the number of MSCs found in bone marrow 
decrease progressively starting at age 17, and the harvesting techniques are 
invasive, often causing severe infections, bleeding, and chronic pain for 
donors. Looking for alternative MSC sources, fetal tissues, extraembryonic 
tissues such as placenta, and amniotic fluid, umbilical cord blood and stroma 
have recently been considered [27-29]. Umbilical cord, due to the unique 
morphological properties, represents an interesting alternate source for 
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MSCs, especially if compared to umbilical cord blood. Umbilical cord, usually 
weighing 40 g and spanning between 60 and 65 cm in length, contains a 
special primitive connective tissue called Wharton‟s jelly. This jelly acts as a 
protective tissue for vessels and contains into its stromal compartment cells 
with specific mesenchymal characteristics, called Wharton‟s jelly MSCs 
(WJMSCs) [30]. Therefore, Wharton‟s jelly can be an ideal, unique, easily 
accessible, and uncontroversial source for early MSCs due to the simple 
collection procedure once umbilical cord is routinely discharged at parturition. 
It has recently been described that WJMSCs are able to support long-term 
maintenance of hematopoietic stem cells [31]. In this respect, it is reasonable 
that WJMSCs, like MSCs collected from other tissues, can release many 
soluble molecules, including interleukins, chemokines, and many growth 
factors. The ability to self-renew and to differentiate into several cell types 
makes the use of MSCs particularly attractive for the development of 
innovative therapeutic strategies aimed at repairing and replacing damaged 
tissues and makes them a very promising cell source for tissue engineering 
applications. 
Nevertheless, several factors still hurdle the extensive clinical use of cell-
based therapy. The protection of implanted cells from the host‟s immune 
response is of primary importance. To solve this problem, WJMSCs human 
umbilical cord isolated, here presented, were immobilized in barium (Ba)–
alginate microbeads by a vibrating nozzle approach. With respect to 
encapsulation/immobilization procedure for MSCs, Langer and co-workers 
have reported a methodology to enhance the vascular differentiation of 
human embryonic stem cells by encapsulating the cells in a bioactive 
scaffold based on a photopolymerizable dextran hydrogels comprising either 
insoluble or soluble endothelial growth factors [32]. Moreover, a protocol 
based on the encapsulation of cells in calcium alginate hydrogels and aimed 
at maintaining human embryonic stem cell in culture, for a period of up to 260 
days, without exposure to animal cells, has recently been published. Finally, 
alginate beads were also tested to study the chondrogenesis of human 
MSCs [33]. 
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2.3.1.1. Materials and methods 
 
WJMSCs: isolation procedure and culture conditions 
Human umbilical cords (all from natural deliveries) were collected after 
mothers‟ consent and approval of the Ethics Committee of the University of 
Ferrara and S. Anna Hospital. Harvesting procedures of Wharton‟s jelly from 
umbilical cord were conducted in full accordance with the Declaration of 
Helsinki as adopted by the 18th World Medical Assembly in 1964 and 
successively revised in Edinburgh (2000) and the Good Clinical Practice 
guidelines. Cords were processed within 4h, and stored at 48C in sterile 
saline until use. Typically, the cord was rinsed several times with sterile 
phosphate-buffered saline (PBS) before processing and was cut into pieces 
(2–4 cm in length). Blood and clots were drained from vessels with PBS to 
avoid any contamination. Single pieces were dissected, first separating the 
epithelium of each section along its length, to expose the underlying 
Wharton‟s jelly. Later, cord vessels (the two arteries and the vein) were 
pulled away without opening them. The soft gel tissue was then finely 
chopped. The same tissue (2–3 mm2 pieces) was placed directly into a 75-
cm2 flask for culture expansion in 10% fetal calf serum (Euroclone S.p.A., 
Milan, Italy)–containing Dulbecco‟s modified Eagle‟s medium low-glucose 
medium supplemented with antibiotics (penicillin 100 mg/mL and 
streptomycin 10 mg/mL) at 37°C in a humidified atmosphere of 5% CO2. 
After 5–7 days, the culture medium was removed and thereafter changed 
twice a week. At a about 70–80% confluence, cells were scraped off by 
0.05% trypsin/ethylene diamine tetraacetic acid (EDTA) (Gibco, Grand 
Island, NE) (2min), washed, counted by hemocytometric analysis, assayed 
for viability, and thereafter used for further in vitro experiments or for 
encapsulation procedures. 
Flow cytometric analysis 
The WJMSCs were analysed for expression of MSC surface marker 
molecules, by direct immunofluorescent staining, as reported in the literature 
[34]. Briefly, cell pellets were resuspended in PBS and incubated with 
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fluorescein iso- thiocyanate (FITC)– or phycoerythrin (PE)–conjugated 
mouse anti-human antibodies CD45-PE, CD34-FITC, CD90- FITC, CD105-
PE, CD44-FITC, and CD29-PE (DakoCytomation; Dako, Denmark) for 15min 
at 4°C. Monoclonal antibodies with no specificity were used as negative 
control. Antibody-treated cells were then washed with PBS and spinned 
down. Cell pellets were resuspended in 400mL of PBS and analyzed by 
FACS Scan (Becton Dickinson, NJ). For each sample, 20,000 events were 
acquired and analyzed using the CellQuest software (Becton Dickinson 
European HQ, Erembodegem Aalst, Belgium). 
Encapsulation of WJMSCs 
Monodisperse alginate beads containing WJMSCs were prepared using the 
encapsulation device based on a vibrating nozzle according, to the 
experimental procedure previously described [16]. The encapsulator is a 2-L 
glass reaction vessel with stainless steel top and bottom plates. The top plate 
contains a feed-line connected to a syringe and a vibrating nozzle. A nozzle 
with an internal diameter of 300 mm was used. The flow of alginate to the 
nozzle is achieved by a precision syringe pump. The production of WJMSC-
filled alginate microcapsules was optimized by changing the following 
experimental parameters: vibrational frequency (freq), vibrational amplitude 
(amp), alginate pumping rate (pump), and distance between the nozzle and 
the surface of the gelling bath (height) (see Table 2). Before encapsulation, 
WJMSCs were suspended in a 1.5% (w/v) aqueous solution of highly purified 
sodium alginate (Stern Italia, Milano, Italy) at a concentration of 8–12x106 
cells/mL. The generated microdroplets were dropped into an isotonic barium 
chloride solution (1.2%; w/v); after gelation (3 min), the microbeads were 
washed twice with saline and cultured in 10% fetal calf serum (Euroclone 
S.p.A.)–containing Dulbecco‟s modified Eagle‟s medium low-glucose medium 
supplemented with antibiotics (penicillin 100 mg/mL and streptomycin 10 
mg/mL) at 37°C in an humidified atmosphere of 5% CO2. The dimensional 
analysis, experimental design and statistical analysis were performed as 
previously reported in paragraph 2.2.1.1. 
 
Stefania Mazzitelli Chapter 2 
 59 
Table 2. Production of alginate microcapsules by vibrational encapsulation procedure: the 
investigated experimental parameters and their range of variation. 
Parameter Abbreviation Meaning Range 
frequency freq frequency of the vibration of the nozzle 100.0-140.0 hz 
amplitude amp amplitude of vibration of the nozzle 1.0-6.0 mm 
pump pump polymer pumping rate 7.5-9.5 mL/min 
height height 
distance from nozzle to surface of gelling 
bath  
100.0-140.0 mm 
 
Viability analysis of WJMSCs 
Before and after encapsulation, the viability of the cells was analysed both by 
colorimetric assay with MTT (thiazolyl blue) and by double staining with 
propidium iodide (PI) and Calcein-AM according to the manufacturer‟s 
instructions. The MTT assay, based on the conversion of the yellow 
tetrazolium salt MTT to purple formazan crystals by metabolically active cells, 
provides a quantitative determination of viable cells [35]. After 3, 6, and 9 
days of culture 200 mL of MTT was added to each well of beads, and the 
plate was incubated at 37°C. After 2h the MTT crystals were solubilized with 
50% dimethyl formamide; after 24 h spectrophotometric absorbance of each 
sample was measured at 570 nm. For the PI and Calcein-AM analysis, cells 
were viewed under a fluorescence microscope (Nikon, Optiphot-2; Nikon 
Corporation, Tokyo, Japan) using the filter block for fluorescein. Dead cells 
stained red, while viable ones appeared green. 
Induction and evaluation of osteogenic differentiation 
For the analysis of osteogenic differentiation, both free WJMSCs (growing in 
monolayer) and microbead-entrapped cells were incubated in human MSC 
osteogenic differentiation medium (Lonza, Walkersville, MD) for 21 days. The 
extracellular matrix composition was analysed by Fourier transform infrared 
spectroscopy. Cell layers were collected in ammoniated water (50mM 
ammonium bicarbonate, pH 8.0), lyophilized, and analysed by FT-IR Spec- 
trometer Perkin Elmer, Spectrum 100 (Perkin Elmer, MA, USA). Absorption 
spectra were collected from 4000 to 600cm-1. After 21 days of incubation in 
standard and osteogenic conditions, microbeads were assayed for alkaline 
phosphatase (ALP) activity. Microbeads were incubated at 37°C in a 50 mM 
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EDTA solution (pH 7.00) for 2 min to dissolve the Ba–alginate microbeads 
and obtain the free cells. The cells were lysed with 300 L of 0.2% Triton X-
100. ALP activity was assayed by measuring, after 30min of incubation at 
37°C, the conversion p-nitrophenylphosphate to p-nitrophenol, using an 
enzyme-linked immunosorbent assay reader at 405 nm wavelength. ALP 
activity was normalized to total cellular proteins, determined by the Bradford 
protein assay protocol and expressed as U/mg of protein. One unit was 
defined as the amount of enzyme that hydrolyzes 1 mmol/min of p-
nitrophenylphosphate. For Alizarin Red S staining, free WJMSCs (growing in 
monolayer) and microbead-entrapped cells were fixed and then stained with 
40 mM Alizarin Red S solution (pH 4.2) at room temperature for 10 min. 
Samples were then rinsed five times with distilled water and washed three 
times in PBS on an orbital shaker at 40 rpm for 5 min each to reduce 
nonspecific binding. The stained matrices were microphotographed by an 
optical microscope (Nikon, Optiphot- 2; Nikon Corporation, Tokyo, Japan). 
For real-time polymerase chain reaction (PCR) analysis, Ba–alginate 
microbeads were dissolved as previously reported, and total RNA was 
isolated from the WJMSC-free cells using Total RNA Isolation system 
(Promega, WI). Two micrograms of total RNA was reverse transcribed with 
the Improm-II RT System (Promega). mRNA of target genes was quantified 
by real-time PCR using the ABI Prism 7700 system and TaqMan probes 
50AACCCAGAAG GCACAGACAGAAGCT30 for RUNX-2 (Applied 
Biosystems, CA). PCR was carried out in a final volume of 25 L. After 10 
min preincubation at 95°C (denaturation) and 1 min at 60°C 
(annealing/elongation), the mRNA levels were corrected for glyceraldehyde 
3-phosphate dehydrogenase mRNA levels (reference gene) and normalized 
to a calibrator sample (control cells). 
Determination of WJMSC secretory pattern by Bio-Plex analysis 
After 72 h of in vitro cell culture, the medium from WJMSCs growing as 
monolayer and embedded in Ba– alginate microbeads was collected and 
analyzed for a set of selected proteins. To compare and normalize the data 
of adherent and encapsulated WJMSCs, the microbeads were washed twice 
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with PBS before the analyses and incubated at 37°C, for 15 min, with 500 L 
of 50 mM EDTA (Sigma) in PBS buffer. EDTA was then neutralized with 
additional 10 mL PBS, and cells were collected by centrifuging at 400 g for 
15 min. Pellets obtained from WJMSCs growing as monolayer and 
embedded in Ba–alginate microbeads were lysed with 50mL buffer (NaCl 
150mM; Tris-HCl pH 7.4 20mM; EDTA 1 mM; EGTA 1 mM; Triton X-100 1%; 
Na3VO4 0.1 mM; PMSF 1 mM; PIC 0.1% v/v). About 10 L of each sample 
was tested with the Bradford method to determine proteins content. 
Concentrations of interferon-alpha 2 (IFN- 2), interleukin-1alpha (IL-1 ), 
IL-2 receptor , IL-3, IL-12 (p40), IL-16, IL-18, CTACK, GRO- , hepatocyte 
growth factor (HGF), ICAM-1, LIF, MCP3, M-CSF, MIF, MIG, beta- nerve 
growth factor, stem cell factor, stem cell growth factor- beta (SCGF- ), SDF-
1, tumor necrosis factor-beta, TRAIL, and VCAM-1 were simultaneously 
evaluated using a commercially available multiplex bead–based sandwich 
immunoassay kit (Human 23-plex; Bio-Rad Laboratories). Bio-Plex analysis 
was performed following the manufacturer‟s instructions. About 23 distinct 
sets of fluorescently dyed beads loaded with capture monoclonal antibodies, 
specific for each cytokine, were used. Secretion and standard samples (50 
L/well) were incubated with 50 L of premixed bead sets in a prewet 96-well 
microtiter plate. After incubation and washing, 25 L of fluorescent detection 
antibody mixture was added and left to react for 30 min under gentle shaking; 
samples were then washed and resuspended in the assay buffer. Standard 
calibration curves for each protein were used, ranging from 2 to 32000 
pg/mL; the minimum detectable dose was 2 pg/mL. The formation of the 
different immunocomplexes was measured by the Bio-Plex Protein Array 
System (Bio-Rad Laboratories). A 50 L volume sample was withdrawn from 
each well, and the fluorescent signal of a minimum of 100 beads per region 
(chemokine/cytokine) was measured. To compare directly secretive con- tent 
of adherent and encapsulated WJMSCs, all values were normalized with 
respect to the total protein amount. 
Data analysis and statistics. Statistical analysis was performed by one-way 
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analysis of variance followed by the Student‟s t-test. A p-value <0.05 was 
considered statistically significant. Cytokine analysis was performed with Bio-
Plex Manager software version 3.0 (Bio-Rad Laboratories). Standard levels 
between 70% and 130% of the expected values were used. In general, at 
least five standards were accepted and used to establish standard curves 
following a five-parameter logistic regression model. Sample concentrations 
were immediately interpolated from the standard curves. Values were 
expressed as pg/mL+ standard deviation. 
 
2.3.1.2. Results  
 
Isolation and characterization of WJMSCs 
As a source of human MSCs, solely Wharton‟s jelly was used instead of the 
whole cord (easier and faster to treat); the choice was made with the aim of 
isolating a relatively homogeneous cell population, possibly avoiding any 
epithelial cell contamination. For the isolation of WJMSCs, a slightly modified 
version of a previously published procedure was used [36]. Can and 
Karahuseyinoglu have recently reported in a review article (dealing with the 
umbilical cord stroma as source for stem cells) that a collagenase treatment 
is critically important, since there is always a risk of over digestion of the 
cellular external lamina, causing the prevention of cell adhesion to the culture 
substrate after isolation. In this respect, collagenase, trypsin, and hyal- 
uronidase treatments were omitted, in agreement with other investigators, 
observing that skipping the enzymatic digestion treatment favours cell 
adhesion and viability [37]. 
When in vitro cultured, the primary cells, isolated from Wharton‟s jelly, 
displayed an MSC-like phenotype. After 3 days of culture, the WJMSCs 
formed adherent colonies, reaching confluence after 10–14 days. High 
percentage of cells appeared viable, as demonstrated by Calcein-AM stain 
(Fig. 13 A), and displayed a spindle shape resembling fibroblasts (Fig. 13 B, 
C). The immunophenotypical profile of WJMSCs was determined by flow 
cytometric analysis (Fig. 13 D–I). It should be underlined that up to now there 
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are the MSC-specific markers are unknow. Nevertheless, according to 
previous studies [38,39], cell surface markers such as CD90 (Thy-1), CD29 
( -1 integrin), CD44 (hyaluronan receptor), and CD105 (SH2, endoglin) were 
analysed to attribute an MSC-like immunophenotype. Flow cytometry 
showed that, since first passage, the WJMSCs expressed these markers 
(Fig. 13 D–G).  
 
Fig. 13. Phenotype characterization of Wharton‟s jelly mesenchymal stem cell (WJMSC) 
monolayers. (A) Representative optical and fluorescence photomicrographs of the WJMSC 
monolayer after Calcein-AM staining (magnification, 20X). Flow cytometric histograms 
showing the immunophenotypic characterization of WJMSCs. The experiments were 
conducted using direct immunofluorescence staining with the indicated fluorescein 
isothiocyanate (FITC)– or phycoerythrin (PE)–conjugated mouse anti-human antibodies. 
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The hematopoietic marker CD45 and the hematopoi-etic/endothelial marker 
CD34 were not detectable in these cells (Fig. 13 H, I), indicating that 
WJMSCs were not contaminated with cells of hematopoietic or endothelial 
origin. Rigorous identification of MSCs requires demonstration of their 
capability to differentiate along specific mesenchymal lineages when induced 
to do so. In this context, we are interested in demonstrating the ability of 
WJMSCs to differentiate into osteoblasts. The osteogenic differentiation of 
expanded WJMSCs was induced by the addition of dexamethasone, b-
glycerophosphate, and ascorbate, and was assessed after 21 days by 
monitoring the production of mineralized extracellular matrix, as a marker for 
terminally differentiated MSCs into osteoblasts. As shown in Figure 14, we 
detected the presence of calcium by Alizarin red staining, and the presence 
of apatite by the Fourier transform infrared spectroscopic assessment of 
mineral content from the induced WJMSC. 
 
Fig. 14. Alizarin red staining (control WJMSCs, left; differentiated WJMSCs, right) and the 
Fourier transform infrared (FTIR) spectrum of the mineralized extracellular matrix containing 
hydroxyapatite matrix formed by WJMSCs after 21 days‟ culture in osteogenic conditions. 
The typical spectrum with mineral (phosphate) and matrix (amide I) absorbance is shown.  
 
Encapsulation of WJMSCs in alginate microbeads 
WJMSCs were embedded into alginate microbeads by the encapsulation 
device based on a vibrating-nozzle (see scheme in Fig. 12) under sterile 
conditions. Firstly, a classical intuitive approach COST (Changing One 
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Separate factor a Time) was used to define the experimental set up, 
including the selection of the crucial experimental parameters. The approach 
was chosen in order to evaluate which factor(s) could mostly affect the 
morphology of the produced alginate microbeads in terms of general 
geometry, surface characteristics and dimensions. Following the above 
procedure, only one experimental parameter was varied at a time (see Table 
2), while all the others were maintained constant. Experiments were 
performed, changing the following parameters: frequency of vibration (freq), 
amplitude of vibration (amp), polymer pumping rate (pump) and distance 
between the nozzle and the gelling bath (height) (Fig. 15). The frequency 
was calculated from knowledge of the alginate solution viscosity for the 
nozzle diameter used, to obtain the desired microbeads size and morphology 
(mean diameter comprised between 550 and 650 μm with a spherical shape) 
[16]. The vibrating frequency of the nozzle was varied from 100.0 to 200.0 
Hertz while the rate of polymer pumping was investigated in the range 7.5-
9.5 (mL/min) (see Table 3). The investigation of these parameters revealed 
that increasing both factors led to a decrease of particle size, but if the 
vibrating frequency was set too high (>200.0 Hertz) a progressive number of 
coalescences (formation of clusters of microbeads partially fused together) 
was detectable in the microbead population. The amplitude of the vibration 
applied to the nozzle (varied in a range from 1.0 to 6.0 mm) had only a slight 
effect on the microbead characteristics such as size, sphericity and presence 
of coalescences. On the contrary, the distance between the nozzle and the 
gelling bath (range 100.0-140.0 mm) had a great effect on the microbead 
morphology. In fact, a distance of 100.0 or 120.0 mm caused the formation of 
microbeads with an elliptic shape (formation of tails). Considering the results 
of this set of experiments (summarized in Table 3), it can be concluded that 
among the 4 different experimental variables, only the amplitude of the 
vibration has minor effect on the microbead formation, while all the others 
exert significant morphological and dimensional changes in the alginate 
beads. 
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Table 3. Analysis of the effect of experimental parameters on the characteristics of 
Wharton‟s Jelly Mesenchymal Stem Cell–filled alginate microbeads. 
Frequency 
(Hz) 
Amplitude 
(mm) 
Pump 
(mL/min) 
Height 
(mm) 
Morphology 
Freq     
100 1 8.5 140 
wrinkled surface, large number of tails and 
colascences. 
150 1 8.5 140 
smooth surface, some tails and 
colascences 
200 1 8.5 140 wrinkled surface and tails and colascences 
Amp     
150 1 8.5 140 
smooth surface and some tails and 
colascences 
150 3 8.5 140 
wrinkled surface and large number of tails 
and colascences 
150 6 8.5 140 wrinkled surface and tails and colascences 
Pump     
150 1 7.5 140 
wrinkled surface and large number of tails 
and colascences 
150 1 8.5 140 
smooth surface and some tails and 
colascences 
150 1 9.5 140 wrinkled surface and tails and colascences 
Height     
150 1 8.5 100 irregular shape 
150 1 8.5 120 irregular shape 
150 1 8.5 140 
regular shape and smooth surface , some 
tails 
Selected     
150 1 8.5 140 regular shape and smooth surface 
The morphological characteristics of microcapsules were assessed on at least 200 
microcapsules/batch, considering the presence of (a) tails, (b) coalescences, and (c) the 
surface characteristic. All the reported microbeads were prepared with an alginate 
concentration of 1.5% (w/v). Data represent the average of three independent 
determinations on different microbead batches. 
 
The microbeads with the best morphology (Fig. 15 A) were produced by the 
following set up: a frequency of 150 Hz, an amplitude of 1.0 mm, a pump flow 
rate of 8.5 mL/min and an height of 140.0 mm. 
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Fig. 15. Optical photomicrographs of empty alginate microbeads prepared by the vibrational 
encapsulator. Effect of different parameters on microcapsules characteristics. In panel A are 
depicted the microcapsules prepared using the optimized parameters (see Table 2). Panels 
B-C effect of the vibrational frequency, B: 100 hz, C: 200 hz; panels D-E: effect of the pump, 
D: 7.5 mL/min, E: 9.5 mL/min; panels F-G: effect of the height, F: 100 mm, G: 200 mm. 
Arrows indicate partially fused microcapsules or microcapsules showing tails or irregular 
morphology. 
 
Effect of alginate concentration on microcapsule characteristics 
Once the instrumental set up was achieved, we focused our attention on 
another important experimental parameter: the concentration of alginate 
solution. Different percentages were tested, ranging from 0.5 to 3.5% (w/v) 
and the effect on the production of microbeads was considered as well. At 
first observation, it should be mentioned that, using the automated vibrating 
nozzle instrument, we succeeded in obtaining microbeads using alginate 
concentration up to 2.0% (w/v). On the contrary, using higher concentrations 
of alginate (>2.0%, w/v), the resulting solution was too viscous to be 
efficiently converted in microdroplets. Samples of microbeads produced with 
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an alginate concentration of 0.5, 1.0, 1.5 and 2.0% were analysed for 
morphology, size and size distribution. Microbeads produced with an alginate 
concentration comprised between 1.0-2.0% (w/v) were spherical in shape 
and characterized by a smooth surface. Lowering the alginate concentration 
down to 0.5% (w/v) caused partial breaking of beads resulting in particles 
with an irregular shape. This behaviour was attributed to the mechanical 
stress caused by the landing in the hardening barium chloride solution. 
Moreover, at the same concentration, some coalescences were detectable. 
We obtained alginate microbeads with a smaller mean diameter and 
homogenous dimensional distribution using a polymer concentration of 1.5% 
(w/v). Increasing the alginate concentration up to 2% (w/v), the size 
distribution became broader and the mean diameter increased from 630 (in 
the case of an alginate concentration of 1.5%) to 645 μm (see dimensional 
distribution plots reported in Fig. 16 A, B). On the other hand, alginate 
microbeads prepared with lower polymer concentrations (0.5 and 1.0%, w/v) 
formed some coalescences (see Table 3), although the size distribution 
remained acceptably narrow. 
 
 
Fig. 16. Cumulative size distribution analysis (A, B) of microbeads prepared using the 
indicated percentage amounts of alginate. Samples were prepared with the selected 
experimental parameters reported in the last row of Table 3. 
 
Encapsulation of WJMSCs in alginate microbeads: a DoE approach.  
After performing the COST study, a “design of the experiments” (DoE) 
optimisation and a screening of the experimental parameters were also 
Stefania Mazzitelli Chapter 2 
 69 
conducted (chapter 2.2.1.1.) 
The parameters frequency, pump and height were chosen as variables and 
tested at three levels. Therefore, in our case we selected 14 experiments by 
a randomized central composite face-centered design (CCF) which requires 
fewer trials together with three center points in order to have an estimation of 
the experimental error (Table 4). 
 
Table 4. Experimental design matrix and results of doe (design of experiments) approach for 
alginate microbeads. 
 Factors Responses 
Frequency 
(Hz) 
Pump 
(mL/min) 
Nozzle to bath 
(mm) 
Tails 
(%) 
Coalescences 
(%) 
100.0 7.5 80.0 8.5 9.0 
200.0 7.5 80.0 9.0 9.5 
100.0 9.5 80.0 7.5 8.0 
200.0 9.5 80.0 8.0 8.6 
100.0 7.5 160.0 6.4 7.0 
200.0 7.5 160.0 6.0 7.8 
100.0 9.5 160.0 6.0 7.3 
200.0 9.5 160.0 6.1 7.0 
100.0 8.5 120.0 6.3 7.1 
200.0 8.5 120.0 6.1 7.2 
150.0 7.5 120.0 5.8 6.0 
150.0 9.5 120.0 6.3 7.0 
150.0 8.5 80.0 4.1 4.2 
150.0 8.5 160.0 4.0 5.0 
150.0 8.5 120.0 3.1 3.3 
150.0 8.5 120.0 2.9 4.2 
150.0 8.5 120.0 2.1 4.0 
Data represent the average of three independent determinations. 
 
By examining the results the main observation was that a change in height 
value from a low to a high level (80-160 mm) results in an increase of tail 
formation as well as of coalescences. On the other hand, the freq and pump 
parameters at high and low levels caused the increase of the both responses 
(see Table 4).  
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Three-dimensional graphs of the investigated factors are given in Fig. 17 
showing the influence of factors on tails (panels A-C) and coalescences 
formation (panels D-F). After investigation of the factor influence, the validity 
and the significance of the model was estimated by analysis of variance 
(ANOVA). All the data obtained fit well the model determining a good 
reproducibility of the studied model. We get a large regression coefficient R2 
that is a necessary condition for a validity model with a significant power of 
prediction of the model Q2 (see Table 5). 
 
Table 5. Anova Analysis of Variance of the Model for Doe Approach 
 N R
2 
R
2
Adj Q
2 
SDY RSD 
Model 
validity 
Reproducibility 
Coalescences 17 0.88 0.73 0.64 1.96 1.03 0.67 0.93 
Tails 17 0.89 0.76 0.61 1.85 0.93 0.66 0.94 
N is the number of experiments; R
2
 is the percent of the variation of the response explained 
by the model; R
2 
Adj. is the fraction of the variation of the response explained by the model 
adjusted for the degree of freedom; Q
2
 is the percent of the variation of the response 
predicted by the model. 
 
Viability, proliferation and osteoblastic differentiation of encapsulated 
WJMSCs. 
The viability was assessed by double staining with Calcein-AM (and with 
propidium iodide, as previously described, indicating that cells were highly 
viable after the embedding procedure by the vibrational system (see Fig. 18). 
In order to strengthen these data, the cell viability was determined after 
different lengths of culture time (up to 9 days) by using two alternative 
procedures, namely, the double staining with a Calcein-AM cell viability 
assay kit (Fig. 19 A) and the MTT test (Fig. 19 B). About one hundred 
alginate beads were incubated with thyazolyl blue, and the presence of 
formazan salts, marker of the viable cells, was reported in the graph as 
percentage of viable cells respect to day “0” (rated to 100%). During each 
day of measurement, we observed a steady but insignificant (p> 0.05) 
decrease in formazan absorption during the first 10 days. 
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Fig. 17. Design of the experimental analysis for the production of alginate microbeads 
containing WJMSCs. Response surface plots of the responses: „„tails‟‟ (A–C) and 
„„coalescences‟‟ (D, E). The following interactions were reported: pump and nozzle to bath 
(A, D); pump and vibrating frequency (B, E); and nozzle to bath and vibrating frequency (C, 
F). 
A 
B 
C 
D 
E 
F 
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Fig. 18. Optical (A, B) and fluorescence (C, D) photomicrographs of freshly prepared 
alginate microbeads containing WJMSCs. Bar corresponds to 340 (A, C) and 125 m (B,D). 
 
 
Fig. 19. (A) Histograms reporting the percentage of viable cells (by double staining) 
determined at days 3 and 6 of cell culture for adherent (gray bars) and encapsulated WJMCs 
(open bars). (B) Graph reporting the percentage of viable cells (by MTT assay) determined 
at days 0, 3, 6, and 9 of cell culture for adherent (open circles, dashed line) and 
encapsulated WJMCs (closed circles, plain line). Values are expressed as percentages of 
viable cells respect to day 0 (rated to 100%), and represent the mean of three independent 
samples analyzed in quadruplicate � standard deviation. 
 
The ability of the WJMSCs entrapped in alginate to differentiate in 
osteoblasts was assessed at day 21 of osteogenic induction 
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(WJMSCs/alg/ost) by a number of classical criteria (Fig. 20) and compared to 
WJMSCs entrapped in alginate in absence of osteogenic medium 
(WJMSCs/alg). The WJMSCs/alg/ost cells showed an appreciable increase 
of ALP activity, an early marker for osteoblast differentiation, (Fig. 20 A). The 
WJMSCs/alg/ost cells showed also an increase of the expression of a bone-
specific gene such as Runx2 analysed by quantitative RT-PCR (Fig. 20 B). 
Similarly, mineralization was present in WJMSCs/alg/ost cells (Fig. 20 C). All 
together, these results suggest that the cells were undergoing osteogenic 
differentiation despite encapsulation. 
 
 
Fig. 20. Osteogenic differentiation of WJMSCs encapsulated in alginate microbeads. 
WJMSCs from different isolations (samples #1, #2, and #3) were cultured in standard (open 
bars) and osteogenic conditions (grey bars). After 21 days, alkaline phosphatase activity (A), 
RUNX-2 mRNA expression (B), and bone matrix deposition (C) were evaluated. Values 
represent the mean of three different determinations run in triplicate (on different microbead 
batches) standard deviation. *p 0.01. 
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Secretive profile: WJMSCs in alginate beads vs adherent WJMSCs 
The secretive profile of both adherent (free) and alginate-encapsulated 
WJMSCs was analysed by multiplex bead-based sandwich immunoassay 
(shortly Bio-Plex). As reported in Table 6, the panel of analysed factors 
includes member of the family of interleukins, chemokines, growth factors 
and soluble forms of adhesion molecules. It should be underlined that all the 
proteins analysed have a molecular weight lower than the molecular weight 
cut off of the microbead membrane. Most of the protein analysed are 
secreted both by the free and encapsulated cells, even if to a different extent. 
The levels of IFN-α, IL-2Rα, TRAIL, M-CSF, IL-12, ICAM-1, SCGF-β, 
CTACK, VCAM, SDF-1α, were higher in the supernatant from free cells. In 
particular, IFN-α, IL-2Rα, TRAIL, M-CSF, IL-12, ICAM-1, SCGF-β, were 
significantly higher in the supernatant from free cells (p<0.05). On the 
contrary, MCP3, GRO-α, MIF and HGF were found more abundantly present 
in the supernatant from the encapsulated cells. In particular, MCP3 and 
GRO-α were significantly higher in the supernatant from free cells (p<0.05). 
Finally, some factors (IL-1α, IL-18, β-NGF, SCF, TNF-β LIF, MIG) were not 
detectable or detected at very low levels (IL-3, IL-16). Without forcing the 
speculations on these preliminary data, nevertheless some considerations 
may be done. The decrease of SCGF-β production by encapsulated 
WJMSCs may be correlated to their cytostaticity. In fact, SCGF-β is a 
cytokine of the C-type lectin family acting in hematopoietic stem/progenitor 
cells to support their proliferation. In addition, an appreciable decrease in the 
production of factors strictly associated with the immune response including 
IFN-α (-63%), IL-12 (-60%) was observed in encapsulated cells. IL-3 and IL-
16 became undetectable after encapsulation. This should be interpreted as a 
benefit in consideration of an effective role of alginate in the protection of the 
cells from the host‟s immune response. In this respect it should be 
highlighted that the optimized microbeads have shown an excellent 
biocompatibility and immunoprotection capabilities, as demonstrated by in 
vivo studies conducted up to 8 months of transplantation in the peritoneal 
cavity of NOD mice (data not shown). The microbeads hardened with barium 
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chloride were freely floating in the peritoneal cavity and morphologically 
intact, with the majority of the microbeads free of fibrotic tissue overgrowth. 
In addition at 8 months of transplantation, the encapsulated cells were 
extraordinarily viable.  
 
Table 6. Secretive Profile of Free and Encapsulated Wharton‟s Jelly Mesenchymal Stem 
Cells. 
Secreted 
protein 
Protein amount (pg/ml/mg ± S.D.)  
Adherent WJMSCs Encapsulated WJMSCs 
IL-1a n.d. n.d. 
MIG n.d. n.d. 
IL-18 n.d. n.d. 
b-NGF n.d. n.d. 
SCF n.d. n.d. 
TNF-b n.d. n.d. 
LIF n.d. n.d. 
IFN-a 4.83 ± 0.67 1.78 ±0.30 
IL-2Ra 1.78 ± 0.73 0.75 ±0.32 
CTACK 4.90 ±1.65 1.86 ±0.28 
IL-16 0.83 ± 0.36 n.d. 
VCAM 1.80 ± 0.40 0.80 ±0.30 
IL-3 0.96 ± 0.41 n.d. 
TRAIL 6.70 ±1.20 2.60 ±1.40 
M-CSF 12.70 ±2.50 3.90 ±0.60 
SDF1a 5.80 ±1.50 3.80 ±1.20 
IL-12 11.20 ±2.16 4.60 ±0.95 
ICAM-1 29.50 ±5.60 13.10 ±3.70 
SCGF-  959.00 ±209.00 289.60 ±98.20 
GRO-  4.20 ±1.70 25.70 ±8.60 
MCP3 6.10 ±2.00 19.60 ±5.00 
HGF 46.70 ±10.90 78.60 ±18.60 
MIF 13.00 ±2.80 13.50 ±3.60 
Data represent the average of four independent experiments conducted in triplicate. 
WJMSCs, Wharton‟s jelly mesenchymal stem cells; IL-1�, interleukin- 1alpha; n.d., not 
detectable; b-NGF, beta-nerve growth factor; SCF, stem cell factor; TNF-b, tumor necrosis 
factor-beta; IFN-�, interferon- alpha; SCGF-b, stem cell growth factor-beta; HGF, 
hepatocyte  
growth factor. 
 
At the same time, the encapsulation may lead to modifications of 
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WJMSCs, inducing a secretion increase of specific proteins such as GRO-α, 
MCP3, and HGF. At present, we don‟t know the correlation between the 
functionality of encapsulated WJMSCs and the over production of two 
important chemokines (GRO-α and MCP3) involved in mesenchymal stem 
cell chemotaxis and a pleyotropic cytokine of mesenchymal origin (HGF, 
hepatocyte growth factor) promoting migration and survival of MSCs.  
The latter (HGF) is one of the factors with therapeutic potential in 
regenerative medicine greatly studied in the last years and many researchers 
are looking for the best approach to maintain the therapeutic level of HGF at 
the repair site for endogenous stem cell recruitment. 
 
2.3.1.3. Discussion 
 
In this work, we present the procedure for the encapsulation of WJMSCs in 
alginate-based microbeads, and its effects on cell viability and secretive 
profile analysed by multiplex Bio-Plex technology. This is, to the best of our 
knowledge, the first report showing the characterization of human WJMSCs 
in view of their potential use in cell therapy and tissue repair. It is evident 
from the literature that multipotential MSCs possess a wide therapeutic 
applicability. Because of their fetal origin WJMSCs have been shown to 
share both bone marrow MSCs, and embryonic stem cells properties. Up to 
now, the ability of MSCs to secrete cytokines was determined only by mRNA 
profile, ELISA or microarray analysis, and the experiments were performed 
using animal MSCs or human MSCs obtained from other sources, such as 
adipose tissue, cord blood and bone marrow. Interestingly, our data on the 
secretion of proteins determined by Bio-Plex suggest that encapsulated 
WJMSCs maintain a secretive activity. Therefore, it is possible to conclude 
that alginate doesn‟t prevent cell functionality, on the contrary, in some cases 
may promote it. Further studies are required to design and select the 
appropriate scaffold for specific application of MSCs to the tissue of interest. 
Nevertheless, our data support the idea that alginate-encapsulated WJMSCs 
may have an important role for tissue engineering strategies, and may be 
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useful for improving a regenerative medicine approach for tissue repair 
based on mesenchymal stem cells. This latter point appears particularly 
important to the potential application of WJMSCs in clinic; in fact, issues 
about the safety of free Wharton‟ jelly derived MSC-based therapy should be 
considered, including the possibility to produce immunogenic responses or to 
induce tumor formation. 
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2.4. Cell encapsulation by microfluidic based approach 
 
Aside the above presented “traditional” bioencapsulation procedures, new 
techniques are emerging in response to already existing methods, such as 
microfluidic approaches.  
Microfluidics is an emerging and popular technology for a wide range of 
applications such as chemical synthesis, biochemical assays, drug 
screening. 
Microfluidic devices were conveniently applied as new tools for the formation 
of multiphasic regimes of flow (constituted of two or more immiscible fluids), 
later converted, in different ways, in highly monodisperse spherical polymeric 
microparticles [40]. The procedures allow generating emulsion droplets with 
the production rates on the order of 1 kg/day, a rate that is sufficient for 
commercial production. The droplet formation is achieved by two different 
strategies; namely T-junction chips (squeezing) where the breakup of the 
flow stream results in a loss of pressure around the emerging drop or Cross-
junction chips (flow focusing) where the formation of droplets is due to the 
viscous forces that extract fluid along the channel (Fig. 21) [41]. 
 
Fig. 21. Droplet formation, within the microfluidic platform, by squeezing and flow focusing 
mechanisms. 
 
The chemical nature of the droplet phase (disperse phase) determines the 
next step in which the droplets are transformed into microparticles by a 
consolidation procedure. Droplets containing monomers can be solidified by 
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means of thermally initiated or UV-initiated polymerization [42]. Alternatively, 
droplets of polymer dispersions can be hardened by different procedures 
including in liquid drying process, [43] interfacial polymerization [44], ionic 
cross linking [45] or thermal gelation (Fig. 22). 
In this respect, we have reported the production of polysaccharidic based 
microparticles with spherical shape, narrow size distribution and smooth 
surface combining the microfluidic technology and alternative gelation.  
 
Fig. 22. Schematic representation of the different procedures to consolidate droplets by 
microfluidic approach. 
 
2.4.1. Application of a microfluidic based approach to Sertoli Cells 
 
Sertoli cells (SCs) have been considered for many years to have only a 
simple mechanical architectural function in testis. Recently, SCs have been 
considered as „nurse‟ cells because they provide numerous factors required 
for the development and protection of the maturing germ cells [46]. Adjacent 
SCs form tight junctions with one another, creating a physical barrier that 
separates the germ cells localized toward the lumen from the blood supply. 
This barrier, called blood–testis barrier, allows the SCs to control and 
regulate the milieu of the developing germ cells and, by the secretion of 
immunomodulatory factors and nutrients, to create an effective 
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immune- privileged environment. These unique immune-privileged properties 
of SCs have led to the idea that SCs could be used for the protection of 
different cell types in transplantation protocols. 
Many papers have described the ability of SC to protect transplanted tissue 
allografts (mainly pancreatic B-cells) [47] from the immune system, by 
formation of a testis-like immunoprivileged environment, with no need for 
prolonged immunosuppression therapy regimens. In particular, it has been 
demonstrated that in vitro neonatal porcine islet (NPI) 
maturation/differentiation pathways can significantly be ameliorate by SC-
pre-culture, with SC not being included in the graft material. Moreover, when 
SCs and islets were co-transplanted in non-obese diabetic (NOD) mice (as a 
model of type 1 diabetes mellitus) the graft survival was significantly 
prolonged with 40–64% of mice remaining normoglycemic for 60 days after 
transplantation. 
The ability of SCs to protect co-grafted cells is not limited to islets of 
Langerhans. Recent studies have demonstrated that transplantation of SC 
can improve the viability/function of both endogenous and co-grafted 
dopaminergic cells in the brain [48]. Transplantation of allogeneic SC into the 
rat striatum of animals affected by Parkinson-like symptoms induced, in the 
plexus of dopaminergic fibres. Finally, a study has demonstrated the ability of 
Sertoli cells injected into the parenchyma of the spinal cord to protect motor 
neurons in SOD1 transgenic mice, as animal model of amyotrophic lateral 
sclerosis [49]. 
These results have fostered intense study in our laboratory in an attempt to 
isolate highly purified SCs that were successively encapsulated by a 
microfluidic approach, in microbeads constituted of alginate and 
alginate/agarose blends. At the moment, the typical methods of preparing 
cells containing agarose microbeads are based on the extrusion of a water-
in-oil dispersion [50]. 
To the best of the authors‟ knowledge, there is only one paper concerning 
cell-enclosing alginate/agarose microcapsules. Alginate–agarose subsieve-
size capsules were produced by a droplet generator-based procedure [51]. 
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The capsules produced, enclosing feline kidney cells, were relatively 
polydisperse, and the number of enclosed cells/capsule was relatively 
scarce. This work focuses on two novel features: (a) the new gelation 
process (ionic plus thermal gelation), which represents the key step to 
obtaining microbeads; and (b) the production of excellent SC containing 
microbeads in terms of perfect spherical shape, narrow size distribution and 
smooth surface.  
In conclusion, the present work describes the production and 
characterization, by a microfluidic approach, of microbeads constituted of 
alginate and alginate/agarose blends, for the encapsulation Sertoli cells. The 
general production strategy is based on the formation of water-in-oil 
multiphase flow by a „„Y” junction squeezing mechanism.  
 
2.4.1.1. Materials and Methods 
Materials 
The polymers used were agarose Type VII (Low Gelling Temperature; 
appearance: white to off-white powder; solubility: clear to hazy colourless to 
light yellow solution at 10 mg/ml in water with heat; gel strength; NTL 200 
g/cm2 at 1.0%; gel point 26 to 30°C at 1.5%; electroendosmosis (-mr) NMT 
0.1; loss on drying; NMT 10% (Sigma Aldrich, Germany) and sodium alginate 
IE-1105 (viscosity: 20.0-40.0 CPS, pH: 6.0-8.0 C=1%, H2O) (Inotech 
Biosystem International, Switzerland). For the gelation of polymers droplets, 
barium chloride dehydrate (Sigma Aldrich, Germany) was employed. 
Sunflower seed oil (Collina d‟oro, Italy) was used as continuous (external) 
phase. All other chemicals were from Fluka and were of the highest purity 
available. For the preparation of microbeads a “Snake mixer slide” chip 
(Thinxxs, Germany) with squared channels (320x320 µm), was used. 
Sertoli cells isolation 
SC were isolated from testis of prepubertal neonatal Large-White piglets as 
previously described [46]. Neonatal pre-pubertal “Large-White” pigs, aging 7-
15 days, were used as Sertoli cells donors. The piglets were anesthetized 
with 0.1 mg/Kg azaperon (Stresnil 40 mg/ml, Janssen, Bruxelles, Belgium) 
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and 15 mg/Kg ketamine (Imalgene 100 mg/ml, Gellini Farmaceutici, Aprilia, 
Italy) co-administered intramuscularly. The technical procedure is based on 
excision of testes; upon removal of their fibrous cap, the testes were finely 
chopped, to obtain a homogeneous dense tissue. The obtained tissue was 
enzymatic digested with a 2 mg/ml Collagenase P (Roche Diagnostics, 
S.p.A., Monza, Italy) solution in HBSS (Sigma Chemical Co, St. Louis, USA) 
until the separation of seminiferous tubules. The collected tubules were 
washed twice in HBSS and spinned down at 500 r.p.m. After washing the 
tubules were incubated with a HBSS solution containing trypsin (2 mg/ml) 
and DNAse I (Sigma). After the second digestion, the trypsin solution was 
diluited 1:1 with Hank‟s + 20% FBS to halt trypsin digestion and washed 
twice by gravity for 15 min. in order to sediment SC aggregates, while 
peritubular cells remained in the supernatant and were aspirated off. The 
tissue pellet was washed twice in Hank‟s and spinned at 800 rpm for 3 min. 
The pellet was then resuspended in Hank‟s, passed through a 500 μM 
stainless steel mesh, centrifuged at 800 rpm for 5 min and resuspended by 
pipetting for 7 min. in 1 M glycine, 2 mM EDTA HBSS pH 7,2, in order to 
eliminate the residual Leydig and peritubular cell. The residual tubules were 
precipitated for 5 min at 800 rpm, washed twice with HBSS, and finally 
collected and culture maintained in HAM F12 (Euroclone) supplemented with 
retinoic acid 0.166 nM (Sigma) and 5 mL/500 ml of insulin-transforming 
selenium (ITS) (Becton Dickinson #354352), in 95% air/CO2 at 37°C. Upon 3 
days of in vitro culture maintenance, the SC were incubated with 20 mM 
Tris(hydroxymethyl)aminomethane hydrochloride (TRIS) buffer (Sigma) at pH 
7.2, for 5 minutes, in order to eliminate the residual germinal cells. After 
washing TRIS off, SC were cultured in the same conditions as above 
reported in 75 cm2 cell culture flasks. 
Microbead preparation 
For the injection, into the microfluidic chip, of both dispersed and continuous 
phases, a syringe pump (KDS Model 100 Series, Kd Scientific) was 
employed. Polymer dispersions (alginate or alginate/agarose blends) were 
used as aqueous internal phase (water phase, WP) and slowly injected into a 
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reagent inlet of the squeezing geometry microchannel. The second 
immiscible liquid (oil phase, OP) was injected into the other inlet as 
continuous phase. Polymer dispersion was forced into the OP at the junction 
of the squeezing channel to form a multiphasic flow (droplets) represented by 
a w/o emulsion. Finally, the microdroplets were gelled into a BaCl2 solution 
(1.5%, w/v), in order to produce the final consolidated microbeads (Fig. 23). 
Morphological characterization of microbeads 
Since an uniform shape and a smooth and regular microbeads membrane 
are essential to assure the viability of the microencapsulated cells and the 
biocompatibility of the immobilization device, microparticle morphology, size 
and size distribution were assessed under inverted phase and 
stereomicroscopy, by counting at least 300 particles/batches. 
Rheological studies 
Rheological measurements were carried out by means of a controlled stress 
rheometer Stresstech HR (Reologica Instruments, AB Milano, Italy) equipped 
with a cone-plate geometry (diameter of 40 mm and angle 1°). The 
alginate/agarose gels were characterized by oscillation measurements 
(oscillation stress sweep at 37°C). The samples were applied to the lower 
plate to ensure that gel shearing did not occur. The frequency sweep 
measurements were performed using the frequency range 0.1-10 Hz and the 
stress value previously determined in the linear viscoelastic region. 
Determination of viability and function of encapsulated Sertoli cells 
The viability of SC encapsulated in alginate/agarose microbeads was 
assessed after different lengths of in vitro culture (immediately after 
microbead preparation and at days 3, 6, 9 and 12) by double staining with 
ethidium bromide (Sigma) and fluorescein diacetate (FDA, Sigma). Cells 
were visualized under fluorescence microscope (Nikon, Optiphot-2, Nikon 
Corporation, Tokyo, Japan) using the filter block for fluorescein. Dead cells 
were stained in red, while viable cells appeared green. The quantification of 
the viability of SC encapsulated in alginate/agarose microbeads was 
determined after dissolution of microbeads by treatment with an EDTA 
solution (50 mM, pH 8) for 10 min at 37°C. Thereafter cells were washed 
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three times with PBS, stained and examined under fluorescence microscope, 
by counting at least 800 cell/batches. The final viability data represent the 
mean of three determinations made in triplicate (on independent microbead 
batches) ± S.D. The evidence of the functions of the encapsulated Sertoli 
cells was determined by assessing the cell -aromatase activity as 
previously described [46]. Briefly, 106 SC as monolayers or encapsulated in 
microbeads, were cultured for 3 days in the absence or in the presence of 1 
μg/ml of follicular stimulating hormone (FSH) (Serono, Rome, Italy); 
thereafter, 0.2 μg/ml of testosterone enantate (SIT, Pavia, Italy) were added 
to the cells culture medium. After 8 h of treatment, the conditioned medium 
was withdrawn and assayed for 17- -estradiol (E2) presence. E2 
concentrations were determined by direct chemiluminescent technology 
(ADVIA Centaur, Estradiol-6 III, Bayer Diagnostics, Germany) (intra-assay 
CV<4.0%; inter-assay CV=6.0%). The reported data represent the mean of 
three determinations made in triplicate (on independent microbead batches) 
± S.D. 
In vivo biocompatibility of encapsulated SC 
Under general anesthesia, induced by intra-peritoneal co-administration of 
100 mg/Kg ketamine (Parke-Davis/Pfizer, Karlsruhe, Germany) and 15 
mg/Kg xylazine, (Bayer, Leverkusen, Germany), microbeads were collected 
by a sterile transfer pipette and delivered into the peritoneal cavity of the 
recipient female NOD mice, weighing approximately 25 g. (Harlan, Italy) 
through a small abdominal incision. Each mouse received 106 SC 
encapsulated in alginate/agarose (1:1 blend, w/w) microbeads. Body weight 
of each recipient was monitored. At 4 months of transplant, the 
microcapsules were retrieved to evaluate their morphology, mechanical 
stability and biocompatibility. After animals‟ anesthesia, performed as above 
described, microbeads were retrieved by peritoneal washing with warm 
saline. General characteristics of the retrieved microcapsules were 
determined by examining extent of the fibrotic overgrowth under phase 
contrast microscopy, and morphological features such as microcapsules 
sphericity, surface smoothness and finally viability by double staining with 
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ethidium bromide and fluorescein diacetate. 
 
2.4.1.2. Results  
 
This study describes the development and optimization of a new method of 
preparation for polysaccharidic microbeads based on a microfluidic 
approach. As general approach, we employed a chip with a “Y” shaped 
microchannel configuration, for the formation of w/o multiphase flow regime. 
The w/o flow was constituted of a water dispersion of a polysaccharide into a 
continuous sun flower seed oil phase.  
 
Fig. 23. Schematic representation of the microfluidic system setup for the preparation of 
polysaccharidic microbeads, including the drawing of the multiphase flow generator by “Y” 
junction squeezing mechanism (upper panel). Microphotographs of the multiphase flow 
formation, bar = 300 µm (lower panel). 
 
Afterwards the generated microdroplets where conveniently converted into 
gelled microbeads by gelation procedures (see scheme in Fig. 23).  
As first approach we tested the possibility to produce pure alginate 
microbeads by an “external gelation” procedure. By injecting the two 
immiscible phases in the microfluidic channels and by tuning their relative 
flow rates, a multiphase flow was easily obtained. Subsequently the formed 
alginate microdroplets were collected into a gelling BaCl2 bath, allowing the 
gelation of the alginate droplets. As reported in Fig. 24, the obtained 
microbeads were unfortunately characterized by a very pronounced tail-
shape (Fig. 24 A, B), even in the presence of a magnetic stirrer (Fig. 24 C, 
B). 
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Fig. 24. Dark field stereophotomicrographs of Ba-alginate microbeads prepared by the 
„external gelation‟ procedure, in the presence (A, B) or the absence (C, D) of a magnetic 
stirrer (250 rpm). 
 
This particular shape was attributed to the slowly pass of the Na-alginate 
liquid droplets through the OP/gelling bath interface. 
In order to possibly solve this main drawback, further experiments were 
conducted adding a thin, low viscous oil layer (OL) above the gelling BaCl2 
bath, to possibly facilitate the passage of the WP droplets through the 
interface (Fig. 24). As further improvement a small percentage (5–10%, w/w) 
of glycerol was added to the initial Na-alginate dispersion, in order to 
increase the density of the WP (Fig. 25). 
As can be seen in the microphotographs shown in Fig. 24 A,B and 25 A,B, 
both approaches resulted in a significant reduction of the tails on the 
microbeads. Nevertheless the microbeads still presented a rather remarkable 
number of tails. In addition, as reported in Tables of Figs. 24 and 25, the 
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microbeads were polydispersed in terms of size (high S.D.). 
 
Fig. 24. Dark field stereophotomicrographs of Ba-alginate microbeads prepared by the 
„external gelation‟ procedure. Effect of the oil layer: mineral oil (A) and cyclohexane (B). In 
the table the dimensional characteristics are reported. 
 
Fig. 25. Dark field stereophotomicrographs of Ba-alginate microbeads prepared by the 
„external gelation‟ procedure, in the presence of 5 (A) and 10 % (B) of glycerol. In the table 
the dimensional characteristics are reported. 
 
Successively, the „internal gelation‟ procedure was assessed to possibly 
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ameliorate the size and shape characteristics of the final Ba-alginate 
microbeads. The experiments were conducted by dispersing an insoluble or 
partially soluble barium salt. (BaCO3, 5–10 mM) into the WP containing Na-
alginate. The microdroplets gelation was achieved by gentle acidification with 
an oil soluble acid (acetic acid 0.15%, v/v) added to the OP. The lowering of 
the pH causes barium ion release and the consequent formation of Ba-
alginate gel. From the analysis of the microphotographs reported in Fig. 26, it 
is evident that the content of BaCO3 strongly influences the final 
characteristics of alginate microbeads. In fact, microbeads prepared with the 
lowest content of BaCO3 (5.0 mM) (Fig. 26 A) are characterized by a high 
polydispersity, a strong tail-shape and by the presence of a remarkable 
number of coalescences.  
 
Fig. 26. Dark field stereophotomicrographs of Ba-alginate microbeads prepared by the 
„internal gelation‟ procedure. Microbeads were prepared by dispersing 5 (A), 7.5 (B) or 10 
mM (C) BaCO3 or dispersing 7.5 mM of BaCO3 in the WP in the presence of 0.2% (D) or 
0.4% (w/v) (E) of span 80 as stabilizer. In the table the dimensional characteristics are 
reported. 
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On the other hand, microbeads prepared with the highest content of BaCO3 
(10.0 mM) are characterized by spherical shape, but an important number of 
coalescences are clearly detectable (chains of partially fused microbeads, 
Fig. 26 C). 
Only with a precise content of BaCO3 (7.5 mM), the produced microbeads 
present acceptable morphological characteristics (Fig. 25 B). The microbead 
morphology was greatly improved by adding to the OP a stabilizer (span 80) 
that deeply reduced the presence of coalescences, resulting in almost 
spherical microbeads (Fig. 26 D,E). 
As further improvement of the quality of the produced alginate microbeads, a 
new gelation approach was tested and the subsequent experiments were 
conducted using alginate/agarose blend dispersions as water phases, with 
the purpose of starting the gelation process of the polymeric droplets when 
they are still resident into the chip microchannel. From the analysis of the 
microphotographs reported in Fig. 27 A-C, it is noticeable that the 
progressively increasing amounts of agarose (with the respect to alginate), 
results in an improvement of the final morphological characteristics of the 
obtained microbeads. 
Microbeads constituted of small amounts of agarose (alginate/agarose from 
9:1 to 4:1, w/w) still present (even if in a less pronounced way), the unwanted 
tail-shape. Only when the agarose content is increased to a ratio of 1:1 
(alginate/agarose, w/w), the produced microbeads are characterized by a 
perfectly spherical shape, without signs of coalescence (Fig. 27 C). 
Interestingly, together with the amelioration of the microbeads morphology, a 
slight and progressive increase of the mean particle diameter, was observed, 
when agarose content was raised (see the size distribution analysis reported 
in Fig. 27 E). This behaviour was tentatively attributed to the different 
hardening process characteristic of agarose, in fact, agarose gelation does 
not involve in the shrink due to the complexation of divalent ions.  
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Fig. 27. Dark field stereophotomicrographs of polysaccharidic microbeads. Microbeads 
consisting of (A) 9:1, (B) 4:1, (C) 1:1, w/w alginate/agarose blends. Alginate/agarose (1:1 
blend, w/w) microbeads containing SC (D). In the insets are reported dark field 
stereophotomicrographs showing, at higher magnification, the microbead surface and 
morphology. E: cumulative size distribution of microbeads prepared with 6:1 (filled circles), 
4:1 (circles), 2:1 (filled squres) and 1:1 (squares) of alginate/agarose blends.  
F: Frequency sweep tests showing the frequency dependence of the elastic G ‟ (solid lines, 
open symbols) and loss G‟‟ (dotted lines, closed symbols) moduli of alginate/agarose gels. 
Gels were prepared using different weight ratios between alginate and agarose, namely: 9:1 
(circles), 4:1 (squares) and 1:1 (diamonds). Data represent the average of three independent 
determinations. Bars correspond to 400 m (A–C) and 150 mm (D). 
 
In spite of these results indicating that only using a 1 to 1 weight ratio 
between alginate and agarose resulted in optimal microbeads (see above), 
we performed a rheological characterization, by oscillatory measurements, of 
gels constituted of alginate/agarose at different ratios (namely: 9:1, 4:1 and 
1:1). Non-destructive oscillatory measurements were indeed performed in 
order to obtain information about the effect of the change of ratio between 
alginate and agarose. 
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Viscoelastic materials (such as alginate/agarose gels) show, after 
mechanical stress, contemporaneously viscous and elastic flow. In this 
respect, oscillation measurements furnish data regarding energy stored 
(storage modulus G‟), dissipated energy (loss modulus G‟‟).  
Gel measurements were performed firstly by increasing stress from 0.1 to 
100 Pa, working at constant frequency of 1 Hz. The test permitted to 
individuate the linear viscoelastic region in which it is possible to recognize 
the stress value useful to ensure instantaneous recovery after the removal of 
the applied force. Successively, oscillatory measurements were performed 
over a frequency range of 0.1 to 10 Pa and at constant stress, identified in 
the linear viscoelastic region. 
As shown in Fig. 27 F, storage modulus (G‟) predominated in all gels 
demonstrating that these formulations were able to keep the furnished 
energy (applied stress) maintaining the primitive structure. 
Particularly, increasing the agarose percentage content causes a progressive 
improvement of both G‟ and G”. 
Once selected the optimal experimental setup and polymer concentration, 
resulting in microbeads with an excellent morphology and narrow size 
distribution (Fig. 27 C), we started a new series of experiments aimed at 
validating the entire experimental set up for the encapsulation of living 
eukaryotic cells, namely Sertoli cell. As reported in Fig. 27 D, the 
stereophotomicrograph clearly indicated that Sertoli cell were conveniently 
encapsulated into alginate/agarose microbeads, prepared with 
alginate/agarose (1/1 blend, w/w), with notable shape and surface, in term of 
microbead morphology. 
Moreover, the fluorescence photomicrographs reported in Fig. 28 A-E 
demonstrated that SCs remain highly viable after encapsulation up to 16 
days of cell culture. In Fig. 28 F is reported the entire viability profile that 
compare free and encapsulated SC.  
These results showed that the encapsulated cells display viability strictly 
comparable to the free ones. In this respect, it is to be underlined that, 
although immortalized cell lines have provided invaluable information about 
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cell biology to researchers, primary cell culture offers a more relevant system 
for the study of cell function, disease states and patient therapy. However, 
working with primary cells in culture presents numerous challenges. 
 
Fig. 28. Fluorescence micrographs showing the viability of SC encapsulated in 
alginate/agarose microbeads immediately after the preparation (A) and after 3 (B), 6 (C), 9 
(D) and 16 (E) days of cell culture. SC encapsulating microbeads were prepared with 
alginate/agarose (1/1 blend, w/w), as described in the experimental section. In panel F is 
reported the comparative analysis of the viability of free (solid bars) and encapsulated 
(stripped bars) SC; data represent the mean of three determinations made in triplicate (on 
independent microbead batches) ± S.D. Bar = to 100 µm. 
 
Primary cell cultures are sensitive to apoptosis due to contact inhibition, 
serum concentration, and the three dimensional (3D) environment, and many 
conditions for optimal growth and proliferation of primary cells remain 
unknown. Generally, primary cells can be maintained in culture for period 
ranging between 3-15 days, after that cells usually die. 
To evaluate the functional capability of the encapsulated SC, the -
aromatase activity (in the presence or absence of FSH) was analysed. As 
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depicted in Fig. 29 A the -aromatase activity, expressed in term of 17- -
estradiol biosynthesis, remain statistically unchanged in free and 
encapsulated SC both in presence (squares) or in absence (circles) of FSH, 
for the entire period of time analysed (6 days of cell culture). 
 
Fig. 29. Functional analysis (A) and biocompatibility (B-D) of alginate/agarose (1:1 blend, 
w/w) microbeads containing SC. As specific marker to evaluate the functional capacity of the 
encapsulated SC, the -aromatase activity (expressed in term of 17- -estradiol biosynthesis) 
was analysed (panel A). Open symbols, plain lines: free SC, closed symbols, dotted lines: 
SC encapsulated in alginate/agarose microbeads. -aromatase activity was evaluated for 
the indicated length of time in the absence (circles) or in the presence of 1 μg/ml of FSH 
(squares). Data represent the mean of three determinations made in triplicate (on 
independent microbead batches) ± S.D. Examination of a typical batch of microbeads 
containing SC upon retrieval after 4 months from the peritoneal cavity (B), after double 
staining with ethidium bromide and fluorescein diacetate (C) bright field (D). 
 
Finally, in order to evaluate the mechanical stability during the implantation 
procedure and the biocompatibility of alginate/agarose (1:1 blend, w/w) 
microbeads containing SC, the microbeads were transplanted in the 
peritoneal cavity of NOD mice as described in the experimental section. The 
obtained results, summarized in Fig. 29 B-D, demonstrated that the 
microbeads were mechanically stable as proved by the morphological 
intactness, with the majority of the microcapsules (over 85%) appearing free 
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of any fibrotic tissue overgrowth at 4 months from transplant (Fig. 29 C). In 
addition, the viability of SC encapsulated in alginate/agarose (1:1 blend, w/w) 
microbeads at 4 months of transplantation, was extraordinarily high. 
 
2.4.1.3. Discussion 
 
In conclusion, this paper confirms that microfluidic methods appear to be a 
promising procedure for the preparation of microparticles intended for cell 
encapsulation and tissue engineering applications. 
In particular, the flow characteristics within microfluidic chip channels and the 
high dimension precision with which the chips are produced result in 
hydrogel based microparticles with highly controlled morphological and 
dimensional properties. In this respect, microfluidic techniques can be 
suitably used to obtain microparticles without common morphological defects 
often associated to other production methods. Batch emulsification or 
electrostatic technologies are indeed prone to the production of 
microparticles with presence of “tails”, coalescences, surface irregularity 
together with large size distribution [51]. 
The reported data demonstrate that the conversion of liquid droplets into 
solid particles represents the critical point for the production of 
morphologically acceptable microbeads by microfluidic approach. In this 
respect, the use of alginate/agarose blends appears to be particularly 
appropriate for producing spherical, smooth monodisperse microbeads 
without interfering with cell viability and functions. 
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CHAPTER 3 
 
Bioencapsulation for cell therapy:  
engineered microparticles and fibrous multifunctional 
scaffolds 
 
This chapter is extracted from the articles: 
1. “Production and characterization of engineered alginate-based 
microparticles containing ECM powder for cell/tissue engineering 
applications”  
S. Mazzitelli, G. Luca, F. Mancuso, M. Calvitti, R. Calafiore, C. Nastruzzi, S. 
Johnson and S.F. Badylak, Acta Biomaterialia, 2011, 7 (3), 1050-1062. 
 
2. “Optimised production of multifunctional microfibres by microfluidic chip 
technology for tissue engineering applications” 
S. Mazzitelli, L. Capretto, D. Carugo, X. Zhang, R. Piva and C. Nastruzzi, 
Lab Chip, 2011, 11, 1776-1785. 
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3.1. Engineered microparticles 
 
Despite of many favourable properties reported in Chapter 1 and 2, alginate-
based scaffolds for cell delivery and tissue engineering applications present 
a number of limitations that require further improvement before they can 
routinely be used in clinical applications. Since alginate hydrogels are 
extremely different (from a molecular and chemical point of view) from the 
cell‟s microenvironment, which is largely composed of extracellular matrix 
(ECM), biochemical interactions between the cells and the polymer is often 
lacking.  
ECM, which is usually isolated from a variety of natural sources, including 
dermis, submucosa of the small intestine and urinary bladder, has been 
proposed as a biologic scaffold from many research groups. It is known to 
play an important role in modulating cell adhesion, signalling, migration, 
proliferation and three-dimensional array [1]. 
On the other hand, ECM-based scaffolds do not offer the opportunity to 
create an immunoisolated environment required to avoid the immune system 
response. Furthermore, ECM scaffolds are inherently constrained by the 
material properties of the tissue from which they are derived, including 
shape, mechanical properties and oxygen diffusion. The material properties 
of ECM scaffolds can also be affected by the manufacturing process (i.e. 
mechanical decellularization vs. chemical decellularization), the age and 
health status of the animal from which the ECM is harvested, and inherent 
biological variability. There are limited ways in which the material and 
mechanical properties of ECM scaffolds can be manipulated to tailor the 
functional properties of the device for specific applications. 
Highly purified and standardized scaffold materials (i.e. alginates) are an 
alternative to naturally derived ECM scaffolds, all marked by uniform and 
reproducible mechanical and material properties. However, as reported 
above, alginates lack the bioactivity and constructive host tissue response 
characteristics of ECM- derived scaffolds. 
Therefore, combining alginates with ECM may capture the advantages of 
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both types of materials, i.e. mechanical and material properties, which can be 
manipulated with the „„on-demand” gelling behaviour of alginates and 
bioactivity, which is provided by the ECM. 
The idea of combining a polysaccharidic polymer with ECM derived materials 
such as collagen or gelatin in a microparticle-based device for cell 
entrapment has been partially investigated by other research groups. Tsai et 
al. [2], in a short communication, described the production of gel beads 
containing a soluble (purified and reconstituted) form of collagen in alginate, 
which in this respect does not offer a solid anchorage to the entrapped cells. 
In a second paper, Del Guerra and co-workers [3] exploited the possibility of 
cultivating bovine pancreatic islets into commercially available macroporous 
gelatin-based microcarriers (Culti-Spher- S) before encapsulation in alginate-
based microcapsules. In this respect, it is important to underline that 
commercial products are not easily distinguished by composition: 
manufacturers only say that the microparticles are produced by cross-linked 
gelatin, without giving technical details about the cross-linking procedure or 
the cross-linker residues ultimately present. In addition, the authors stated 
that they encountered serious problems with the microcarrier loading 
procedure. In fact, only about 50% of the dispersed islet cells were embodied 
within the microcarriers. In addition, the islets within microcarriers-in-alginate-
microcapsules released an amount of insulin which was only about 60% of 
that secreted by islets directly within alginate microcapsules. 
In an attempt to reconstitute the cell environment within an immunoisolatory 
device for cell immobilization in a much more controlled, biocompatible and 
cell-friendly environment, we tested the feasibility of entrapping a powder 
form of ECM, isolated and purified from urinary bladder (urinary bladder 
matrix; UMB) [4], together with living Sertoli cells (SCs), in alginate-based 
microparticles. This is a relatively new approach, completely different, in 
terms of innovation, design and production strategy, from those above 
reported. SCs were selected as the cell model since they have been 
recognized as playing important roles at different levels, as described in 
Chapter 2.4.1. 
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The specific aims of the study were to demonstrate that the inclusion of a 
powdered form of UBM: (i) does not alter the morphological and dimensional 
characteristics of the fabricated micro- particles; and (ii) results in an optimal 
substrate for in vitro culture that predictably ameliorates the viability and 
function of the co- entrapped cells. Alginate microparticles were applied for 
SC encapsulation, while extracellular matrix (UBM) was embodied within 
these constructs to enhance cell survival and function. 
 
3.1.1. Materials and methods 
 
Isolation of SCs 
SCs were isolated as previously described (Chapter 2.4.1.1). After isolation, 
purified SC monolayers were identified by anti-Mullerian inhibiting substance 
(MIS) immunostaining. Cell viability was assessed, before and after 
encapsulation, by double staining with PI and Calcein-AM according to the 
manufacturer‟s instructions. 
UBM powder preparation 
The preparation of UBM has been previously described [5]. In brief, porcine 
urinary bladders were harvested from 6-month old 108–118 kg pigs 
immediately following euthanasia. The excess connective tissue and residual 
urine were removed. The tunica serosa, tunica muscularis externa, tunica 
submucosa and the majority of the tunica muscularis mucosae were 
mechanically removed. The urothelial cells of the tunica mucosa were 
dissociated from the luminal surface by soaking the tissue in 1.0 N saline 
solution. The resulting material, which was composed of the basement 
membrane of the urothelial cells plus the subjacent lamina propria, was 
referred to as urinary bladder matrix (UBM). UBM sheets were placed in a 
solution containing 0.1 vol.% peracetic acid (Sigma), 4 vol.% ethanol (Sigma) 
and 95.9 vol.% sterile water for 2 h. Peracetic acid residue was then 
removed with two 15min phosphate- buffered saline (pH 7.4) washes, 
followed by two washes with sterile water for 15 min each. The decellularized 
UBM sheets were then lyophilized using an FTS Systems Bulk Freeze Dryer 
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Model 8-54 and comminuted to a particulate form using a Wiley Mini Mill. 
Preparation of engineered alginate microparticles 
The preparation of engineered alginate microparticles was performed with 
minor modification of previously reported method, by a gas-driven monojet 
device (Chapter 2.2). Depending on microparticle type, the gas-driven 
monojet device was fed with: (i) alginate dispersions in water (0.5–3.0%, 
w/v); (ii) alginate dispersions containing SC (4–12x106 cells ml�1); (iii) 
alginate dispersions containing UBM powder (0.5–1.5%, w/v); and (iv) 
alginate dispersions containing SCs plus UBM powder (Fig.1). 
The dimensional and morphological characterization of engineered alginate 
microparticles was performed as reported in Chapter 2.  
The optimization of the preparation procedure of engineered alginate 
microparticles was evaluated by design of experiment (DoE) approach 
(Chapter 2.2.1.1), studying the effect and the influence of the different 
experimental parameters: „„height”, „„gas” and „„pump” (Table 1). 
Reverse transcription–polymerase chain reaction (RT-PCR) analysis 
Total RNA was isolated from SC by Invisorb Spin-cell RNA mini-kit (Invitek 
GmbH, Berlin, Germany). Reverse transcription (RT) was performed by 
RevertAidtm H Minus First Strand cDNA Synthesis kit (Fermentas, Canada). 
Oligos sequences used are listed as forward then reverse, 5‟ to 3‟: -actin 5'-
ATGGTGGGTATGGGTCAGAA-3' and 5‟-CTTCTCCATGTCGTCCCAGT-3' 
amplify a product of 123 bp; Mullerian Inhibiting Substance (MIS) 5‟-
GCGAACTTAGCGTGGACCTG-3' and 5‟-
CTTGGCAGTTGTTGGCTTGATATG-3' amplify a product of 75 bp; 
indoleamine 2,3 dioxygenase (IDO) 5‟-ATGAAGGCGTTTGGGACACC-3' and 
5‟-GAGGAATCCAGCAGCAGAGC-3' amplify a product of 140 bp; 
Transforming Growth Factor  2 (TGF 2) 5‟- AATGTTGTTGCCCTCCTACG-
3' and 5‟-TGCTATGCTGG GTGTCAGAG-3' amplify a product of 140 bp; c-kit 
receptor also called Stem Cell Factor Receptor (c-kit) 5‟-
ACAAATCCATGCCCACACCCT-3' and 5‟-
TTAAGCCGTATGCAGTGGCCTC-3' amplify a product of 293 bp; Laminin 5‟-
CCGCCTTCTGGATGAACTG-3' and 5‟-CCGCCACACTCTGTCTCG-3‟ 
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amplify a product of 114 bp; Laminin receptor 5‟-
ATGCCTGACCTCTACTTCTAC-3‟ and 5‟-ACCTTCGGACCAATCTGC-3' 
amplify a product of 162 bp; Integrin -6 5‟-CGGCTGTGGCTGCTCTAC-3' 
and 5‟-TCTCTGGTGTCCAAGTTGAAGG-3' amplify a product of 74 bp, 
Integrin 1 5‟- CAAGCGAGCCGAGGACTATC-3' and 5‟-
GCTGGTGTTGTGCTAATGTAAGG-3' amplify a product of 198 bp; Clusterin 
5‟-ATCTCGGACAAAGAGCTCCA-3' and 5‟-TTGCGCTCTTCATTTGATTG-3' 
amplify a product of 128 bp; Transferrin 5‟- CAGCAGAACACTGACGGAAA-
3' and 5‟-CTCCTCAGCAACACAGGTCA-3' amplify a product of 186 bp; c-kit 
ligand also called Stem Cell Factor (SCF) 5‟-GATGCCTTCAAGGATTTGGA-
3' and 5‟-ATGGAATCTGAGGCCTTCCT-3' amplify a product of 182 bp; type 
IV Collagen 5‟-CACACGCCTTCCCTCCTG-3' and 5‟-
GAACCACGACGCCTTTGC-3' amplify a product of 90 bp. RT-PCR analyses 
were performed in the Mx3000P® Instruments (Stratagene, CA) in a total 
volume of 20 l reaction mixture following the manufacturer‟s 
recommendations, using the Brilliant® SYBR Green QPCR Master Mix 2x 
(Stratagene, CA) and 10 M of each primer using the dissociation protocol. 
Negative controls contained water instead of first-strand cDNA. Each sample 
was normalized on the basis of its housekeeping gene ( -actin). The relative 
gene expression levels were normalized to a calibrator that was chosen to be 
the control sample (untreated). Final results, expressed as relative  
expression, were calculated by MxProTM software (Stratagene, CA). 
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3.1.2. Results 
 
Production of engineered alginate microparticles containing UBM powder 
and SC 
Encapsulation scaffolds (i.e. microparticles) for cell transplantation protocols 
would require a number of specific requisites, such as a spherical shape, a 
dimensional range usually between 200 and 600 m, good mechanical 
stability and a suitable extracellular microenvironment, with care being taken 
to ensure the viability of the embodied cell (eventually by also including 
extracellular adhesion molecules and growth factors) [6]. 
Keeping in mind these points, we started a series of experiments aimed at 
fabricating engineered alginate microparticles for tissue engineering 
applications, by the gas-driven monojet device, developed in our laboratory.  
In Fig. 1, the general scheme depicting the preparation of alginate 
microparticles is reported. We designed engineered microparticles that 
simultaneously contained living cells (i.e. SCs) and an extracellular matrix 
component, namely a particulate ECM. This form of powdered ECM, 
consisting of UBM, could be combined advantageously with natural or 
synthetic polymers to create hybrid biomaterials [4]. 
Before the preparation of the engineered microparticles, the UBM-ECM 
powder, was characterized by stereomicroscopic and fluorescence 
microscopic analysis. The photomicrographs reported in Fig. 2 show the 
fibrous flakes aspect typical of the UBM powder, with a mean size usually 
comprised between 50 to 200 m. It is noteworthy that UBM particles also 
when in comminuted form largely retain the ultrastructural, 3-D surface 
characteristics of the parent UBM sheets.  
Therefore, suspensions made from the powdered form of lyophilized UBM 
into biopolymer dispersions can be successfully used in mixture with cells for 
the direct production of engineered alginate microparticles.  
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Fig. 1. General scheme depicting the preparation of barium alginate microparticles by a gas-
driven monojet device. The insets present bright-field stereophotomicrographs of empty 
alginate microparticles (A), alginate microparticles containing UBM powder (B) and alginate 
microparticles containing UBM powder plus SCs (C); the bar corresponds to 260 m. In the 
red boxes, the optimized experimental parameters considered for the microparticle 
preparation are indicated. 
 
Alginate microparticles containing different amounts of UBM powders (Fig. 2 
A-C) were produced and the effect of the presence of the powder was 
determined on microparticle morphology. Fig. 3 A-C shows that using UBM 
powder at 2.5-7.5 mg/mL (in alginate suspension) did not cause any 
appreciable alteration of the microparticle geometry. In addition the 
microparticle surface remains smooth without any signs of particle protrusion 
from the microparticle body. 
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Fig. 2. Morphological characterization of UBM particles by stereomicroscopy: dark (A) and 
bright fields (B); by optical microscopy: bright field (C); and by fluorescence microscopy, 
after staining with fluorescein (D). The inset of panel C shows in detail the microfibrous 
structure typical of the UBM flakes. The bar corresponds to 50 lm for panels A–D and 10 m 
for the inset of panel C, respectively. 
 
Pre-pubertal Large-White piglets were used as SC animal donors. SC 
preparations were grown as monolayers (Fig. 3 D). After isolation, SC purity 
was assessed by immunostaining for MIS, as presented in Fig. 3 E. The 
presence of MIS has been detected in SCs of various mammals, including 
humans and immature mice. This cytoplasmic staining is essential to identify 
SC cells because, currently, there are no definitive function markers for this 
cell type [7]. In addition, viability of the final culture was excellent (>95%), as 
demonstrated by the fluorescence photomicrograph shown in Fig. 3 F. 
For UBM powder, we tested the effects of different amounts of cells (4–
12x106 cells ml-1) on microparticle morphology. Fig. 3 G–I shows that in the 
presence of cells the geometry and surface of the microparticles remained 
unaltered. 
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Fig. 3. Optical stereophotomicrographs of alginate microparticles containing UBM powder 
(A–C), prepared by a gas-driven monojet device. The microparticles contain 2.5, 5.0 and 7.5 
mg of UBM powder per ml of alginate. Optical photomicrographs of SC monolayers: (D) 
before encapsulation; (E) SCs after immunostaining with specific antibody for MIS; and (F) 
the viability of SCs after double staining with Calcein-AM and propidium bromide. (G–I) 
Optical stereophotomicrographs of alginate microparticles containing SCs at (G) 4.0, (H) 8.0 
and (I) 12.0x10
6
 cells ml
-
1. The bar corresponds to 180, 90, 10, 40 and 180 m in panels A–
C, D, E, F and G–I, respectively. 
 
Finally, alginate microparticles containing both UBM powder and SCs were 
prepared (Fig. 4 A) and characterized for size distribution (Fig. 4 B). The 
photomicrographs presented in Fig. 4 clearly indicated that the combined 
presence of UBM and SCs, at the tested concentrations, did not cause any 
morphological alterations of the microparticles, which presented with smooth 
and regular surfaces. Likewise, as indicated in Fig. 4, SCs were uniformly 
distributed throughout the entire microparticle volume. 
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Fig. 4. Optical micrographs of alginate microparticles containing UBM powder plus SC (A). 
The inset presents an image at higher magnification showing the detail of the smooth 
microparticle surface. (B) Cumulative size distribution analysis of optical micrographs of 
alginate microparticles containing UBM powder plus SCs. The bar corresponds to 220 m in 
A and 70 m in the inset, respectively. 
 
Nevertheless, in order to gather further information about the possible effects 
of UBM powder and SCs on microparticle production, a statistical experiment 
design was also planned. 
 
Effects of the operating conditions on microparticle characteristics: DoE 
approach 
Microparticle production was performed following the DoE approach (Chapter 
2.2.1.1). The parameters „„height”, „„gas” and „„pump” (Table 1) were chosen 
as variables and tested at three levels, resulting in 27 possible combinations, 
to give a full factorial design. In our case, we selected fewer experiments by 
a randomized CCF design, which requires fewer trials (namely, 14). We also 
added three centre points in order to get estimation figures of the 
experimental error. In Table 2 the complete list of experiments for the CCF 
study is reported. In this way, we obtained a response surface modelling. 
 
Stefania Mazzitelli Chapter 3 
 
 113 
Table 1. Production of barium alginate microparticles by mono gas-jet device: investigated 
experimental parameters and their range of variation. 
Parameter Abbreviation Meaning Range 
nozzle-to-gelling 
bath distance 
height 
the distance between the nozzle of the 
mono gas-jet device and the surface of 
aqueous barium chloride solution used to 
promote the ionotropic gelation of alginate  
32.0-44.0 mm 
atomizing gas gas 
the flow of atomizing gas causing the 
transformation of sodium alginate solution 
into microdroplets 
3.8-5.8 L/min 
feeding rate pump 
the pumping rate of alginate solution to the 
inlet of mono gas-jet device 
0.38-0.52 
mL/min 
 
The multiple linear regression (MLR) equation (Eq. 1) for the responses of 
the chosen model is reported below: 
 
yi = Constant + A1F + A2P + A3H + A4F2+ A5 P2 +A6H2+A7FP+A8FH+A9PH  
 
where constant is the mean of the seventeen runs and Ai the regression 
coefficients of the factors and their interactions. 
The three-dimensional graphs of the investigated factors are presented in 
Fig. 5, which shows the influence of factors on „„mean diameter” (panels A–
C) and „„SD” (panels D–F). 
By examining the results presented in Table 3 and Fig. 5, the main finding 
was that a change in the factor „„gas” from a low to a high level (from 3.5 to 
4.5 L/min) resulted in a strong decrease of response „„mean diameter”, which 
decreased from over 600 to around 450 m. In addition, the increase in „„gas” 
was beneficial for the response „„SD”, which was progressively lowered. 
The factor „„pump” was associated with only marginal influence on the 
response „„mean diameter”, which declined slightly with increasing pump 
values. In contrast, this factor plays an important role in the microparticle size 
distribution, its high and low levels causing a marked increase in the 
response „„SD”. 
Finally, the factor „„height” appeared to exert minor effects on both 
responses, showing an effect at its upper level, on the microparticle size. 
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Table 2. Experimental design matrix and results of the DoE (design of experiments) 
approach for of engineered alginate microparticles containing ECM powder. 
Run Factors Responses 
 
Air 
(L/min) 
Pump 
(mL/min) 
Height 
(cm) 
Mean Diameter 
( m) 
SD 
#1 3.5 0.45 3.2 606.0 43.8 
#2 4.5 0.45 3.2 459.0 17.2 
#3 3.5 0.55 3.2 606.0 48.6 
#4 4.5 0.55 3.2 455.0 23.7 
#5 3.5 0.45 4.0 650.0 22.8 
#6 4.5 0.45 4.0 454.0 18.5 
#7 3.5 0.55 4.0 638.0 23.2 
#8 4.5 0,55 4.0 442.0 36.2 
#9 3.5 0.50 3.6 644.0 22.3 
#10 4.5 0.50 3.6 438.0 23.3 
#11 4.0 0.45 3.6 552.0 33.7 
#12 4.0 0.55 3.6 488.0 39.8 
#13 4.0 0.50 3.2 524.0 21.8 
#14 4.0 0.50 4.0 538.0 36.3 
#15 4.0 0.50 3.6 547.0 26.7 
#16 4.0 0.50 3.6 551.0 33.8 
#17 4.0 0.50 3.6 553.0 32.8 
 
 
In order to assess the validity and the significance of the DoE model, an 
analysis of variance (ANOVA), was performed. This demonstrated that all the 
obtained experimental data fitted well the model, indicating its good 
reproducibility. In addition, in Table 3 are reported the results obtained for R2 
and Q2, which respectively represent the percentage variation of the 
response explained by the model and that predicted by the model. The high 
values of both coefficients indicate that the model has good validity (R2) and 
a significant power of prediction for new data (Q2). 
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Fig. 5. DoE analysis for alginate microparticles containing UBM powder. Surface plots of the 
responses „„mean diameter” (A–C) and „„standard deviation” (D–F) for the interactions 
between gas and pump (A, D), gas and height (B, E), and pump and height (C, F). Factors, 
levels and responses employed for the DoE analysis are presented in Table 2. 
 
 
Table 3. ANOVA analysis of variance of the model for DoE approach 
 N R
2 
R
2
Adj. Q
2 
Model validity Reproducibility 
Mean diameter 17 0.97 0.93 0.81 0.62 0.99 
SD 17 0.76 0.41 0.61 0.81 0.72 
N is the number of experiments; R
2
 is the percent of the variation of the response explained 
by the model; R
2 
Adj. is the fraction of the variation of the response explained by the model 
adjusted for the degree of freedom; Q
2
 is the percent of the variation of the response 
predicted by the model. 
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Effect of UBM powder on the viability of SCs entrapped in engineered, 
alginate-based microparticles 
 
The viability of SCs encapsulated in standard vs. engineered alginate 
microparticles containing UBM powder was investigated. 
The fluorescent photomicrographs recorded immediately after the 
encapsulation (presented in Fig. 6 A and D) indicated that the cells were 
highly viable (>95%) for both standard and engineered microparticles 
(containing UBM). As indicated also by the bar plot presented in Fig. 6 G, 
after 24 h of cell culture, the viability of SCs remain very high (>85%). 
Significant differences between the viability of SCs encapsulated in standard 
vs. engineered microparticles became evident at day 7 (Fig. 6 B and E) and 
even more so at day 14 (Fig. 6 C and F) of encapsulation, assumed as day 
0. The viability of SCs in standard vs. engineered microparticles is indeed 
significantly different being 65 vs. 79 and 45 vs. 65%, respectively, at days 7 
and 14 (p < 0.0001). 
These data clearly indicate that the viability of SCs encapsulated in 
engineered microparticles (containing UBM) increased. This effect was 
possibly due to the presence of individual UBM components in the same 
relative amounts existing in nature and in an ultrastructural milieu similar to 
that of native UBM. Likely, it is the diverse combination of both the structural 
and functional components present within UBM scaffolds that accounts for 
the success of UBM-based biomaterials. For instance, UBM has been shown 
to contain adhesion molecules such as fibronectin and laminin, the 
proteoglycan decorin and the glycoproteins biglycan and entactin [4]. 
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Fig. 6. Fluorescence micrographs of SCs encapsulated in alginate microparticles (A, B, C) 
and in alginate microparticles containing UBM powder (D, E, F) after a double-staining assay 
with Calcein-AM and propidium bromide, determined at days 0 (A, C), 7 (B, E) and 14 (C,F) 
of cell culture. The bar corresponds to 180 lm. The histogram plot of panel G reports the 
percentage of viable cells (by double staining) determined at days 0, 1, 7 and 14 of cell 
culture, for SCs encapsulated in alginate microparticles (open bars) and SCs encapsulated 
in alginate microparticles containing UBM powder (closed bars). Values are expressed as 
percentage of viable cells with respect to day 0 (rated to 100%), and represent the mean of 
five independent samples analysed in quadruplicate ±SD (*p < 0.0001). 
 
Effect of UBM powder on the functions of SC entrapped in engineered 
alginate microparticles.  
 
In order to investigate whether the presence of UBM components, in powder 
form, in alginate microparticles could influence the cell function of the 
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embedded SCs, expression levels of a number of selected genes were 
analysed by quantitative real-time PCR. The gene expression of SCs 
encapsulated into plain alginate microcapsules was compared to SCs 
encapsulated into engineered microparticles (containing UBM) (Fig. 7). 
To collect general evidence about the effect of UBM on SC function, different 
genes were studied, with special regard to those related to biomedical 
applications of SCs. Three different categories were considered, namely: (i) 
genes that support the maintenance of differentiated phenotype (MIS, IDO); 
(ii) genes related to cell growth and viability (TGF- 2, c-kit, clusterin, 
transferrin, SCF); and finally (iii) genes involved in the adhesion to 
extracellular matrix constituents (type IV collagen, laminin, laminin receptor, 
integrin 1, integrin 6). 
The expression levels of the above-listed genes was quantified by real-time 
RT-PCR on reverse-transcribed mRNA isolated from SCs that were 
embedded in standard and engineered microparticles after 7 and 14 days of 
in vitro cell culture. The obtained result levels were normalized to mRNA 
levels of the reference gene -actin. 
Genes that support the maintenance of differentiated cell phenotypes 
SC preparations were analysed for the expression of MIS. The presence of 
MIS has in fact been detected in SCs of various mammals, including 
humans. The obtained data indicated that MIS expression was not 
decreased by the presence of UBM (Fig. 7 A); this finding is particularly 
important since it clearly indicates that the embedding into alginate 
microparticles does not alter the typical SC phenotype and thus the 
differentiated status of cells. It should be remembered that MIS marker is 
currently the only marker used to identify SC cells because there are no 
other exclusive markers for this cell type [7]. 
To further characterize the effects of UBM on SC function, we analysed the 
expression of the IDO gene, since it represents a crucial enzyme. Recently, 
has been reported that isolated neonatal porcine SC, administered alone in 
highly biocompatible microcapsules, led to diabetes prevention (88% of 
cases) and reversion (81% of cases) in overtly diabetic NOD (nonobese 
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diabetic) mice, with no need for additional beta cells or insulin therapy. The 
effect was associated with the restoration of systemic immune tolerance and 
detection of functional pancreatic islets that consisted of glucose-responsive 
and insulin-secreting cells. The curative effects by SCs were strictly 
dependent on efficient tryptophan metabolism in the xenografts, which is 
regulated by IDO activity [8]. For this reason, the level of IDO, which is an 
immune regulatory enzyme, was carefully considered. 
Interestingly, IDO expression was remarkably up-regulated in SCs co-
entrapped with UBM powder, which displayed a 5.5-fold increase (at day 14, 
Fig. 7 A) in IDO mRNA with respect to control SCs (encapsulated in plain 
alginate). 
The positive effect of UBM on IDO suggests that SCs embedded in 
engineered alginate microparticles containing UBM could exert an increased 
ability to prevent/revert diabetes, at least in experimental animals. We plan 
extending the application of new SC-containing microparticles to other 
autoimmune disorders, e.g. experimental encephalomyelitis and cholitis, 
using rodent animal models. 
Genes related to cell growth and viability. In addition to IDO, SCs secrete a 
number of proteins that are involved in the ability of SCs to inducing acquired 
tolerance to transplantation with no interference from the host‟s systemic 
immune surveillance system. Therefore we extended the study of the UBM 
activity on SC gene expression to TGF- 2 and c-kit (Fig. 7 B), clusterin and 
transferrin (Fig. 7 C) and SCF (Fig. 7 D). All are involved in the physiological 
proliferation and differentiation of germ cells [9,10] and influence the 
functional activity of SCs upon their transplantation. In particular, TGF- 2 
was shown to modulate mesenchymal–epithelial interactions between 
peritubular cells and SCs [11]. The comparative mRNA expression levels for 
the above-reported secretion proteins was only marginally affected by the 
presence of UBM except for c-kit, which was slightly increased at both 7 and 
14 days within engineered microparticles containing SCs. 
Genes involved in the adhesion to extracellular matrix constituents. SCs are 
also known to produce ECM macromolecules. In vitro studies have 
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demonstrated that SCs synthesize laminin and type IV collagen, but not 
fibronectin [12]. In vivo, while the 1- and 3- laminin isoforms [13] and type IV 
collagen are immunolocalized in the basement membrane underlying the 
seminiferous tubular epithelium, upon direct contact with SCs, fibronectin is 
localized in the connective tissue external to the peritubular cells, and ap- 
pears to be secreted by this cell type in a polarized manner. Stem cell factor 
receptor (c-kit or CD117) is secreted by fibroblasts, always localized in the 
connective tissue. Like many other ECM adhesion molecules, laminin binds 
to cell surface receptors of the integrin superfamily. There are an increasing 
number of laminin receptors, including the 1 subunit, that may be 
associated with 1, 2, 3, 6 or a7 and the 4 subunits, associated with 
either 5 or 6. Integrin receptors not only serve as structural receptors 
connecting the extracellular matrix to the cytoskeleton in order to attach the 
cell to their substrate, but also function as signalling receptors that lead to 
changes at the second messenger molecule level. Thus, the ability of ECM to 
influence growth, differentiation and other cell functions is likely related to its 
effects on signalling pathways inside the cells [14]. 
Interestingly, mRNA expression levels for type IV collagen (Fig. 7 D), laminin 
and laminin receptor (Fig. 7 E), and integrins 6 and 1 (Fig. 7 F) were 
remarkably increased in SCs encapsulated in UBM, suggesting a role of the 
adhesion molecules present in the ECM powder form. 
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Fig. 7. Effect of UBM powder on mRNA expression levels of SCs entrapped in engineered 
alginate microparticles, as determined by real-time PCR. (A) MIS (open bar); IDO (closed 
bar); (B) TGF- 2 (open bar); c-kit proto-oncogene (closed bar); (C) clasterin (open bar); 
transferrin (closed bar); (D) SCR (open bar), type IV collagen (closed bar); (E) laminin (open 
bar), laminin receptor (closed bar); (F) integrin 6 (open bar), integrin 1 (closed bar). Data 
represent the mean of three determinations performed on three independent samples ±SD. 
The reported values were obtained by normalization, on the basis of the housekeeping gene 
( -actin). The relative gene expression levels were normalized to a calibrator that was 
chosen to be the control samples (SCs encapsulated in alginate microbeads without UBM 
powder). 
 
3.1.3. Discussion 
 
This work confirms that the production of alginate microparticles, with highly 
controlled morphological and dimensional properties, by a gas-driven 
monojet device-based-procedure, is an important procedure for the 
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preparation of novel hybrid microparticles intended for cell encapsulation and 
tissue engineering applications. 
In particular, we have demonstrated that the combined use of alginate and 
urinary bladder matrix resulted in a synergistic activity of both materials. 
While the engineered microparticles offer the mechanical and material 
properties of alginates, which can be varied through „„on-demand” gelling 
procedures, UBM provides an array of bioactive functions that seem to 
improve the viability and function of the co-entrapped SCs. 
UBM is constituted by an epithelial basement membrane on one surface and 
the connective tissue of the underlying tunica propria on the opposite surface 
[15]. This bimodal microstructure provides an ideal environment for the 
attachment and growth of cells. Moreover, UBM contains a variety of 
bioactive molecules, including cytokines and growth factors that act as potent 
modulators of cell behaviour. The list of growth factors is large, and includes 
vascular endothelial growth factor (VEGF), basic fibroblast growth factor 
( FGF), epidermal growth factor (EGF), transforming growth factor beta 
(TGF- ), keratinocyte growth factor (KGF), hepatocyte growth factor (HGF) 
and platelet-derived growth factor (PDGF) [16]. 
In conclusion, the engineered microparticle concept presented here could be 
used to improve both the encapsulated cell survival and function of cells 
micro- and macro-encapsulated in devices fabricated for tissue engineering 
and cell transplantation purposes. 
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3.2. Fibrous multifunctional scaffolds 
 
Scaffolds in a fibrous form could be an appealing alternative to spherical 
microparticles, representing an example of scaffold with controlled physical 
and architectural features for tissue engineering applications. This statement 
derives from the fact that they can enable the guided growth, alignment and 
migration of cells and they could find many potential applications as small 
vascular grafts [17], nerve conduits [18], artificial kidney tubules [19] as well 
as drug release vehicles [20]. 
Many technologies have been developed to create fibres with well-defined 
physical and architectural features including melt spinning [21] wet spinning 
[22] electrospinning [23] and microfluidics [24]. The latest technology 
developments have already shown the feasibility to produce monodispersed 
spheres [25] microcapsules (chapter 2) and colloidal crystals [26].  
Microfluidics, due to the small channel dimensions typical of microchips and 
the efficient mixing, allows a precise control of the dimensional and 
morphological characteristics of the produced microfibers, providing new 
routes for in situ fabrication of micro/nanofibres. However, only a few reports 
are found in the literature describing the use of microfluidic devices for the 
production of polymeric microfibres. For instance, a recent report presented a 
method to produce poly(lactic-co-glycolic acid) (PLGA) microfibers within a 
microfluidic chip for the generation of 3D tissue engineering scaffolds [27]. 
Changing the flow rate of PLGA solution and of the sheath flow, it was 
possible to obtain microfibres with diameters ranging from 20 to 230 m. 
Using a similar flow configuration (i.e., a coaxial flow channel) a novel 
cylindrical channel microdevice that generated coaxial flow without using a 
glass microcapillary or complicated silicon processing was recently 
developed by Kang and colleagues for the fabrication of microfibres [28]. 
Microfibres were fabricated without clogging the downstream channel, and 
the dimensions of the fibres were successfully controlled by regulating the 
flow rate through the channels. The generation of alginate microfibers with a 
roller-assisted microfluidic system was also reported [29]. This work used a 
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convenient microfluidic strategy with a simple and minimal-requirement 
design for the generation of uniformly sized alginate gel fibres that were 
collected with a rotor. In addition, Shin and colleagues reported the use of a 
poly (dimethylsiloxane) (PDMS) microfluidic device embedded capillary glass 
pipette as an apparatus for fibre generation [30]. Sodium alginate (sample 
flow) and CaCl2 (sheath solution) were used, and the final fibre diameter was 
varied by changing both flow rates. 
In addition, new technique for the control of inner and outer diameters of 
calcium-alginate hydrogel hollow microﬁbres, was also reported, using a 
coaxial triple cylinder. Aqueous solutions of dextran (core solution), sodium 
alginate (sample solution) and CaCl2 (sheath solution) were extruded 
simultaneously from the inner, intermediate and outer cylinders, respectively 
[31]. 
While the control of dimensional characteristics are crucial for the possible 
implantation of such tissue engineering scaffolds, there are other important 
aspects to address for the final in vivo applications of fibrous, scaffolds, as 
cellular adhesion, proliferation and tissue formation are greatly influenced by 
the scaffolds‟ physical properties such as surface roughness, porosity, 
flexibility and three-dimensional geometries. As already discussed already for 
mircrocapsular scaffolds (Chapter 1 and Chapter 2) the surface roughness of 
the tissue engineering device can affect the scaffold in vivo effectiveness, 
since irregularities of biomaterial surface can promote cell adhesion of 
immune host cells, causing the so called cellular overgrowth and the 
decrease of diffusion rate.  
The dimensional homogeneity of microfibres is also an important issue since 
the device thickness is crucial in controlling the rate of exchange of nutrient 
and bio-regulatory product (such as hormones and growth factor) in and out 
the tissue engineering device. Despite the important role played by 
morphological characteristic of the fibres on their in vivo applicability, the 
dimensional homogeneity and the surface smoothness of the produced 
scaffold are not evident from the previous mentioned papers. In order to 
address this issue, a simple but milder microfluidic production strategy, that 
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does not imply the use of either sheath flow or rotating roller, was applied for 
the generation of alginate based microfibres with different diameters and 
characterized by an uniform size and a smooth surface. Moreover in order to 
increase the encapsulated cell viability and to reduce of the foreign body 
response, engineered microfibres were considered.  
Recent findings demonstrated that co-encapsulation of cells and drug 
delivery systems (DDS) offered a rational alternative to reduce the foreign 
body response to the encapsulating scaffold, favour retention of the cell 
viability, functional competence and therefore enhances the effectiveness of 
the tissue engineering construct [32]. Based on the promising results showed 
by this strategy, we used a microfluidic dispersing platform for the 
simultaneous immobilization, within the hydrogel matrix, of living cells 
together with other particulate DDS. 
For the construction of microfluidic devices, glass was preferred to polymers 
such as PDMS and PMMA, since it offers good optical properties and the 
possibility to easily sterilize the devices, by autoclaving. Owing to its high 
biocompatibility and biodegradability we chose alginate as polymer for the 
production of scaffolds. Considering the different applications of biomaterial 
based-scaffolds in terms of implant site and animal size, it is important to 
have the possibility to finely regulate the size and mechanical properties of 
the device. 
In this respect, aims of the present work were the production of alginate 
microfibres and the investigation of the effect of microfluidic chip geometry 
and experimental parameters, including polymer concentration and 
composition, on the morphological and functional characteristics of 
engineered microfibres for cell transplantation. Using microfluidic technique 
the production of engineered microfibres containing cells and drug delivery 
systems was performed while the fibre diameters and content (amount of cell 
and DDS) were controlled on demand.  
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3.2.1. Materials and methods 
 
Production of glass microfluidic chips 
A photolithography-wet etching procedure was used for the fabrication of 
glass microchips (Fig. 8 A) [33]. Briefly, the channel network was designed 
using AutoCAD software, and a film negative of the desired size was 
prepared by a commercial photo mask producer (J.D. Photo Tools, UK) to 
form the optical mask. Crown white glass (B-270) photolithographic plates 
(thickness of 1.5 mm) coated with a thin chromium metal mask layer plus an 
upper layer of positive photoresist (AZ1500), supplied by Telic (Telic, USA), 
were used for channel network fabrication. With UV exposure, the pattern of 
interconnecting channels was transferred from the optical mask to the 
photoresist layer which was then developed and removed, together with the 
chromium layer, to reveal the channel areas of glass to be etched. Once the 
pattern had been transferred, the glass plate was baked in oven overnight 
(~17 h) at 80°C to dry and harden the mask on glass. The channels were 
then etched using 1% hydrofluoric acid (Sigma-Aldrich, USA) buffered with 
5% ammonium fluoride (Sigma-Aldrich, USA) solution at 65°C, under 
ultrasonic agitation (Ultrasonic Cleaner, VWR, UK). Before the bonding step 
the cross section profile of the etched microchannel was measured by a 
surface profiler (P-16+ stylus profiler, KLA Tencor, U.S.A.). Finally, the 
etched glass was thermally bonded (595 °C for 3 h) with a top plate of the 
same material into which outlet and inlet holes had been previously drilled to 
link the channels. TEFLON tubes (Upchurch Scientific, Oak Harbor, WA) with 
an inner diameter of 0.75 mm connected the microchip to a syringe. Teflon 
tube with different internal diameter vary from 210 to 700 μm were connected 
with the outlet. Fluidic reagents were introduced to the microfluidic network 
from glass gastight syringes (Hamilton, Reno, NV) by syringe pumps (model 
KD100, KD scientific Inc., Holliston, MA). 
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Fig. 8 Schematic representation of the fabrication procedure for glass microfluidic chips. 
Chip fabrication strategy and two microchip designs, Chips #1 and #2.  
 
Production of drug delivery systems (DDS) 
The materials used for the preparation of DDS included cellulose acetate 
(CA) CA-398/10-NF from EASTMAN (Tennessee USA), acrylic resin 
Eudragit® RS 100 (Eudragit RS) from Rohm Pharma GmbH (Germany), lipid 
mixture (glyceryl tristearate/glyceryl monostearate) from Fluka (Buchs, 
Switzerland) and Corn oil from Gattefossé (SaintPriest Cedex, France). For 
the preparation of coloured microparticles, oil red O and Sudan black from 
Fluka (Buchs, Switzerland) were used as dyes. CA microspheres (CAM) and 
Eudragit RS microspheres (ERSM), lipospheres (LS) and corn oil based-
emulsion (COBE) were prepared following the experimental procedures 
described in the supplementary information. CAM were prepared by solvent 
evaporation technique [34], ERSM by an in-liquid drying process from an oil-
in-oil system [35], LS by melt dispersion technique and COBE by a 
microfluidic flow focusing technique [36,37]. Drug release experiments were 
performed as previously described [38]. Briefly, 20-25 mg of DDS were 
poured into a dialysis tube (molecular weight cut-off 10,000-12,000), then 
placed into 100 mL of isotonic borate buffer. Afterwards, samples were 
withdrawn at regular time intervals from the receiving buffer. The amount of 
release drug was determined by reverse-phase HPLC. Two cell types, 
namely Wharton‟s Jelly Mesenchymal Stem Cells (WJMSCs, isolated as 
Stefania Mazzitelli Chapter 3 
 
 128 
described in Chapter 2.3.1) and human myeloid leukemia K562, were used 
for the production of multifunctional alginate microfibre encapsulation.  
Production of alginate microfibers 
The polymer used was sodium alginate IE-1105 (viscosity, 20.0–40.0 cP; pH, 
6.0–8.0, C = 1%, H2O) (Inotech Biosystem International, Switzerland). For 
the gelation of polymer, barium chloride dehydrate (Sigma Aldrich, Germany) 
was employed. “Empty” and “multifunctional” (containing cells, DDS or both) 
barium alginate microfibres were produced with Chip #1 and Chip #2 (Fig. 1), 
respectively. Using Chip #1, a sodium alginate solution (1.5-2.5%, w/v), used 
as main constituent of the microfibres, was introduced into the inlet of the 
microchip at appropriate flow rates (see Table 4). 
 
Table 4 Production of alginate microfibres by microfluidic chip technology: investigated 
experimental parameters and their range of variation. 
Parameter Abbreviation Meaning Range 
outlet internal 
diameter 
Outlet 
The internal diameter of the outlet tube 
used to deliver the alginate solution into 
the gelling ionotropic bath 
210-700 
 
alginate concentration Alg 
The concentration of sodium alginate 
solution employed for the encapsulation 
procedure 
1.5-2.5 
%, w/v 
BaCl2 
concentration 
barium 
The concentration of the barium 
chloride solution employed for the 
microfibre gelation 
0.5-3.0 
%, w/v 
pumping 
rate 
pump 
The pumping rate of alginate solution to 
the inlet of the microfluidic chip 
15-35 
 
 
Using Chip #2, a sodium alginate solution and two sodium alginate 
suspensions were delivered via the three inlets. The two suspensions 
contained different amounts (10-40 mg/mL) of either CAM, ERSM, LS, COBE 
or cell suspensions (2-9 x 106 cells/mL). The output from the outlet of the two 
chips was transferred via a Teflon microtube (with different diameters, see 
Table 4) into a BaCl2 solution (0.5-3.0%, w/v) where the Na alginate flow 
stream was gelled to produce the final Ba-alginate consolidated microfibres. 
The produced microfibres were then examined by an optical 
stereomicroscope (Nikon SMZ 1500, Japan) with imaging analysis software 
(Eclipsenet version 1.16.5, Laboratory Imaging s.r.o. for Nikon 
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B.V.) to determine their dimensions. The mean diameter of microfibres (± 
SD) was obtained by taking 9 measurements along the (10 mm) length of the 
samples at equal interval. Each microfibre was measured in triplicate. For the 
determination of the gel strength, microfibres were prepared using Chip #1 
equipped with a Teflon microtube (700 μm) and different BaCl2 gelling 
solutions (0.5-3.0%, w/v). The strength of the microfibres was studied by 
measuring the mechanical resistances of hydrogels under compression with 
an Instron 1193 (Instron, Norwood, MA) mechanical testing machine. Freshly 
prepared microfibres were placed below the probe, which travelled toward 
the lower plane with a constant speed set as 0.5 mm/s. During probe 
displacement, the resistance of the samples to the compression was 
recorded at 50% compression and 75% compression. Ten microfibre 
samples of each batch were measured separately at room temperature. 
Experimental design and statistical analysis were evaluated by design of 
experiment (DoE) approach (Chapter 2), studying the effect of the 
experimental parameters alginate (alg) and BaCl2 (barium) concentrations, 
and pumping flow rate (pump), on the dimension and morphology of the 
microfibers. The Cell viability was assessed using a double staining method 
with propidium iodide (PI) and Calcein-AM26 before and after encapsulation 
in alginate microfibers (Chapter 2). 
 
3.2.2. Results  
 
Production of alginate microfibres based on an intuitive COST approach 
It is understood that there are a number of operational parameters which 
affect the production of multifunctional alginate microfibres and their 
characteristics. The optimization of the operational conditions was achieved 
by either a classical intuitive approach “COST” (Changing One Separate 
factor a Time), or a “design of the experiments” (DoE) method. Initial 
experiments were carried out using Chip #1 (Fig. 8 A) with the general 
preparation procedure reported in Fig. 9 to evaluate the robustness of both 
preparation strategy and device selected for the generation of microfibres of 
Stefania Mazzitelli Chapter 3 
 
 130 
desired lengths (> 100 cm), with a controlled and homogeneous morphology 
(i.e. thickness). 
An initial standard-line experiment, using mid-range variable values for a 
combination of safe physiological conditions and process control, was used 
to establish the reproducibility of the device and experimental conditions.  
Microfibres obtained under different conditions (see Fig. 9) possessed a 
uniform shape (i.e. constant diameter through the entire microfibre length) 
and a highly smooth surface. 
 
Fig. 9. Microfluidic set-up for producing multifunctional alginate microfibers and micrograph 
of the produced microfibers. Scale bar: 200 µm. 
 
With respect to the microfibre surface characteristics (i.e. smoothness), as 
already mentioned, the surface properties of any implantable biomaterial 
have been recognized as key factors for its in vivo applicability and 
biocompatibility. The properties of a material surface, including the chemical 
composition, roughness and functional groups, play a significant role in 
determining the differential cell responses to the implants, including the host 
response and the inflammatory cell adhesion and infiltration.  
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Fig. 10. Optical stereo photomicrographs of alginate microfibres, showing the effect of the 
experimental setup (following a COST approach) on microfibre dimension and morphology. 
Microfibres were produced by the single inlet linear microchip (#1). The investigated factors 
were: the diameter of the outlet tube (A-C) and the polymer concentration (D-E). The 
complete experimental conditions are reported in Table 5. Bar corresponds to 400 µm. 
 
Native inflammatory responses often dominate the effects of biomaterials 
that are intended to guide tissue repair. These responses are characterized 
by invasion of macrophages, which initiate a host defence program involving 
production of oxygen radicals and matrix-degrading enzymes. 
Therefore, to preserve scaffold functionality over weeks or months, it is of 
paramount importance to minimize the immune response activity over the 
tissue environment surrounding the implanted device.  
Using different outlet tube dimensions (I.D. ranging from 210 to 700 μm), the 
corresponding diameter of the produced microfibre, spanned from 180 to 500 
μm (Fig. 10 A-C), demonstrating the capability of this system for microfibre 
size control. It was found that by varying the diameter of the outlet tube, 
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thinner or thicker microfibres could also be easily produced (data not shown). 
Microfibres were designed for cell encapsulation, where the size of cells or 
cell clusters (i.e. pancreatic islets) usually exceeds one hundred microns, the 
microfibres with greater diameters (>200 μm) were desired. If the fibre 
diameters were too small, the number of partially protruding cell/cells cluster 
could proportionally increase, which could also increase the probability of 
inflammatory response after in vivo transplantation. When changing alginate 
concentrations (Fig. 10 G-I), the microfibre dimension varied 
correspondingly, spanning from 368 to 398 μm, though the effect was not as 
significant as that on mechanical proprieties. 
Finally, different BaCl2 concentrations were also considered for the initial 
experiments designed by intuitive COST approach. 
This choice was made since the structural and mechanical properties of 
ionically cross-linked alginate hydrogels largely depend on the ionic strength 
of the gelation medium or the ion source. When selecting a hydrogel network 
for a given application (e.g. tissue engineering), it is necessary to tune its 
properties such as gel strength, handling, surface smoothness and cell 
viability, through the formulation parameters. For these reasons, different 
BaCl2 concentrations were considered, ranging from 0.5 to 3.0% (w/v). 
The results are displayed in Fig. 11. As it can be seen from the plot and 
microphotographs (Fig. 11 A), the diameter of the obtained microfibres 
decreased significantly and progressively from 500 μm to 350 μm, when 
BaCl2 concentrations increased. BaCl2 influenced also significantly the 
mechanical properties of the microfibres Fig. 11 B shows the mechanical 
resistance of alginate microfibres determined at 50% and 75% compression. 
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Fig. 11. Effect of barium chloride (expressed as percentage, w/v of BaCl2, in the gelling bath) 
on the dimension (diameter) (A) and on the mechanical resistance (B) of alginate 
microfibres; 50% compression (open circles), 75% compression (closed circles). Ten 
microfibre samples of each batch were measured separately. Data represent the mean ± 
SD. Microfibres were produced using Chip #1 with an alginate concentration of 2 % (w/v). 
The insets of panel A report the optical stereo photomicrographs of microfibres obtained 
using 1.0 (a), 1.5 (a) and 2.0 %, w/v BaCl2 (c). Bar corresponds to 370 µm. 
 
Table 5 summarises the effect of a number of selected experimental 
parameters, including outlet internal diameter, alginate and barium chloride 
concentrations, and pumping flow rate of alginate solution on the final 
microfibre mean diameter. The experiments were performed using the 
intuitive COST approach. 
 
Table 5 Production of alginate based microfibres by Chip #1: experimental parameters used 
for the COST approach. 
Run 
Outlet diameter 
 
Alginate 
concentration 
(%, w/v) 
BaCl2 
concentration 
(%, w/v) 
Mean diameter 
 
A 212 2.0 1.5 180 (12) 
B 400 2.0 1.5 398 (12) 
C 700 2.0 1.5 510 (35) 
D 400 1.5 1.5 368 (22) 
E 400 2.5 1.5 386 (19) 
F 400 2.0 1.0 408 (24) 
G 400 2.0 2.0 366 (14) 
 
It is generally understood that concentrations of alginate and barium 
solutions are closely related to the cross linking extent and thus the porosity 
and mechanical strength of microfibres produced. These effects were 
examined by varying the concentration of alginate in the 
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range of 1.5-2.5% (w/v) and barium chloride between 1.0% and 2.0% (w/v). 
When the concentrations of alginate and barium chloride solutions were 
selected below 1.5 and 1.0 %, respectively, the resulting microfibres 
exhibited an insufficient mechanical strength when handling with standard 
procedures (e.g. by tweezers). On the other hand, when the alginate was 
employed at concentrations above 3%, the solution became very viscous 
causing difficulties to flow through the microchip channels. It was also 
observed that using a gelling bath containing barium chloride at 
concentrations above 2.5% caused severe viability impairment to the 
eventually present cells. 
 
Applications of DoE approach 
The DoE analysis was employed for the optimization of microfibre production 
based on results of COST approach. 
Three experimental parameters were selected as key factors, namely, “alg” 
(i.e., alginate concentration), “barium” (i.e., BaCl2 concentration) and “pump” 
(i.e., flow rate) which were tested at three levels (Table 6) resulting in 27 
possible combinations in a full factorial design. By using a randomized 
central composite face-centred design (CCF), we selected 14 experiments 
with two center points in order to have an estimation of the experimental 
error. 
The results of these experiments are reported in Fig. 11 as three-dimensional 
graphs showing the responses of both microfibre diameter and relative 
standard deviation to the three key factors. The surface plots show the 
inverse relationship between microfibre diameters and both BaCl2 
concentrations and pumping rate. Conversely, the diameter of the produced 
microfibre increased when the alginate concentration was increased. 
However, the diameter reaches its maximum for an alginate concentration of 
2.2 % (w/v). A further increase in alginate concentration caused the diameter 
of the microfibre to decrease. The results provided clear guidelines for 
selecting appropriate experimental conditions in order to obtain microfibres 
with desired dimensions and mechanical and biological properties. 
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Table 6. Production of alginate based microfibres by Chip #1: experimental design matrix 
and results of the DoE (design of experiments) approach
a
. 
Run Factors Responses 
 
Alg 
(%, w/v) 
BaCl2 
(%, w/v) 
Pump 
(mL/min) 
Mean Diameter 
( m) 
SD 
#1 1.5 1.0 15 372 30 
#2 2.5 1.0 15 368 9 
#3 1.5 2.0 15 350 25 
#4 2.5 2.0 15 359 15 
#5 1.5 1.0 35 399 11 
#6 2.5 1.0 35 372 32 
#7 1.5 2.0 35 368 16 
#8 2.5 2.0 35 367 20 
#9 1.5 1.5 25 368 22 
#10 2.5 1.5 25 386 19 
#11 2.0 1.0 25 409 16 
#12 2.0 2.0 25 363 12 
#13 2.0 1.5 15 379 18 
#14 2.0 1.5 35 402 13 
#15 2.0 1.5 25 398 12 
#16 2.0 1.5 25 396 13 
#17 2.0 1.5 25 400 15 
a
 For all the reported experiments a 400 mm I.D. outlet tube was used. 
 
After investigating the factors and their interactions on the responses, the 
validity and the significance of the model was estimated by analysis of 
variance (ANOVA) (data not shown). 
All the data obtained fitted well with the model, suggesting a good 
reproducibility of the studied model. We got a large regression coefficient R2 
that resulted in a necessary condition for a validity model with a significant 
power of prediction Q2 . 
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Fig. 11. DoE analysis of the alginate microfibre production. Surface plots of the responses 
“diameter (A-C)” and “SD” (D-F) for the interactions between “alg” and “BaCl2” (A, D); “pump” 
and “alg” (B, E); “pump” and “BaCl2” (C, F). Factors, levels and responses employed for the 
DoE analysis are reported in Table 6. 
 
Production of multifunctional alginate microfibres by single channel chip 
In the first set of experiments, Chip #1 was used to produce microfibres, 
containing different DDS or cells. The DDS included into the alginate 
microfibres were produced and characterized in our laboratory, namely: 
CAM, ERSM, LS and COBE. The experimental procedures for the 
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preparation of the different DDS were reported in figures 12-15. In addition, 
different cell types were also embedded into the microfibres, they include the 
human myeloid leukemia K562 (representing a stable cell line growing in 
suspension) and the Wharton‟s Jelly Mesenchymal Stem Cells (WJMSC) 
(representing a primary cell population isolated from the umbilical cord). Fig. 
16 shows the optical photomicrographs of some examples of the produced 
alginate microfibres containing ERMS (A-C) or WJMSCs (D-E). In order to 
quantitatively evaluate the influence of the presence of DDS or cells, 
multifunctional microfibres were produced including variable amounts of 
dispersed phase. It is important to underline that, when using the single inlet 
chip, the homogeneous dispersion of the particulate phase (DDS or cells) 
within the alginate solution was accomplished by vortexing, prior to the 
injection into the microfluidic device. This procedure was crucial to obtain an 
even dispersion of particles into the final microfibre hydrogel matrix. 
 
Fig. 12. Schematic representation of the solvent evaporation technique used for cellulose 
acetate microspheres (CAM) production. Optical stereo photomicrograph (B) and SEM 
image (C) of the produced CAM. Scale bars correspond to 100 (B) and 40 (C) μm. 
Typically, 1 to 2 g of polymer (cellulose acetate (CA) CA-398/10-NF from EASTMAN, 
Tennessee USA) were dissolved in 5 mL of CH2Cl2. The organic solution was emulsified with 
an aqueous phase containing hydrolysed poly(vinyl alcohol) (PVA) (Airvol 205, Air Products 
Corp., PA, USA) as stabilizer. The obtained emulsion was maintained under continuous 
stirring with a four-blade turbine impeller at 350 rpm. At different time intervals, samples 
were observed microscopically throughout complete evaporation of CH2Cl2, usually 
occurring in 3–5 h. Once the consolidation of CAM was complete, microspheres were 
isolated by filtration and extensively washed. 
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Different final ratios (w/v), between DDS and alginate, were tested, namely: 
10 (Fig. 16 A), 20 (Fig. 16 B) or 40 mg mL-1 (Fig. 16 C). Whilst, cells were 
added to the alginate at the ratios of 2 (Fig. 16 D) 6 (Fig. 16 E) or 9x106 cells 
per mL (Fig. 16 F). 
In all cases, the inclusion of the DDS, in form of either rigid polymeric 
microspheres (CAM and ERSM), soft lipospheres (LS) or liquid droplets 
(COBE) had no significant effect on the morphology, including surface 
characteristics, and homogeneity of microfibres.  
 
 
Fig. 13. Schematic representation of the “in-liquid drying process from an oil-in-oil system” 
technique used for Eudragit RS microspheres (ERSM) production. Optical stereo 
photomicrograph (B) and SEM image (C) of the produced ERSM. Scale bars correspond to 
150 (B) and 40 (C) μm. Typically, 500 mg of polymer (acrylic resin Eudragit® RS 100) were 
dissolved in 15 ml of CH2Cl2. The solution was then poured into 100 ml of light mineral oil: 
d=0.84 g/ml (Sigma Chemical Co., St. Louis, Missouri, USA) containing 0.5% (w/v) soybean 
lecithin as emulsifier. The mixture was stirred at 350 r.p.m. by a four blade turbine impeller. 
The system was then heated at 35°C, in order to evaporate CH2Cl2. After 5 hours, the 
microspheres were isolated by filtration, and extensively washed with n-hexane to remove 
residues of mineral oil. 
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Fig. 14. Schematic representation of the melt dispersion techniques used for liposphere (LS) 
production. Optical stereo photomicrograph (B) and SEM image (C) of the produced LS. 
Scale bars correspond to 100 (B) and 20 (C) m. A lipid mixture constituted of glyceryl 
tristearate/glyceryl monostearate from Fluka (Buchs, Switzerland) was melted at 70–75°C 
and then emulsified into 15 mL of an external aqueous phase containing 2% (w/v) of PVA as 
the dispersing agent. The emulsion was stirred at 8000 rpm using an IKA T25 Ultra-turrax 
(IKA Labortechnik, Germany) for 2 min. Once the agitation was stopped, the milky emulsion 
was rapidly cooled to about 10°C by immersing in a cool water bath. The obtained LS were 
isolated by centrifugation (10 min at 5200×g) and the pellet was washed three times with 
water and finally dried under vacuum. For the preparation of coloured LS, the dye oil red O 
from Aldrich (Germany), was used. 
 
 
Fig. 15. Schematic representation of the microfluidic flow focusing technique used for the 
production of corn oil based-emulsion (COBE). Photographs of microfluidic chip (B) and of 
produced COBE (C). Scale bar corresponds to 250 m. The used microfluidic chip was 
constituted of polydimethylsiloxane (PDMS) and contains channels with a square section of 
200×200 µm. Both dispersed and continuous phases were injected into the microfluidic chip 
by a syringe pump (KDS Model 100 Series, Kd Scientific). The microchip was 
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connected to syringes through fluorinated ethylene propylene FEP tubes. Corn oil 
(Gattefossé, SaintPriest Cedex, France) was used as oil internal phase and slowly injected 
into the central inlet of the flow focusing geometry. The second immiscible liquid (water) was 
injected into the two lateral inlets as continuous phase. Corn oil was forced into the water 
phase at the junction of the focusing channel, forming a multiphasic flow (droplets) 
represented by a o/w emulsion. For the preparation of coloured COBE, the dye oil red O 
from Aldrich (Germany), was used. 
 
Moreover, microfibres maintained a highly uniform diameter distribution 
throughout the entire fibre length; finally the results indicated that the 
presence of either DDS (Fig. 16 A–C) or cells (Fig. 16 D–F) did not affect the 
ionic gelation molecular mechanism accounting for microfibre formation. 
These results suggest that various DDS can be easily loaded during the 
alginate microfibres fabrication and that the resulting engineered fibres can 
be utilized for the delivery of drugs. In addition, DDS can be included into the 
microfibres to produce multifunctional scaffolds in order to enhance and/or 
prolong the viability, function and/or differentiation of the embedded cells. To 
this aim, different drug classes can be usefully selected, such as: 
differentiating and/or antioxidant vitamins, steroidal hormones and 
nonsteroidal anti-inflammatory drugs (NSAIDs). 
 
Fig. 16. Optical stereo photomicrographs of typical alginate microfibres, produced by Chip 
#1, containing DDS (A–C) or cells (D–F). The fibres contained different amounts of: ERSM 
(A–C) or WJMSC cells (D–F). The dispersed phases were added to the alginate solution 
giving final ratios of 10 (A) 20 (B) or 40 mg mL
-
1 (C) for ERSM or 2 (D) 6 (E) or 9x10
6
 cells 
per mL (F) in the case of cells. Bar corresponds to 200 m. 
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As an example, Fig. 17 shows the drug release profiles from vitamin D3 from 
CAM (Fig. 17 A), vitamin C from ERSM, progesterone from LS and 
flurbiprofen from COBE (Fig. 17 B). Notably, no significant differences were 
found when the release profiles of tested drugs were comparatively 
measured from DDS embedded in microfibres of different diameters (Fig. 
18). This result was attributed by the fact that alginate gel is constituted 
mainly by water (98% by weight) and the pores of the polymer network, 
forming the hydrophilic gel, are comparatively very large with respect to the 
drug molecular volume. In this respect, it is noteworthy to remember that the 
molecular weight cut-off of barium alginate gels is above 80 kDa, well 
exceeding all the molecular weights of all the tested drugs. 
 
Fig.17. Drug release profiles from different DDS. A: release of vitamin D3 from CAM, B: 
release of vitamin C from ERSM (filled squares), progesterone from LS (open circles) and 
flurbiprofen from COBE (filled circles). Data represent the average of four independent 
experiments±SD. 
 
Fig. 18. Flurbiprofen release from COBE embedded into alginate microfibres with a mean 
diameter of 180 (green symbols), 398 (black symbols) and 510 μm (red symbols). Data 
represent the average of four independent experiments ± SD. 
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Production of multifunctional alginate microfibres by multiple inlet chip 
As the next step, we aimed to produce microfibres containing desired 
amounts of DDS/cells in an „„on-demand‟‟ adjustable manner. The first 
microfluidic device considered was constituted of two inlets and a straight 
channel (as shown in Fig. 19). Unfortunately, as clearly appreciable from the 
optical stereo photomicrographs of the produced microfibres (see Fig. 19 B 
and C), the use of such chips resulted in an undesirable uneven distribution 
of the particulate phase along the fibre minor axis. The particulate phase 
segregated along one side of the microfiber corresponding to the inlet 
position (relatively to the main chip channel), from which it was injected. This 
result was assigned to the fact that the dispersion of particulate matter, in 
laminar fluid flow conditions, typical of microfluidic devices, is only scarcely 
affected by passive molecular diffusion.  
 
Fig. 19. Schematic representation of the microfluidic device with two inlets and a single 
straight channel used for the production of multifunctional alginate microfibres containing 
DDS or cells. The inset shows the mechanism of segregation of the particulate matter within 
the chip channel. Optical stereo photomicrographs showing alginate microfibres containing 
CAM (B) or K562 cells (C). Microfibres were produced by two independent syringe pumps, 
one pumping alginate solution (Pump #1), the other pumping alginate solution containing 
microparticles (80 mg/mL) or cells (18 x 10
6
 mg/mL) (Pump #2). Microfibres were prepared 
with a Pump #1/Pump #2 rate ratio of 50/200 µl/min. Bar corresponds to 400 µm. 
 
The use of particulate elements (DDS, cells or both) that are characterized 
by low diffusion coefficients, together with the high viscosity of the carrier 
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flow (alginate solution), resulted in a poor dispersion of the particulate phase 
(segregation), within the microfibre structure. Therefore, in order to possibly 
overcome this issue, a microchip design that produces transverse transport 
inside the microfluidic device was considered, for an effective dispersion of 
the particulate phase. 
The design of Chip #2 provided for three dispersing chambers, each of them 
containing cylindrical-type pillar obstructions. Pillars were regularly alternated 
along the dispersing chamber axes; each row of obstacles is laterally offset 
with respect to the previous row above it. Pillars have a diameter of 750 mm; 
the centre-to-centre spacing between pillars and the relative shift between 
adjacent pillar rows are equal to 900 and 450 mm, respectively (see Fig. 20). 
In addition, Chip #2 has three inlets that allow varying „„on demand‟‟ the 
content of the dispersed phase within the microfibre, by adjusting the flow 
rates of independent pumps, delivering either plain alginate or alginate 
containing particulate matter, through three independent feeding channels. 
Specifically, using the microfluidic set-up shown in Fig. 9, different alginate 
solution/suspensions were pumped into the chip through three separate 
inlets, namely: (a) plain alginate through inlet 1 (I1), (b) alginate containing 
DDS through inlet 2 (I2) and (c) alginate containing living cells through Inlet 3 
(I3). 
After flow through the array of micropillars present in the dispersing 
chambers, the alginate suspension was driven, through a variable size outlet, 
into a gelling bath, constituted of a barium chloride solution. The Ba2+ ions 
rapidly diffuse into the alginate suspensions causing the almost 
instantaneous ionic crosslinking, forming the typical egg box structure. 
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Fig. 20. Schematic representation of the microfluidic Chip #2. Inset reports the characteristic 
dimensions of the particulate dispersing chamber with pillar obstructions. 
 
Fig. 21 shows the photomicrographs of microfibres produced with Chip #2, at 
selected pump #1/pump #2 flow rate ratios: 50/ 50 (Fig. 21 A and D), 50/100 
(Fig. 21 B and E), and 50/200 mL min-1 (Fig. 21 C and F). The microfibres 
produced with Chip #2 confirmed the good morphological properties in terms 
of shape, dimension and surface characteristics. These features remained 
stable under all conditions tested. It is important to note that comparing the 
microfibres produced by Chip #1 (Fig. 16) and Chip #2 (Fig. 21), there was 
no evident difference in DDS/cells distribution within the microfibre matrix. 
For instance, the microfibres always presented a homogeneous dispersion of 
the DDS and cells. This result indicates that the dispersion strategy 
implemented in Chip #2 was capable to produce a dispersion extent 
comparable with the „„off-chip‟‟ vortexing, employed as the preliminary 
dispersion step, for the production of microfibres by Chip #1. This feature 
was further confirmed by the observation that, although the particulate 
elements were introduced as a suspension, via one of the lateral inlets, the 
DDS/cells were distributed evenly across the microfibres (Fig. 21). Moreover, 
photomicrographs reported in Fig. 22 illustrate alginate microfibres 
simultaneously containing K562 cells and CAM (Fig. 22 A), ERSM (Fig. 22 B) 
or LS (Fig. 22 C). 
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Fig. 21. Dark field (A–C) and bright field (D–E) optical stereo photomicrographs of alginate 
microfibres, containing different amounts of ERSM (A–C) and K562 cells (D–F). Microfibres 
were produced by the triple inlet pillar Chip #2 and two independent syringe pumps, one 
pumping alginate solution (Pump #1), the other pumping alginate containing microparticles 
(80 mg mL
-
1) or cells (18x10
6
 mg mL1) (Pump #2). Microfibres were prepared at different 
pumping rates, Pump #1/ Pump #2: 50/50 (A and D), 50/100 (B and E) or 50/200 mL min
-
1 
(C and F). Bar corresponds to 200 m. 
 
The cylindrical-type pillar obstruction geometry of Chip #2 resulted in a 
marked improvement of the dispersion, by the size- dependent hydrodynamic 
behaviour of the suspended particles in the constructed microgeometry. 
Particles were observed to attain different y-positions within the dispersing 
chamber feeding channels (with y being the direction perpendicular to the 
main flow direction), depending on the spatial location of the injection site, 
injection flow rate and particle size. It should be noted that particulate matter 
suspensions in alginate were characterized by a relatively wide range of 
dimensions, with DDS and cells having a diameter ranging between 20–130 
and 10–20 m, respectively. 
However, given the low-Reynolds regime, the radial position at the injection 
site was maintained along the channel. Lift- generated radial migration of 
particle/cells within confined microdomains was indeed observed only at Re 
> 1.32. Given the specific design of Chip #2, where pillars were considerably 
shifted at subsequent rows and the fluid flow was divided into two main 
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streams by the first obstacle, the radial position and size of the suspended 
particulate played a significant contribution to the flow behaviour of DDS and 
cells. In this regard, particles entering the dispersing chamber within 
peripheral flow streams were observed to be confined in the near-wall region, 
while particles having a central y-position at the chamber inlet interacted with 
the first pillar and were observed to partition according to the flow 
distribution, similarly to what shown for particles flowing at branching 
microchannels. In addition, both particle size and inter-particle interactions 
were observed to alter the particle spatial distribution, improving the 
dispersion outcome. 
With respect to their dimensions, particles had two different flow behaviours. 
Those above the critical diameter were moved by hydrodynamic lateral drag 
(i.e. bumped) into adjacent streamlines at subsequent rows of micropillars. 
Larger particles moved through different flow streams and their y-position, at 
the dispersing chamber outlet, differed from the corresponding position at the 
dispersing chamber inlet. 
 
Fig. 22. Optical stereo photomicrographs of multifunctional alginate microfibres, containing 
K562 cells and different DDS. Microfibres were produced by the Chip #2 and three 
independent syringe pumps. Pump #1: alginate solution; pump #2: alginate containing K562 
(18x10
6
mg mL
-
1) and pump #3: alginate containing different DDS (80 mg mL
-
1), namely: 
CAM (A), ERSM (B) and LS (C). Microfibres were prepared at pumping rates pump 
#1/pump/#2/pump #3: 50/50/50 mL min
-
1 (D). Bar corresponds to 400 m. 
 
In contrast, small particles were observed to behave in a „„zigzag mode‟‟, 
maintaining a y-position at the chamber outlet similar to their location at the 
chamber inlet. These variabilities in particle flow behaviour contributed to 
enhance the dispersion of the injected suspension. 
 
Effect of embedding into alginate microfibres on cell viability 
Immortalized cell lines have been largely used as model cells for 
bioencapsulation and biomaterial seeding. In this respect, the effect of 
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embedding into alginate microfibres on the cell viability was firstly evaluated 
on human myeloid leukemia K562. The performed experiment demonstrated 
that K562 cells can be efficiently encapsulated in alginate microfibres with no 
significant changes in the cell viability, when analysed after 10 days of in vitro 
cell culture, thereby facilitating consideration of these encapsulated cells for 
in vitro studies (see the viability kinetics reported in Fig.23). 
Nevertheless, primary cell culture offers a more relevant system for the study 
of cell function, disease states and patient therapy. This aspect is particularly 
important for tissue engineering and cell transplantation applications, though 
working with primary cells in culture presents numerous challenges such as 
including the requirement for unique cell supplements and growth conditions.  
 
Fig. 23. Graph reporting the percentage of viable K562 cells determined by double staining, 
after different length of time of in vitro cell culture. Values are expressed as percentages of 
viable cells respect to total entrapped cells and represent the mean of three independent 
samples analysed in quadruplicate ± SD. In the inset is reported a fluorescence 
microphotograph of multifunctional alginate microfibres containing K562 cells. Microfibres 
were produced by Chip #2. Fluorescence photomicrograph was taken after double staining 
with Calcein-AM and propidium iodide, after 4 days of cell culture. Bar corresponds to 200 
µm. 
 
In spite of these possible drawbacks, in this study, the microfibre preparation 
protocol developed was evaluated with human primary mesenchymal stem 
cells that represent a much more challenging and informative model. We 
prepared microfibres containing WJMSC and the cells embedded in 
microfibres were double-stained (following different times of in vitro cell 
growth) with calcein-AM (a marker of living cells; fluorescent signal was 
monitored using 485 nm excitation wavelength and 530 nm emission 
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wavelength) and with PI (a marker of cell death; excitation, 535 nm; 
emission, >610 nm). 
The fluorescence photomicrograph recorded immediately after the microfibre 
preparation (time 0, Fig. 24 A) shows that the cells maintained a very high 
viability (>95%), indicating that the presented preparation strategy is highly 
biological compatible and suitable for the encapsulation of primary cells. After 
3 and 7 days of cell culture (Fig. 24 B and 24 C), the viability of WJMSC 
remained high (85% and 62%, respectively). It was observed that the viability 
decreased below 50% after 12 days (Fig. 24 D) from the preparation. The 
entire viability kinetics, reported in Fig. 24 E, is comparable to most primary 
cell types when seeded/embedded in biomaterials scaffolds. 
 
Fig. 24. Optical bright field and fluorescence microphotographs of multifunctional alginate 
microfibres, containing WJMSCs, produced by Chip #2. Fluorescence photomicrographs 
were taken after double staining with calcein-AM and propidium iodide, at day 0 (A), 3 (B), 7 
(C) and 12 (D) of cell culture. Bar corresponds to 250 m. (E): graph reporting the 
percentage of viable WJMSCs determined, by double staining, after different lengths of time 
of in vitro cell culture. Values are expressed as percentages of viable cells with respect to 
total entrapped cells and represent the mean of three independent samples analysed in 
quadruplicate SD. 
Stefania Mazzitelli Chapter 3 
 
 149 
3.2.3. Discussion 
 
A simple, cost-effective, well-controlled and biological compatible process 
has been developed for the production of uniform alginate microfibres, with 
controlled size and content, possibly capable of scaling up, working towards 
FDA approval. The effect of different experimental parameters such as the 
total flow rate, sodium alginate and barium ion concentrations were 
investigated and their effects on the morphological and dimensional 
characteristics of the produced microfibres were statistically evaluated. 
We demonstrated that the fibre diameter is controllable with the highly 
uniform diameter distribution along the entire fibre length. The key 
advantages of the microfluidic fibre generation system are the versatility of 
size, little limitation in fibre length and possible incorporation of DDS and 
living cells. The process has been indeed used to produce multifunctional 
microfibres based on a wide range of DDS, especially designed to control the 
release of the entrapped molecules. 
In conclusion, it is worth highlighting that a fibre shaped carrier offers an 
important advantage over spherical shaped carriers since fibre can be easily 
located and removed from patients when either adverse effects are observed 
or after the cessation of function. 
Moreover, the proposed DDS co-encapsulation may pose a significant 
impact on the way that cells respond to the external signals, thus providing 
potentials to better understand and regulate cell differentiation, more co-
ordinately and in a precisely defined 3D configuration. 
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CHAPTER 4 
 
4.1. Conclusions 
Hydrogel encapsulation of mammalian cells is finding increasing applications 
in biomedical applications (i.e. cell therapy and tissue engineering). The 
protection of transplanted cells from the surrounding host environment is 
indeed crucial to the potential in vivo use of cell-based scaffolds for 
controlled delivery of therapeutics to specific physiological sites.  
The key to the success of this technology is the development of 
microcapsules with number of fundamental characteristics including: the 
manufacturing process, material biocompatibility, mechanical properties and 
adequate permeability for the controlled transport of biological molecules 
trough the hydrogels. 
 
The production of microcapsular scaffolds typically starts with the generation 
of a controlled-size droplet, followed by a gelation process resulting in solid 
microcapsule structure. Firstly, new encapsulation devices and procedures 
were designed and tested, along side with the optimization of a commercially 
available encapsulator for large scale productions. Specifically, the novel 
technique, based a coaxial bead generator with unique and peculiar features 
named “gas driven mono-jet device”, demonstrated its great applicability and 
flexibility for alginate microbead preparation 
 
Aside these traditional technologies, innovative techniques based on the use 
of microfluidic platforms have been developed in order to obtain hydrogel 
based microparticles with highly controlled morphological and dimensional 
properties. Noteworthy, the obtained results demonstrated that all the 
encapsulation procedures, optimized by a statistical approach, do not 
interfere with cell performances, whereas in some cases an improvement of 
specific cell functionalities was observed (i.e. the osteogenic differentation of 
encapsulated WJMSCs). 
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Despite the great potential of immunoisolating microcapsules as cell-delivery 
vehicles, for their in vivo application several challenges still exist, including 
the problem of reaching an optimum balance between the mechanical 
strength of the device and the long-term viability as well as the lacking of cell 
adhesion and homing exhibited by many hydrogels. 
Given these cons, new approaches to modify the conventional alginate 
hydrogel were developed resulting in hybrid hydrogel able to the control the 
cell fate in a more effective way. The hybrid hydrogels were processed in 
form of engineered microparticles or multifunctional microfibres.  
Since the survival of certain cells requires attachment to the ECM (i.e. Sertoli 
cells) a powered form of ECM was included in the alginate forming 
engineered microcapsules, to improve cell viability and functions.  
With respect to microfibres, a simple and cost-effective microfluidic platform 
was used to produce multifunctional microfibres based on a wide range of 
drug delivery systems, especially designed to the controlled release of the 
entrapped therapeutics. The aforementioned approach, referred as 
“multifunctional”, was successfully used to release differentiating and/or 
antioxidant vitamins, steroidal hormones and non steroidal anti-inflammatory 
drugs in order to prevent acute inﬂammation or to ameliorate the 
performances of the entrapped cells. 
 
Further studies are obviously necessary to progress towards routine clinical 
applications, including a detailed analysis, at molecular level, of the complex 
events occurring after the in vivo cell transplantations and an accurate 
evaluation of the processes underlying the interactions of the scaffold and 
host immune systems. 
 
Taken together, the presented results represent a strong starting point for the 
effective application of hybrid immunoisolation systems towards the 
development of embedding techniques meeting GMP regulations, finally 
resulting in the gain of medical approval and bridging the bench to bedside. 
